脳神経病態学

694  件  
※ 登録方法の違いにより重複して表示されている場合があります。
  1. Matsubayashi T, Yokoyama K, Tateishi U, Yokota T, Sanjo N: Specifically Decreased Thalamic Blood Flow Following COVID-19 Infection. Clinical nuclear medicine. 2024.11; 49 (11): 1041-1043. ( PubMed , DOI )

  2. Kawai, H; Nishida, Y; Ishiguro, T; Akaza, M; Miyazaki, S; Yokota, T: Severe respiratory failure secondary to unilateral phrenic nerve injury: A case report NEUROLOGY AND CLINICAL NEUROSCIENCE. 2024.11; 12 (6): 379-382. ( DOI )

  3. Yokote H, Miyazaki Y, Fujimori J, Nishida Y, Toru S, Niino M, Nakashima I, Miura Y, Yokota T: Slowly expanding lesions are associated with disease activity and gray matter loss in relapse-onset multiple sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2024.10; ( PubMed , DOI )

  4. Masahiro Ohara, Tetsuya Nagata, Rintaro Iwata Hara, Kie Yoshida-Tanaka, Nozomi Toide, Kazunori Takagi, Kazuki Sato, Tomoya Takenaka, Masanori Nakakariya, Kenichi Miyata, Yusuke Maeda, Kazuko Toh, Takeshi Wada, Takanori Yokota: DNA/RNA heteroduplex technology with cationic oligopeptide reduces class-related adverse effects of nucleic acid drugs. Mol Ther Nucleic Acids. 2024.09; 35 (3): 102289. ( PubMed , DOI )

  5. Takahashi S, Ono D, Shintaku H, Oyama J, Nishida Y, Ishikawa K, Yokota T: Cryptogenic New-onset Refractory Status Epilepticus with Hyperintensity of T1-weighted Magnetic Resonance Imaging in the Bilateral Basal Ganglia: An Autopsy Report. Internal medicine (Tokyo, Japan). 2024.09; ( PubMed , DOI )

  6. Hasegawa J, Nagata T, Ihara K, Tanihata J, Ebihara S, Yoshida-Tanaka K, Yanagidaira M, Ohara M, Sasaki A, Nakayama M, Yamamoto S, Ishii T, Iwata-Hara R, Naito M, Miyata K, Sakaue F, Yokota T: Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model. Nature communications. 2024.09; 15 (1): 7530. ( PubMed , DOI )

  7. Kuwabara S, Kusunoki S, Kuwahara M, Yamano Y, Nishida Y, Ishida H, Kasuya T, Kupperman E, Lin Q, Frick G, Misawa S: Efficacy and safety of eculizumab in Guillain-Barré syndrome: A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial. Journal of the peripheral nervous system : JPNS. 2024.09; 29 (3): 339-349. ( PubMed , DOI )

  8. Chikada Ayaka, Orimo Kenta, Mitsui Jun, Matsukawa Takashi, Ishiura Hiroyuki, Toda Tatsushi, Mizusawa Hidehiro, Takahashi Yuji, Katsuno Masahisa, Hara Kazuhiro, Onodera Osamu, Ishihara Tomohiko, Tada Masayoshi, Kuwabara Satoshi, Sugiyama Atsuhiko, Yamanaka Yoshitaka, Takahashi Ryosuke, Sawamoto Nobukatsu, Sakato Yusuke, Ishimoto Tomoyuki, Hanajima Ritsuko, Watanabe Yasuhiro, Takigawa Hiroshi, Adachi Tadashi, Abe Koji, Yamashita Toru, Takashima Hiroshi, Higashi Keiko, Kira Junichi, Yabe Ichiro, Matsushima Masaaki, Ogata Katsuhisa, Ishikawa Kinya, Nishida Yoichiro, Ishiguro Taro, Ozaki Kokoro, Nagata Tetsuya, Tsuji Shoji: The Japan MSA registry: A multicenter cohort study of multiple system atrophy(タイトル和訳中) Neurology and Clinical Neuroscience. 2024.09; 12 (5): 271-277. ( 医中誌 )

  9. Hidetaka Torigoe , Sumire Nakayama , Tomomi Shiraishi , Kazuki Sato , Rintaro Iwata Hara , Takeshi Wada: Development of cationic oligodiaminogalactoses specifically binding to duplex RNA, but not to duplex DNA Thermochimica Acta. 2024.08; 738 179789. ( DOI )

  10. Takahashi Sunao, Sanjo Nobuo, Koike Ryuji, Yokota Takanori: Eculizumab administration for myasthenia gravis also stabilizes thrombogenicity of catastrophic antiphospholipid syndrome Clinical and Experimental Neuroimmunology. 2024.08; 15 (3): 143-145. ( 医中誌 )

  11. Sakurai K, Tokumaru AM, Yoshida M, Saito Y, Wakabayashi K, Komori T, Hasegawa M, Ikeuchi T, Hayashi Y, Shimohata T, Murayama S, Iwasaki Y, Uchihara T, Sakai M, Yabe I, Tanikawa S, Takigawa H, Adachi T, Hanajima R, Fujimura H, Hayashi K, Sugaya K, Hasegawa K, Sano T, Takao M, Yokota O, Miki T, Kobayashi M, Arai N, Ohkubo T, Yokota T, Mori K, Ito M, Ishida C, Idezuka J, Toyoshima Y, Kanazawa M, Aoki M, Hasegawa T, Watanabe H, Hashizume A, Niwa H, Yasui K, Ito K, Washimi Y, Kubota A, Toda T, Nakashima K, Aiba I, J-VAC study group: Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study. Neuroradiology. 2024.07; ( PubMed , DOI )

  12. Yokote H, Miyazaki Y, Fujimori J, Nishida Y, Toru S, Niino M, Nakashima I, Miura Y, Yokota T: Characterization of Japanese multiple sclerosis patients with progression independent of relapse activity: A 2-year multicenter cohort study. Journal of neuroimmunology. 2024.07; 394 578407. ( PubMed , DOI )

  13. Ohara M, Hirata K, Matsubayashi T, Chen Q, Shimano K, Hanazawa R, Hirakawa A, Yokota T, Hattori T: Circular walking is useful for assessing the risk of falls in early progressive supranuclear palsy. Journal of neurology. 2024.07; ( PubMed , DOI )

  14. Matsubayashi T, Yoshioka K, Lei Mon SS, Katsuyama M, Jia C, Yamaguchi T, Hara RI, Nagata T, Nakagawa O, Obika S, Yokota T: Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4'-BNA/LNA with 9-(aminoethoxy)phenoxazine. Molecular therapy. Nucleic acids. 2024.06; 35 (2): 102161. ( PubMed , DOI )

  15. Ohara, M; Hattori, T; Chen, QM; Shimano, K; Hirata, K; Matsui, M; Yokota, T: Is there a spinal tap responder in progressive supranuclear palsy? The first prospective study JOURNAL OF NEUROLOGY. 2024.05; ( PubMed , DOI )

  16. Hirata K, Matsuoka K, Tagai K, Endo H, Tatebe H, Ono M, Kokubo N, Kataoka Y, Oyama A, Shinotoh H, Takahata K, Obata T, Dehghani M, Near J, Kawamura K, Zhang MR, Shimada H, Shimizu H, Kakita A, Yokota T, Tokuda T, Higuchi M, Takado Y: In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy. Annals of neurology. 2024.05; ( PubMed , DOI )

  17. Sano T, Nagata T, Ebihara S, Yoshida-Tanaka K, Nakamura A, Sasaki A, Shimozawa A, Mochizuki H, Uchihara T, Hasegawa M, Yokota T: Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice. Acta neuropathologica communications. 2024.05; 12 (1): 75. ( PubMed , DOI )

  18. Joachim F. R. Van Guyse, Saed Abbasi,Kazuko Toh, Zlata Nagorna, Junjie Li, Anjaneyulu Dirisala, Sabina Quader, Satoshi Uchida, Kazunori Kataoka: Facile generation of heterotelechelic poly(2-oxazoline)s towards accelerated exploration of poly(2-oxazoline)-based nanomedicine Angewandte Chemie International Edition. 2024.04; ( DOI )

  19. Ono D, Kawai H, Kuwahara H, Yokota T: Automated whole slide morphometry of sural nerve biopsy using machine learning. Neuropathology and applied neurobiology. 2024.04; 50 (2): e12967. ( PubMed , DOI )

  20. Hiroyuki Maruoka, Takaaki Hattori, Takeshi Hase, Kunihiko Takahashi, Masahiro Ohara, Satoshi Orimo, Takanori Yokota: Aberrant morphometric networks in Alzheimer's disease have hemispheric asymmetry and age dependence. Eur J Neurosci. 2024.03; 59 (6): 1332-1347. ( PubMed , DOI )

  21. Amano E, Sato W, Kimura Y, Kimura A, Lin Y, Okamoto T, Sato N, Yokota T, Yamamura T: CD11c(high) B Cell Expansion Is Associated With Severity and Brain Atrophy in Neuromyelitis Optica. Neurology(R) neuroimmunology & neuroinflammation. 2024.03; 11 (2): e200206. ( PubMed , DOI )

  22. Miki Suzuki, Yuki Mochida, Mao Hori, Akimasa Hayashi, Kazuko Toh, Theofilus A. Tockary, Xueying Liu, Victor Marx, Hidetomo Yokoo, Kanjiro Miyata, Makoto Oba, and Satoshi Uchida: Poly(ethylene Glycol) (PEG)–OligoRNA Hybridization to mRNA Enables Fine-Tuned Polyplex PEGylation for Spleen-Targeted mRNA Delivery Small Science. 2024.02; ( DOI )

  23. Yum J, Aulia F, Kamiya K, Hori M, Qiao N, Kim BS, Naito M, Ogura S, Nagata T, Yokota T, Uchida S, Obika S, Kim HJ, Miyata K: Hydrophobicity Tuning of Cationic Polyaspartamide Derivatives for Enhanced Antisense Oligonucleotide Delivery. Bioconjugate chemistry. 2024.01; 35 (2): 125-131. ( PubMed , DOI )

  24. Sanjo Nobuo, Suzuki Motohiro, Yoshihama Rei, Toyoshima Yasuko, Mizuta Ikuko, Fujita Nobuya, Usuda Hiroyuki, Uchiyama Yumiko, Yasuda Rei, Yoshida Tomokatsu, Yamada Masahito, Yokota Takanori: GFAP遺伝子コドン332におけるGluのLysへの置換は単独で成人発症アレキサンダー病の原因となる(Substitution of Glu to Lys at Codon 332 on the GFAP Gene Alone Is Causative for Adult-onset Alexander Disease) Internal Medicine. 2024.01; 63 (2): 309-313. ( 医中誌 )

  25. Nishina K, Yoshioka K, Yokota T, Hara RI: Comparison of interaction between antimiR and microRNA versus HDO-antimiR and microRNA by molecular dynamics simulation. Nucleosides, nucleotides & nucleic acids. 2024.01; 1-16. ( PubMed , DOI )

  26. Sanjo N, Suzuki M, Yoshihama R, Toyoshima Y, Mizuta I, Fujita N, Usuda H, Uchiyama Y, Yasuda R, Yoshida T, Yamada M, Yokota T: Substitution of Glu to Lys at Codon 332 on the GFAP Gene Alone Is Causative for Adult-onset Alexander Disease. Internal medicine (Tokyo, Japan). 2024.01; 63 (2): 309-313. ( PubMed , DOI )

  27. Okamoto T, Ishizuka T, Shimizu R, Asahina Y, Nakamura H, Shimizu Y, Nishida Y, Yokota T, Lin Y, Sato W, Yamamura T: Efficacy and Safety of the Natural Killer T Cell-Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial. JMIR research protocols. 2024.01; 13 e46709. ( PubMed , DOI )

  28. Rayle Mamuti, Sato Nozomu, Ozaki Kokoro, Higashi Miwa, Okita Michi, Yajima Reiko, Amano Akiko, Mizusawa Hidehiro, Yokota Takanori, Ishikawa Kinya: Analysis of the polymorphic SCA37 locus in a cohort of 167 Japanese patients with degenerative ataxia Journal of Medical and Dental Sciences. 2024; 71 11-17. ( 医中誌 )

  29. Masahiro Ohara, Tetsuya Nagata, Rintaro Iwata Hara, Kie Yoshida-Tanaka, Nozomi Toide, Kazunori Takagi, Kazuki Sato, Tomoya Takenaka, Masanori Nakakariya, Kenichi Miyata, Yusuke Maeda, Kazuko Toh, Takeshi Wada, Takanori Yokota: DNA/RNA heteroduplex technology with cationic oligopeptide reduces class-related adverse effects of nucleic acid drugs Molecular Therapy: Nucleic Acid. 2024; ( DOI )

  1. Kawai H, Matsubayashi T, Yokota T, Sanjo N: Serial changes in regional cerebral blood flow in Gerstmann-Sträussler-Scheinker disease caused by a Pro-to-Leu mutation at codon 105 in the prion protein gene. Prion. 2023.12; 17 (1): 138-140. ( PubMed , DOI )

  2. Hirata K, Matsuoka K, Tagai K, Endo H, Tatebe H, Ono M, Kokubo N, Oyama A, Shinotoh H, Takahata K, Obata T, Dehghani M, Near J, Kawamura K, Zhang MR, Shimada H, Yokota T, Tokuda T, Higuchi M, Takado Y: Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's Disease. Annals of neurology. 2023.09; ( PubMed , DOI )

  3. Noda K, Hattori Y, Hori M, Nakaoku Y, Tanaka A, Yoshimoto T, Nishimura K, Yokota T, Harada-Shiba M, Ihara M: Amplified Risk of Intracranial Artery Stenosis/Occlusion Associated With RNF213 p.R4810K in Familial Hypercholesterolemia. JACC. Asia. 2023.08; 3 (4): 625-633. ( PubMed , DOI )

  4. Iida S, Kanouchi T, Hattori T, Kanai K, Nakazato T, Hattori N, Yokota T: Verification of propagation hypothesis in patients with sporadic hand onset amyotrophic lateral sclerosis. Acta neurologica Belgica. 2023.08; 123 (4): 1511-1517. ( PubMed , DOI )

  5. Yuhei Takahashi, Kiyoshi Kakuta, Yukichi Namioka, Ayumi Igarashi, Taiichi Sakamoto, Rintaro Iwata Hara, Kazuki Sato, Takeshi Wada: Synthesis of P-Modified DNA from Boranophosphate DNA as a Precursor via Acyl Phosphite Intermediates The Journal of Organic Chemistry. 2023.07; 88 (15): 10617-10631. ( DOI )

  6. Motoki Miura, Fumika Sakaue, Hirokazu Matsuno, Kento Morita, Akiko Yoshida, Rintaro Iwata Hara, Ren Nishimura, Yurika Nishida, Mariko Yokogawa, Masanori Osawa, Takanori Yokota: TDP‐43 N‐terminal domain dimerisation or spatial separation by RNA binding decreases its propensity to aggregate FEBS Letters. 2023.06; 597 (12): 1667-1676. ( DOI )

  7. Mitsui J, Matsukawa T, Uemura Y, Kawahara T, Chikada A, Porto KJL, Naruse H, Tanaka M, Ishiura H, Toda T, Kuzuyama H, Hirano M, Wada I, Ga T, Moritoyo T, Takahashi Y, Mizusawa H, Ishikawa K, Yokota T, Kuwabara S, Sawamoto N, Takahashi R, Abe K, Ishihara T, Onodera O, Matsuse D, Yamasaki R, Kira JI, Katsuno M, Hanajima R, Ogata K, Takashima H, Matsushima M, Yabe I, Sasaki H, Tsuji S: High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial. EClinicalMedicine. 2023.05; 59 101920. ( PubMed , DOI )

  8. Kazuki Sato, Kazumasa Muramoto, Tomoya Hagio, Rintaro I. Hara, Takeshi Wada: Solid-Phase Synthesis of Glycosyl Phosphate Repeating Units via Glycosyl Boranophosphates as Stable Intermediates Organic Letters. 2023.05; 25 (21): 3927-3931. ( DOI )

  9. Nakamura R, Tohnai G, Nakatochi M, Atsuta N, Watanabe H, Ito D, Katsuno M, Hirakawa A, Izumi Y, Morita M, Hirayama T, Kano O, Kanai K, Hattori N, Taniguchi A, Suzuki N, Aoki M, Iwata I, Yabe I, Shibuya K, Kuwabara S, Oda M, Hashimoto R, Aiba I, Ishihara T, Onodera O, Yamashita T, Abe K, Mizoguchi K, Shimizu T, Ikeda Y, Yokota T, Hasegawa K, Tanaka F, Nakashima K, Kaji R, Niwa JI, Doyu M, Terao C, Ikegawa S, Fujimori K, Nakamura S, Ozawa F, Morimoto S, Onodera K, Ito T, Okada Y, Okano H, Sobue G, Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS) study group: Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients. Journal of neurology, neurosurgery, and psychiatry. 2023.05; 94 (10): 816-824. ( PubMed , DOI )

  10. Yanagidaira M, Yoshioka K, Nagata T, Nakao S, Miyata K, Yokota T: Effects of combinations of gapmer antisense oligonucleotides on the target reduction. Molecular biology reports. 2023.04; 50 (4): 3539-3546. ( PubMed , DOI )

  11. Li F, Ichinose K, Ishibashi S, Yamamoto S, Iwasawa E, Suzuki M, Yoshida-Tanaka K, Yoshioka K, Nagata T, Hirabayashi H, Mogushi K, Yokota T: Preferential delivery of lipid-ligand conjugated DNA/RNA heteroduplex oligonucleotide to ischemic brain in hyperacute stage. Molecular therapy : the journal of the American Society of Gene Therapy. 2023.04; 31 (4): 1106-1122. ( PubMed , DOI )

  12. Honda T, Matsumura K, Hashimoto Y, Yokota T, Mizusawa H, Nagao S, Ishikawa K: Temporal Relationship between Impairment of Cerebellar Motor Learning and Deterioration of Ataxia in Patients with Cerebellar Degeneration. Cerebellum (London, England). 2023.04; 23 (4): 1280-1292. ( PubMed , DOI )

  13. Jia C, Lei Mon SS, Yang Y, Katsuyama M, Yoshida-Tanaka K, Nagata T, Yoshioka K, Yokota T: Change of intracellular calcium level causes acute neurotoxicity by antisense oligonucleotides via CSF route. Molecular therapy. Nucleic acids. 2023.03; 31 182-196. ( PubMed , DOI )

  14. Ohara M, Hirata K, Hallett M, Matsubayashi T, Chen Q, Kina S, Shimano K, Hirakawa A, Yokota T, Hattori T: Long-term levodopa ameliorates sequence effect in simple, but not complex walking in early Parkinson's disease patients. Parkinsonism & related disorders. 2023.03; 108 105322. ( PubMed , DOI )

  15. Miyashita A, Kobayashi M, Yokota T, Zochodne DW: Diabetic Polyneuropathy: New Strategies to Target Sensory Neurons in Dorsal Root Ganglia. International journal of molecular sciences. 2023.03; 24 (6): ( PubMed , DOI )

  16. Tomomi Shiraishi, Kazuki Sato, Rintaro Iwata Hara, Takeshi Wada: Properties of artificial cationic oligodiaminosaccharides and oligopeptides that bind to A-type oligonucleotide duplexes Nucleosides, Nucleotides & Nucleic Acids. 2023.02; 619-636. ( DOI )

  17. Hattori T, Ohara M, Yuasa T, Azuma R, Chen Q, Hanazawa R, Hirakawa A, Orimo S, Yokota T: Correlation of callosal angle at the splenium with gait and cognition in normal pressure hydrocephalus. Journal of neurosurgery. 2023.01; 139 (2): 1-11. ( PubMed , DOI )

  18. Amano A, Sanjo N, Araki W, Anraku Y, Nakakido M, Matsubara E, Tomiyama T, Nagata T, Tsumoto K, Kataoka K, Yokota T: Peripheral administration of nanomicelle-encapsulated anti-Aβ oligomer fragment antibody reduces various toxic Aβ species in the brain. Journal of nanobiotechnology. 2023.01; 21 (1): 36. ( PubMed , DOI )

  19. Takaaki Koide, Shintaro Mandai*, Reo Kitaoka, Hisazumi Matsuki, Motoko Chiga, Kouhei Yamamoto, Kotaro Yoshioka, Yohsuke Yagi, Soichiro Suzuki, Tamami Fujiki, Fumiaki Ando, Takayasu Mori, Koichiro Susa, Soichiro Iimori, Shotaro Naito, Eisei Sohara, Tatemitsu Rai, Takanori Yokota, Shinichi Uchida: Circulating Extracellular Vesicle-Propagated microRNA Signature as a Vascular Calcification Factor in Chronic Kidney Disease. Circ Res. 2023.01; ( PubMed , DOI )

  20. Aiba I, Hayashi Y, Shimohata T, Yoshida M, Saito Y, Wakabayashi K, Komori T, Hasegawa M, Ikeuchi T, Tokumaru AM, Sakurai K, Murayama S, Hasegawa K, Uchihara T, Toyoshima Y, Saito Y, Yabe I, Tanikawa S, Sugaya K, Hayashi K, Sano T, Takao M, Sakai M, Fujimura H, Takigawa H, Adachi T, Hanajima R, Yokota O, Miki T, Iwasaki Y, Kobayashi M, Arai N, Ohkubo T, Yokota T, Mori K, Ito M, Ishida C, Tanaka M, Idezuka J, Kanazawa M, Aoki K, Aoki M, Hasegawa T, Watanabe H, Hashizume A, Niwa H, Yasui K, Ito K, Washimi Y, Mukai E, Kubota A, Toda T, Nakashima K, J-VAC study group: Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome. Brain communications. 2023; 5 (6): fcad296. ( PubMed , DOI )

  1. Taiki Matsubayashi, Nobuo Sanjo: Systematic Review of Clinical and Pathophysiological Features of Genetic Creutzfeldt–Jakob Disease Caused by a Val-to-Ile Mutation at Codon 180 in the Prion Protein Gene International Journal of Molecular Science. 2022.12; 23 15172.

  2. Matsuda Hiroshi, Okita Kyoji, Motoi Yumiko, Mizuno Toshiki, Ikeda Manabu, Sanjo Nobuo, Murakami Koji, Kambe Taiki, Takayama Toshiki, Yamada Kei, Suehiro Takashi, Matsunaga Keiko, Yokota Takanori, Tateishi Ukihide, Shigemoto Yoko, Kimura Yukio, Chiba Emiko, Kawashima Takahiro, Tomo Yui, Tachimori Hisateru, Kimura Yuichi, Sato Noriko: Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study Annals of Nuclear Medicine. 2022.12; 36 (12): 1039-1049. ( 医中誌 )

  3. Matsuda Hiroshi, Okita Kyoji, Motoi Yumiko, Mizuno Toshiki, Ikeda Manabu, Sanjo Nobuo, Murakami Koji, Kambe Taiki, Takayama Toshiki, Yamada Kei, Suehiro Takashi, Matsunaga Keiko, Yokota Takanori, Tateishi Ukihide, Shigemoto Yoko, Kimura Yukio, Chiba Emiko, Kawashima Takahiro, Tomo Yui, Tachimori Hisateru, Kimura Yuichi, Sato Noriko: Clinical impact of amyloid PET using F-18-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study ANNALS OF NUCLEAR MEDICINE. 2022.12; 36 (12): 1039-1049. ( PubMed , DOI )

  4. Masaaki Niino, Shoko Fukumoto, Tatsusada Okuno, Nobuo Sanjo, Hikoaki Fukaura, Masahiro Mori, Takashi Ohashi, Hideyuki Takeuchi, Yuko Shimizu, Juichi Fujimori, Izumi Kawachi, Jun-ichi Kira, Eri Takahashi, Yusei Miyazaki, Nobuhiro Mifune: Health related quality of life in Japanese patients with multiple sclerosis Journal of Neurology. 2022.11; 270 1011-1018.

  5. Ohara M, Sanjo N, Kanouchi T, Yokota T: Entrapment partly participates in the longitudinal progression of neuropathy with anti-MAG antibodies. Revue neurologique. 2022.11; 179 (1-2): 118-122. ( PubMed , DOI )

  6. Chen Q, Hattori T, Tomisato H, Ohara M, Hirata K, Yokota T, Alzheimer's Disease Neuroimaging Initiative: Turning and multitask gait unmask gait disturbance in mild-to-moderate multiple sclerosis: Underlying specific cortical thinning and connecting fibers damage. Human brain mapping. 2022.11; 44 (3): 1193-1208. ( PubMed , DOI )

  7. Goto A, Yamamoto S, Igari T, Matsumoto SI, Chisaki I, Iida K, Nakayama M, Oda A, Kakoi Y, Uchida A, Miyata K, Nishikawa M, Nagata T, Kusuhara H, Yokota T, Hirabayashi H: Quantitative Model Analysis and Simulation of Pharmacokinetics and Malat1 RNA Knockdown Effect After Systemic Administration of Cholesterol-conjugated DNA/RNA Heteroduplex Oligonucleotide Crossing Blood-Brain Barrier of Mice. The Journal of pharmacology and experimental therapeutics. 2022.10; 384 (1): 197-204. ( PubMed , DOI )

  8. Tomomi Shiraishi, Kazuki Sato, Rintaro Iwata Hara, Takeshi Wada: Synthesis and properties of oligodiaminogalactoses that bind to A-type oligonucleotide duplexes Organic & Biomolecular Chemistry. 2022.09; 20 (42): 8243-8258. ( DOI )

  9. Zeniya S, Sanjo N, Kuwahara H, Ishikawa K, Higashi M, Matsunaga A, Yoneda M, Mizusawa Ho, Yokota T: Spinocerebellar Ataxia Type 31 Exacerbated by Anti-amino Terminal of Alpha-enolase Autoantibodies Internal Medicine. 2022.09; 61 (18): 2793-2796. ( 医中誌 )

  10. Kazuki Sato, Akie Chiba, Tomomi Shiraishi, Yuki Ogawa, Rintaro Iwata Hara, Takeshi Wada: Solid-phase synthesis of N-trichloroacetyl mannosamine 1-phosphate repeating units mimicking capsular polysaccharide derived from Neisseria meningitidis serotype A Carbohydrate Research. 2022.08; 518 108585. ( DOI )

  11. Yokote H, Miyazaki Y, Toru S, Nishida Y, Hattori T, Niino M, Sanjo N, Yokota T: High-efficacy therapy reduces subcortical grey matter volume loss in Japanese patients with relapse-onset multiple sclerosis: A 2-year cohort study. Mult Scler Relat Disord. 2022.07; 67 104077. ( PubMed , DOI )

  12. Winklehner M, Bauer J, Endmayr V, Schwaiger C, Ricken G, Motomura M, Yoshimura S, Shintaku H, Ishikawa K, Tsuura Y, Iizuka T, Yokota T, Irioka T, Höftberger R: Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies. Neurology(R) neuroimmunology & neuroinflammation. 2022.07; 9 (4): e200006. ( PubMed , DOI )

  13. Toshitaka Yoshii, Takashi Hirai, Satoru Egawa, Motonori Hashimoto, Yu Matsukura, Hiroyuki Inose, Nobuo Sanjo, Takanori Yokota, Atsushi Okawa: Case Report: Dural Dissection With Ventral Spinal Fluid-Filled Collection in Superficial Siderosis: Insights Into the Pathology From Anterior-Approached Surgical Cases. Front Neurol. 2022.07; 13 919280. ( PubMed , DOI )

  14. Kaburagi Hidetoshi, Nagata Tetsuya, Enomoto Mitsuhiro, Hirai Takashi, Ohyagi Masaki, Ihara Kensuke, Yoshida-Tanaka Kie, Ebihara Satoe, Asada Ken, Yokoyama Hiroyuki, Okawa Atsushi, Yokota Takanori: Systemic DNA/RNA heteroduplex oligonucleotide administration for regulating the gene expression of dorsal root ganglion and sciatic nerve MOLECULAR THERAPY-NUCLEIC ACIDS. 2022.06; 28 910-919. ( PubMed , DOI )

  15. Ryo Iwase, Tadashi Kanouchi, Toshitaka Yoshii, Taro Ishiguro, Takashi Hirai, Atsushi Okawa, Takanori Yokota, Nobuo Sanjo: Diverging pathophysiology in superficial siderosis with proximal upper limb amyotrophy. J Neurol Sci. 2022.05; 436 120248. ( PubMed , DOI )

  16. Tamaki Kana, Nishida Yoichiro, Sanjo Nobuo, Yokota Takanori: A patient with generalized myasthenia gravis facing an impending crisis triggered by early fast-acting treatment Clinical and Experimental Neuroimmunology. 2022.05; 13 (2): 99-101. ( 医中誌 )

  17. Koki Kosami, Ryusuke Ae, Tsuyoshi Hamaguchi, Nobuo Sanjo, Tadashi Tsukamoto, Tetsuyuki Kitamoto, Masahito Yamada, Hidehiro Mizusawa, Yosikazu Nakamura: Methionine homozygosity for PRNP polymorphism and susceptibility to human prion diseases Journal of Neurology, Neurosurgery, and Psychiatry. 2022.04; 93 779-784.

  18. Noda Kotaro, Nosaka Nobuyuki, Hara Nobuhiro, Yokota Takanori, Shigemitsu Hidenobu, Takahashi Hideo: We Should Pay Attention to "Referred Pain": A Case of Acute Myocardial Infarction That Masked and Delayed the Diagnosis of Esophageal Perforation(和訳中) Internal Medicine. 2022.04; 61 (8): 1295-1298. ( 医中誌 )

  19. Bannawongsil T, Yamada A, Nakamura A, Uchihara T, Yokota T: Neuronal internalization of immunoglobulin G injected into the mouse brain by a novel absorption strategy to avoid unwanted interaction with immune complex using centrifugal filtration. Histochemistry and cell biology. 2022.04; ( PubMed , DOI )

  20. Uematsu M, Mikami K, Nakamura A, Takahashi R, Yokota T, Hirokawa K, Uchihara T: Parallel gold enhancement of quantum dots 565/655 for double-labelling correlative light and electron microscopy on human autopsied samples. Sci Rep. 2022.04; 12 (1): 6113. ( PubMed , DOI )

  21. Yamada Akane, Nishida Yoichiro, Wake Kenjiro, Nakamura Ayako, Sakamaki Yuriko, Kuwahara Hiroya, Uchihara Toshiki, Yokota Takanori: Serial ultrathin sections to identify ultrastructural localization of GLUT1 molecules in vesicles in brain endothelial cells-correlative light and electron microscopy in depth(和訳中) Microscopy. 2022.04; 71 (2): 124-131. ( 医中誌 )

  22. Matsubayashi T, Akaza M, Hayashi Y, Hamaguchi T, Satoh K, Kosami K, Ae R, Kitamoto T, Yamada M, Shimohata T, Yokota T, Sanjo N: Specific electroencephalogram features in the very early phases of sporadic Creutzfeldt-Jakob disease. J Neurol Sci. 2022.04; 437 120265. ( PubMed , DOI )

  23. Miyashita A, Kobayashi M, Ishibashi S, Nagata T, Chandrasekahr A, Zochodne DW, Yokota T: The Role of Long Non-coding RNA MALAT1 in Diabetic Polyneuropathy and the Impact of its Silencing in the Dorsal Root Ganglion by a DNA/RNA Heteroduplex Oligonucleotide. Diabetes. 2022.03; 71 (6): 1299-1312. ( PubMed , DOI )

  24. Taniguchi K, Yamamoto F, Amamo A, Tamaoka A, Sanjo N, Yokota T, Kametani F, Araki W: Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer's disease. Neurosci Res. 2022.03; ( PubMed , DOI )

  25. Yamada A, Nishida Y, Wake K, Nakamura A, Sakamaki Y, Kuwahara H, Uchihara T, Yokota T: Serial ultrathin sections to identify ultrastructural localization of GLUT1 molecules in vesicles in brain endothelial cells-correlative light and electron microscopy in depth. Microscopy (Oxford, England). 2022.02; 71 (2): 124-131. ( PubMed , DOI )

  26. Nishi R, Ohyagi M, Nagata T, Mabuchi Y, Yokota T: Regulation of activated microglia and macrophages by systemically administered DNA/RNA heteroduplex oligonucleotides. Mol Ther. 2022.02; 30 (6): 2210-23. ( PubMed , DOI )

  27. Aoki H, Higashi M, Okita M, Ando N, Murayama S, Ishikawa K, Yokota T: Thymidine Kinase 2 and Mitochondrial Protein COX I in the Cerebellum of Patients with Spinocerebellar Ataxia Type 31 Caused by Penta-nucleotide Repeats (TTCCA)n. Cerebellum . 2022.01; 22 (1): 70-84. ( PubMed , DOI )

  28. Masaaki Niino, Shoko Fukumoto, Tatsusada Okuno, Nobuo Sanjo, Hikoaki Fukaura, Masahiro Mori, Takashi Ohashi, Hideyuki Takeuchi, Yuko Shimizu, Juichi Fujimori, Izumi Kawachi, Jun-ichi Kira, Eri Takahashi, Yusei Miyazaki, Nobuhiro Mifune: Correlation of the Symbol Digit Modalities Test with the Quality of Life and Depression in Japanese Patients with Multiple Sclerosis Multiple Sclerosis and Related Disorders. 2022.01; 57 103427.

  29. Yohsuke Yagi, Yutaro Asami, Mitsuki Kyoya, Takanori Yokota: Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination. Neurol Sci. 2022.01; 43 (1): 41-43. ( PubMed , DOI )

  30. Zeniya S, Sanjo N, Kuwahara H, Ishikawa K, Higashi M, Matsunaga A, Yoneda M, Mizusawa H, Yokota T: Spinocerebellar Ataxia Type 31 Exacerbated by Anti-amino Terminal of Alpha-enolase Autoantibodies. Internal medicine (Tokyo, Japan). 2022; 61 (18): 2793-2796. ( PubMed , DOI )

  1. Masaki Ohyagi, Tetsuya Nagata,Kensuke Ihara, Kie Yoshida-Tanaka, Rieko Nishi, Haruka Miyata, Aya Abe,Yo Mabuchi, Chihiro Akazawa, Takanori Yokota: DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo. Nat Commun. 2021.12; 12 (1): 7344. ( PubMed , DOI )

  2. Tohnai G, Nakamura R, Atsuta N, Nakatochi M, Hayashi N, Ito D, Watanabe H, Watanabe H, Katsuno M, Izumi Y, Taniguchi A, Kanai K, Morita M, Kano O, Kuwabara S, Oda M, Abe K, Aoki M, Aiba I, Okamoto K, Mizoguchi K, Ishihara T, Kawata A, Yokota T, Hasegawa K, Nagano I, Yabe I, Tanaka F, Kuru S, Hattori N, Nakashima K, Kaji R, Sobue G, Japanese Consortium for Amyotrophic Lateral Sclerosis Research (JaCALS).: Mutation screening of the DNAJC7 gene in Japanese patients with sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2021.12; 113 131-136. ( PubMed , DOI )

  3. Hiromasa Matsuda , Hiroaki Ito , Yohei Nukaga , Sho Uehara , Kazuki Sato , Rintaro Iwata Hara , Takeshi Wada: Solid-phase synthesis of oligouridine boranophosphates using the H-boranophosphonate method with 2′-O-(2-cyanoethoxymethyl) protection Tetrahedron Letters. 2021.12; 87 (21): 153526. ( DOI )

  4. Kotaro Noda, Yohsuke Yagi, Takanori Yokota: Evaluation of the risk factors predicting thrombotic complications associated with intravenous immunoglobulin therapy in neuroimmunological diseases. Neurol Sci. 2021.12; 42 (12): 5321-5326. ( PubMed , DOI )

  5. Eiichiro Amano, Tomokatsu Yoshida, Ikuko Mizuta, Jun Oyama, Shingo Sakashita, Syunsuke Ueyama, Akira Machida, Takanori Yokota: Activation of a Cryptic Splice Site of GFAP in a Patient With Adult-Onset Alexander Disease. Neurol Genet. 2021.12; 7 (6): e626. ( PubMed , DOI )

  6. Yoichiro Nishida,Taro Ishiguro, Takanori Yokota: Tap-Elicited Clonus of the Biceps and Triceps Brachii. JAMA Neurol. 2021.11; 79 (2): 194. ( PubMed , DOI )

  7. Hiromasa Matsuda, Erina Yoshida, Takaaki Shinoda, Kazuki Sato, Rintaro Iwata Hara, Takeshi Wada: Solution-phase synthesis of oligodeoxyribonucleotides using the H-phosphonate method with N-unprotected 5′-phosphite monomers RSC Advances. 2021.11; 11 (60): 38094-38107. ( DOI )

  8. Kokoro Ozaki, Takashi Irioka, Toshiki Uchihara, Akane Yamada, Ayako Nakamura, Takamasa Majima, Susumu Igarashi, Hiroshi Shintaku, Mayumi Yakeishi, Yukio Tsuura, Yasushi Okazaki, Kinya Ishikawa, Takanori Yokota: Neuropathology of SCA34 showing widespread oligodendroglial pathology with vacuolar white matter degeneration: a case study. Acta neuropathol commun. 2021.10; 9 (1): 172. ( PubMed , DOI )

  9. Yurie Nose, Ikuko Uwano, Ukihide Tateishi, Makoto Sasaki, Takanori Yokota, Nobuo Sanjo: Quantitative clinical and radiological recovery in post-operative patients with superficial siderosis by an iron chelator. J Neurol. 2021.10; 269 (5): 2539-2548. ( PubMed , DOI )

  10. Takayuki Kuroda, Miho Akaza, Kazunori Miki, Shoko Fujii, Yousuke Yagi, Tadashi Kanouchi, Nobuo Sanjo, Kazutaka Sumita, Takanori Yokota: Sacral dural arteriovenous fistula mimicking multiple mononeuropathy. Clin Neurol Neurosurg. 2021.10; 210 106993. ( PubMed , DOI )

  11. Noda K, Nosaka N, Hara N, Yokota T, Shigemitsu H, Takahashi H: We Should Pay Attention to "Referred Pain" - A Case of Acute Myocardial Infarction that Masked and Delayed the Diagnosis of Esophageal Perforation. Internal medicine (Tokyo, Japan). 2021.09; 61 (8): 1295-1298. ( PubMed , DOI )

  12. Rintaro Iwata Hara, Takeshi Wada: Inhibition of off-target cleavage by RNase H using an artificial cationic oligosaccharide. Org Biomol Chem. 2021.08; 19 (31): 6865-6870. ( PubMed , DOI )

  13. Tetsuya Nagata, Chrissa A. Dwyer, Kie Yoshida-Tanaka, Kensuke Ihara, Masaki Ohyagi, Hidetoshi Kaburagi, Haruka Miyata, Satoe Ebihara, Kotaro Yoshioka, Takashi Ishii, Kanjiro Miyata, Kenichi Miyata, Berit Powers, Tomoko Igari, Syunsuke Yamamoto, Naoto Arimura, Hideki Hirabayashi, Toshiki Uchihara, Rintaro Iwata Hara, Takeshi Wada, C. Frank Bennett, Punit P. Seth, Frank Rigo and Takanori Yokota: Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS. Nat Biotechnol. 2021.08; ( PubMed , DOI )

  14. Kazuki Sato, Tomoya Hagio, Michi Sano, Kazumasa Muramoto, Aya Yaoita, Mihoko Noro, Rintaro Iwata Hara, Takeshi Wada: Solid-Phase Stereocontrolled Synthesis of Oligomeric P-Modified Glycosyl Phosphate Derivatives Using the Oxazaphospholidine Method. ACS Omega. 2021.08; 6 (30): 20026-20041. ( PubMed , DOI )

  15. Kazumasa Kawata, Hideyuki Koga, Kunikazu Tsuji, Kazumasa Miyatake, Yusuke Nakagawa, Takanori Yokota, Ichiro Sekiya, Hiroki Katagiri: Extracellular vesicles derived from mesenchymal stromal cells mediate endogenous cell growth and migration via the CXCL5 and CXCL6/CXCR2 axes and repair menisci. Stem Cell Res Ther. 2021.07; 12 (1): 414. ( PubMed , DOI )

  16. Shinya Akiko, Takahashi Makoto, Sato Nozomu, Nishida Yoichiro, Inaba Akira, Inaji Motoki, Yokota Takanori, Orimo Satoshi: Oculo-dento-digital Dysplasia Presenting as Spastic Paraparesis Which Was Successfully Treated by Intrathecal Baclofen Therapy Internal Medicine. 2021.07; 60 (14): 2301-2305. ( 医中誌 )

  17. Motohiro Suzuki, Satoru Ishibashi, Eri Iwasawa , Takahiro Oguma, Yasuhiro Saito, Fuying Li, Shinichi Otsu, Keiko Ichinose, Kotaro Yoshioka, Tetsuya Nagata, Takanori Yokota: Effective silencing of miR-126 after ischemic stroke by means of intravenous α-tocopherol-conjugated heteroduplex oligonucleotide in mice. Sci Rep. 2021.07; 11 (1): 14237. ( PubMed , DOI )

  18. Homma H, Tanaka H, Jin M, Jin X, Huang Y, Yoshioka Y, Bertens CJ, Tsumaki K, Kondo K, Shiwaku H, Tagawa K, Akatsu H, Atsuta N, Katsuno M, Furukawa K, Ishiki A, Waragai M, Ohtomo G, Iwata A, Yokota T, Inoue H, Arai H, Sobue G, Sone M, Fujita K, Okazawa H: DNA damage in embryonic neural stem cell determines FTLDs' fate via early-stage neuronal necrosis. Life Sci Alliance. 2021.06; 4 (7): e202101022. ( PubMed , DOI )

  19. Ken Asada, Fumika Sakaue, Tetsuya Nagata, Ji-Chun Zhang, Kie Yoshida-Tanaka, Aya Abe, Makiko Nawa, Kazutaka Nishina , Takanori Yokota: Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing. Nucleic Acids Res.. 2021.05; 49 (9): 4864-4876. ( PubMed , DOI )

  20. Yoichiro Nishida, Takanori Yokota: Reversible reduction of dopamine transporter uptake in a case of hydrocephalus. Ann Neurol. 2021.05; ( PubMed , DOI )

  21. Nobuo Sanjo, Yurie Nose, Shouhei Miyamoto, Yukiko Shishido-Hara, Tatsuya Saito, Tetsuya Fukuda, Kurara Yamamoto, Daisuke Kobayashi, Takanori Yokota: Early pathological JC virus lesions in a patient without any MRI-based indications Inten Med. 2021.04; 60 (8): 1279-1282. ( 医中誌 )

  22. Daisuke Ono, Ken Asada, Daishi Yui, Fumika Sakaue, Kotaro Yoshioka, Tetsuya Nagata, Takanori Yokota: Separation-related rapid nuclear transport of DNA/RNA heteroduplex oligonucleotide: unveiling distinctive intracellular trafficking. Mol Ther Nucleic Acids. 2021.03; 23 1360-1370. ( PubMed , DOI )

  23. Hiroaki Yokote, Shuta Toru, Yoichiro Nishida, Takaaki Hattori, Nobuo Sanjo, Takanori Yokota : Serum amyloid A level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis. J Neuroimmunol. 2021.02; 351 577466. ( PubMed , DOI )

  24. Asami Yutaro, Nagata Tetsuya, Yoshioka Kotaro, Kunieda Taiki, Yoshida-Tanaka Kie, Bennett C. Frank, Seth Punit P., Yokota Takanori: Efficient Gene Suppression by DNA/DNA Double-Stranded Oligonucleotide In Vivo. Mol Ther. 2021.02; 29 (2): 838-847. ( PubMed , DOI )

  25. Akiko Shinya, Makoto Takahashi, Nozomu Sato, Yoichiro Nishida, Akira Inaba, Motoki Inaji, Takanori Yokota, Satoshi Orimo: A case of oculo-dento-digital dysplasia presenting as spastic paraparesis which was successfully treated by intrathecal baclofen therapy. Intern Med. 2021.02; 60 (14): 2301-2305. ( PubMed , DOI )

  26. Mitsuru Naito, Hiroyuki Chaya, Kazuko Toh, Beob Soo Kim, Kotaro Hayashi, Shigeto Fukushima, Tetsuya Nagata, Takanori Yokota, Kazunori Kataoka, Kanjiro Miyata: Structural tuning of oligonucleotides for enhanced blood circulation properties of unit polyion complexes prepared from two-branched poly(ethylene glycol)-block-poly(l-lysine). J control Release . 2021.01; 330 812-820. ( PubMed , DOI )

  27. Mitsuru Watanabe, Yuri Nakamura, Shinya Sato, Masaaki Niino, Hikoaki Fukaura, Masami Tanaka, Hirofumi Ochi, Takashi Kanda, Yukio Takeshita, Takanori Yokota, Yoichiro Nishida, Makoto Matsui, Shigemi Nagayama, Susumu Kusunoki, Katsuichi Miyamoto, Masanori Mizuno, Izumi Kawachi, Etsuji Saji, Takashi Ohashi, Shun Shimohama, Shin Hisahara, Kazutoshi Nishiyama, Takahiro Iizuka, Yuji Nakatsuji, Tatsusada Okuno, Kazuhide Ochi, Akio Suzumura, Ken Yamamoto, Yuji Kawano, Shoji Tsuji, Makoto Hirata, Ryuichi Sakate, Tomonori Kimura, Yuko Shimizu, Akiko Nagaishi, Kazumasa Okada, Fumie Hayashi, Ayako Sakoda, Katsuhisa Masaki, Koji Shinoda, Noriko Isobe, Takuya Matsushita, Jun-Ichi Kira : HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data. Sci rep. 2021.01; 11 (1): 607. ( PubMed , DOI )

  1. Miho Akaza, Shigenori Kawabata, Isamu Ozaki, Yuki Miyano, Taishi Watanabe, Yoshiaki Adachi, Kensuke Sekihara, Yuki Sumi, Takanori Yokota: Noninvasive measurement of sensory action currents in the cervical cord by magnetospinography. Clin Neurophysiol. 2020.12; 132 (2): 382-391. ( PubMed , DOI )

  2. Matsubayashi T, Akaza M, Hayashi Y, Hamaguchi T, Yamada M, Shimohata T, Yokota T, Sanjo N: Focal sharp waves are a specific early-stage marker of the MM2-cortical form of sporadic Creutzfeldt-Jakob disease. Prion. 2020.12; 14 (1): 207-213. ( PubMed , DOI )

  3. Matsuhisa Koji, Cai Longjie, Saito Atsushi, Sakaue Fumika, Kamikawa Yasunao, Fujiwara Sachiko, Asada Rie, Kudo Yukitsuka, Imaizumi Kazunori: Toxic effects of endoplasmic reticulum stress transducer BBF2H7-derived small peptide fragments on neuronal cells. Brain Res. 2020.12; 1749 147139. ( PubMed , DOI )

  4. Takahashi Sunao, Sanjo Nobuo, Miyamoto Shohei, Hattori Takaaki, Oyama Jun, Tateishi Ukihide, Yokota Takanori: Width of the third ventricle as a highly-sensitive biomarker in chronic progressive neuro-Behçet's disease. J Neurol Sci. 2020.12; 421 117284. ( PubMed , DOI )

  5. Hirata K, Yokota T, Miura Y: Teaching-Neuroimages: Parkinsonism secondary to a metastatic lesion involving the substantia nigra. Neurology. 2020.11; 96 (13): e1800-e1801. ( PubMed , DOI )

  6. Sanjo N, Nose Y, Miyamoto S, Shishido-Hara Y, Saito T, Fukuda T, Yamamoto K, Kobayashi D, Yokota T: Early Pathological JC Virus Lesions in a Patient without any MRI-based Indications. Intern Med. 2020.11; 60 (8): 1279-1282. ( PubMed , DOI )

  7. Sugita Y, Nishida Y, Ishibashi S, Yokota T: Convexity Subarachnoid Hemorrhage Soon after Starting a Direct Oral Anticoagulant in 2 Patients with Acute Infarction. J Stroke Cerebrovasc Dis .. 2020.11; 29 (11): 105216. ( PubMed , DOI )

  8. Hiroyuki Yokoyama, Takashi Hirai, Tetsuya Nagata, Mitsuhiro Enomoto, Hidetoshi Kaburagi, Li Leiyo, Takayuki Motoyoshi, Toshitaka Yoshii, Atsushi Okawa, Takanori Yokota: DNA Microarray Analysis of Differential Gene Expression in the Dorsal Root Ganglia of Four Different Neuropathic Pain Mouse Models. J Pain Res. 2020.11; 13 3031-3043. ( PubMed , DOI )

  9. Yuko Yamagishi, Motoi Kuwahara, Hidekazu Suzuki, Masahiro Sonoo, Satoshi Kuwabara, Takanori Yokota, Kyoichi Nomura, Atsuro Chiba, Ryuji Kaji, Takashi Kanda, Ken-Ichi Kaida, Tatsuro Mutoh, Ryo Yamasaki, Hiroshi Takashima, Makoto Matsui, Kazutoshi Nishiyama, Gen Sobue, Susumu Kusunoki: Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2020.10; 91 (12): 1339-1342. ( PubMed , DOI )

  10. Kishimoto Y, Nakagawa O, Fujii A, Yoshioka K, Nagata T, Yokota T, Hari Y, Obika S: 2',4'-BNA/LNA with 9-(2-Aminoethoxy)-1,3-diaza-2-oxophenoxazine Efficiently Forms Duplexes and Has Enhanced Enzymatic Resistance*. Chemistry . 2020.10; 27 (7): 2427-2438. ( PubMed , DOI )

  11. Atsushi Irie, Kazuki Sato, Rintaro Iwata Hara, Takeshi Wada, Futoshi Shibasaki: An artificial cationic oligosaccharide combined with phosphorothioate linkages strongly improves siRNA stability. Sci Rep. 2020.09; 10 (1): 14845. ( PubMed , DOI )

  12. Rintaro Iwata Hara, Reijiro Yoshino, Yohei Nukaga, Kazuki Sato, Takeshi Wada: Synthesis and properties of DNA oligomers containing stereopure phosphorothioate linkages and C-5 modified deoxyuridine derivatives RSC Advances. 2020.09; 10 (56): 34006-34013. ( DOI )

  13. Abe T, Yokota T, Fukushima A, Kakutani N, Katayama T, Shirakawa R, Maekawa S, Nambu H, Obata Y, Yamanashi K, Nakano I, Takada S, Yokota I, Okita K, Kinugawa S, Anzai T: Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction. Cardiovascular diabetology. 2020.09; 19 (1): 142. ( PubMed , DOI )

  14. Wenqing Liao, Sakiko Akahira, Rintaro Iwata Hara, Takeshi Wada, Kosuke Kusamori, Yoshinobu Takakura, Makiya Nishikawa: Enhanced Immunostimulatory Activity of CpG Oligodeoxynucleotide by the Combination of Mannose Modification and Incorporation into Nanostructured DNA. Biol Pharm Bull. 2020.08; 43 (8): 1188-1195. ( PubMed , DOI )

  15. Iwase R, Irioka T, Igarashi S, Ayabe J, Yokota T: Intracranial dural arteriovenous fistula mimicking neuromyelitis optica spectrum disorder: A case report. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2020.08; 29 (8): 105007. ( PubMed , DOI )

  16. Kosei Hirata, Takaaki Hattori, Satoko Kina, Qingmeng Chen, Masahiro Ohara, Takanori Yokota: Striatal Dopamine Denervation Impairs Gait Automaticity in Drug-Naïve Parkinson's Disease Patients. Mov. Disord.. 2020.06; 35 (6): 1037-1045. ( PubMed , DOI )

  17. Ryo Iwase, Taro Ishiguro, Kyohei Fujita, Satoru Ishibashi, Takanori Yokota: Dupilumab for Atopic Dermatitis, a Possible Risk Factor of Juvenile Ischemic Stroke: A Case Report. J Stroke Cerebrovasc Dis. 2020.06; 29 (6): 104763. ( PubMed , DOI )

  18. Tai Otani, Takashi Irioka, Susumu Igarashi, Kimihiko Kaneko, Toshiyuki Takahashi, Takanori Yokota: Self-remitting cerebral cortical encephalitis associated with myelin oligodendrocyte glycoprotein antibody mimicking acute viral encephalitis: A case report. Mult Scler Relat Disord. 2020.06; 41 102033. ( PubMed , DOI )

  19. Hirata K, Kobayashi M, Miyashita A, Yokota T: Steroid-responsive myositis in a patient with Sjögren's syndrome and refractory peripheral neuropathy. Neurological sciences . 2020.05; 41 (5): 1303-1305. ( PubMed , DOI )

  20. Jinbing Xie, Daniel Gonzalez-Carter, Theofilus A Tockary, Noriko Nakamura, Yonger Xue, Makoto Nakakido, Hiroki Akiba, Anjaneyulu Dirisala, Xueying Liu, Kazuko Toh, Tao Yang, Zengtao Wang, Shigeto Fukushima, Junjie Li, Sabina Quader, Kouhei Tsumoto, Takanori Yokota, Yasutaka Anraku, Kazunori Kataoka: Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain. ACS Nano. 2020.05; 14 (6): 6729-6742. ( PubMed , DOI )

  21. Masahiro Ohara, Takaaki Hattori, Takanori Yokota: Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like MRI features. Eur. J. Neurol.. 2020.05; 27 (10): 1930-1936. ( PubMed , DOI )

  22. Teruhiko Sekiguchi, Satoru Ishibashi, Jo Sasame, Jun-Ichi Mukae, Kotaro Noda, Hiroaki Tanaka, Koh Yamamoto, Yasunori Takemoto, Jiro Kumagai, Takanori Yokota: Recurrent stroke due to quasi-moyamoya disease associated with POEMS syndrome: An autopsy case. J. Neurol. Sci.. 2020.02; 412 116738. ( PubMed , DOI )

  23. Lei Mon SS, Yoshioka K, Jia C, Kunieda T, Asami Y, Yoshida-Tanaka K, Piao W, Kuwahara H, Nishina K, Nagata T, Yokota T: Highly efficient gene silencing in mouse brain by overhanging-duplex oligonucleotides via intraventricular route. FEBS letters. 2020.01; 594 (9): 1413-1423. ( PubMed , DOI )

  24. Nishida Y, Takahashi YK, Kanai T, Nose Y, Ishibashi S, Sanjo N, Uzawa A, Oda F, Ozawa Y, Kuwabara S, Noguchi E, Suzuki S, Nakahara J, Suzuki N, Ogawa T, Yokoyama K, Hattori N, Konno S, Fujioka T, Kawaguchi N, Hatanaka Y, Sonoo M, Kaneko J, Ogino M, Nishiyama K, Nomura K, Yokota T: Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis. European journal of neurology. 2020.01; 27 (1): 100-104. ( PubMed , DOI )

  25. Matsuhisa Koji, Saito Atsushi, Cai Longjie, Kaneko Masayuki, Okamoto Takumi, Sakaue Fumika, Asada Rie, Urano Fumihiko, Yanagida Kanta, Okochi Masayasu, Kudo Yukitsuka, Matsumoto Masaki, Nakayama Keiichi I, Imaizumi Kazunori: Production of BBF2H7-derived small peptide fragments via endoplasmic reticulum stress-dependent regulated intramembrane proteolysis. FASEB J. 2020.01; 34 (1): 865-880. ( PubMed , DOI )

  26. Okamoto Takumi, Wu Yan, Matsuhisa Koji, Saito Atsushi, Sakaue Fumika, Imaizumi Kazunori, Kaneko Masayuki: Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit. Biochem Biophys Res Commun. 2020.01; 521 (4): 1030-1035. ( PubMed , DOI )

  27. Kenji Sakai, Tsuyoshi Hamaguchi, Nobuo Sanjo, Hiroyuki Murai, Yasushi Iwasaki, Tadanori Hamano, Mari Honma, Moeko Noguchi-Shinohara, Ichiro Nozaki, Yosikazu Nakamura, Tetsuyuki Kitamoto, Masafumi Harada, Hidehiro Mizusawa, MasahitoYamada. : Diffusion-weighted magnetic resonance imaging in dura mater graftassociated Creutzfeldt-Jakob disease. Journal of the Neurological Sciences . 2020; in press

  28. Rintaro Iwata Hara, Kotaro Yoshioka, Takanori Yokota: DNA-RNA Heteroduplex Oligonucleotide for Highly Efficient Gene Silencing. Methods Mol. Biol.. 2020; 2176 113-119. ( PubMed , DOI )

  29. Tsuyoshi Hamaguchi, Nobuo Sanjo, Ryusuke Ae, Yosikazu Nakamura, Kenji Sakai, Masaki Takao, Shigeo Murayama, Yasushi Iwasaki, Katsuya Satoh, Hiroyuki Murai, Masafumi Harada, Tadashi Tsukamoto, Hidehiro Mizusawa, Masahito Yamada.: MM2 type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type. Journal of Neurology, Neurosurgery & Psychiatry . 2020; in press in press.

  1. Wu Yan, Kimura Yuka, Okamoto Takumi, Matsuhisa Koji, Asada Rie, Saito Atsushi, Sakaue Fumika, Imaizumi Kazunori, Kaneko Masayuki: Inflammatory bowel disease-associated ubiquitin ligase RNF183 promotes lysosomal degradation of DR5 and TRAIL-induced caspase activation. Sci Rep. 2019.12; 9 (1): 20301. ( PubMed , DOI )

  2. Yanagidaira M, Nishida Y, Yokota T: Temporal correlation between serum CH50 level and symptom severity of myasthenia gravis during eculizumab therapy. Clinical neurology and neurosurgery. 2019.12; 189 105630. ( PubMed , DOI )

  3. Masaki Ohyagi, Takashi Irioka, Takuya Ohkubo, Satoru Ishibashi, Yuko K Takahashi, Eiichiro Amano, Akira Machida, Hiroya Kuwahara, Takanori Yokota: Intrathecal IgG Synthesis and Persistent Inflammation Are Associated with White Matter Lesions in HIV-negative Patients with Cryptococcal Meningoencephalitis. Intern. Med.. 2019.11; 58 (21): 3077-3082. ( PubMed , DOI )

  4. Yokote Hiroaki, Amano Ryota, Toru Shuta, Hattori Takaaki, Nishida Yoichiro, Sanjo Nobuo, Yokota Takanori: 多発性硬化症患者における血清アミロイドA蛋白の上昇と脳萎縮との関連(Brain atrophy is associated with higher serum amyloid A levels in patients with multiple sclerosis) 臨床神経学. 2019.11; 59 (Suppl.): S400. ( 医中誌 )

  5. Yanagidaira M, Hattori T, Emoto H, Kiyosawa M, Yokota T: Optic perineuritis with anti-myelin oligodendrocyte glycoprotein antibody. Multiple sclerosis and related disorders. 2019.10; 38 101444. ( PubMed , DOI )

  6. Murai H., Nakamura Y., Matsushita T., Kitamoto T., Tsuboi Y., Sanjo N., Yamada M., Mizusawa H.: Epidemiological study of Gerstmann-Straussler-Scheinker disease with codon 102 mutation in Japan JOURNAL OF THE NEUROLOGICAL SCIENCES. 2019.10; 405 (73): 73 -73. ( DOI )

  7. Amano Akiko, Sanjo Nobuo, Nakakido Makoto, Tsumoto Kouhei, Matsubara Etsuro, Furukawa Fumiko, Nishida Yoichiro, Saito Takashi, Saido Takaomi, Yokota Takanori: ドットブロット法を用いたマウス脳におけるAβオリゴマーの定量的評価(Quantitative evaluation of Aβ oligomer in mouse brain using dot blot method) Dementia Japan. 2019.10; 33 (4): 515. ( 医中誌 )

  8. Kazuki Sato , Hiroki Imai , Tomohito Shuto , Rintaro Iwata Hara , Takeshi Wada: Solid-Phase Synthesis of Phosphate/Boranophosphate Chimeric DNAs using the H-Phosphonate–H-Boranophosphonate Method Journal of Organic Chemistry. 2019.10; 84 (23): 15032-15041. ( DOI )

  9. Ohara M, Sanjo N, Hattori T, Oyama J, Hamada M, Ozaki K, Yokota T: Olivary hypertrophy improved by steroid treatment: Two case reports with unique presentations. Journal of neuroimmunology. 2019.09; 334 577003. ( PubMed , DOI )

  10. Yoshioka K, Kunieda T, Asami Y, Guo H, Miyata H, Yoshida-Tanaka K, Sujino Y, Piao W, Kuwahara H, Nishina K, Hara RI, Nagata T, Wada T, Obika S, Yokota T: Highly efficient silencing of microRNA by heteroduplex oligonucleotides. Nucleic acids research. 2019.08; 47 (14): 7321-7332. ( PubMed , DOI )

  11. Head and Neck Cancer Study Group (HNCSG); Nobuya Monden, Takahiro Asakage, Naomi Kiyota, Akihiro Homma, Kazuto Matsuura, Nobuhiro Hanai, Takeshi Kodaira, Sadamoto Zenda, Hirofumi Fujii, Makoto Tahara, Tomoya Yokota, Tetsuo Akimoto, Shigemichi Iwae, Tetsuro Onitsuka, Takenori Ogawa, Susumu Okano, Shunji Takahashi, Yasushi Shimizu, Koichiro Yonezawa, Ryuichi Hayashi: A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition). Jpn J Clin Oncol. 2019.07; 49 (7): 589-595. ( PubMed , DOI )

  12. Fujita K, Tanaka K, Yamagami H, Ide T, Ishiyama H, Sonoda K, Satow T, Takahashi JC, Ihara M, Koga M, Yokota T, Toyoda K: Detrimental Effect of Chronic Hypertension on Leptomeningeal Collateral Flow in Acute Ischemic Stroke. Stroke. 2019.07; 50 (7): 1751-1757. ( PubMed , DOI )

  13. Momoko Ebashi, Shuta Toru, Ayako Nakamura, Satoshi Kamei, Takanori Yokota, Katsuiku Hirokawa, Toshiki Uchihara: Detection of AD-specific four repeat tau with deamidated asparagine residue 279-specific fraction purified from 4R tau polyclonal antibody Acta Neuropathologica. 2019.07; 138 (1): 163-166.

  14. Minikel Eric Vallabh, Vallabh Sonia M., Orseth Margaret C., Brandel Jean-Philippe, Haik Stephane, Laplanche Jean-Louis, Zerr Inga, Parchi Piero, Capellari Sabina, Safar Jiri, Kenny Janna, Fong Jamie C., Takada Leonel T., Ponto Claudia, Hermann Peter, Knipper Tobias, Stehmann Christiane, Kitamoto Tetsuyuki, Ae Ryusuke, Hamaguchi Tsuyoshi, Sanjo Nobuo, Tsukamoto Tadashi, Mizusawa Hidehiro, Collins Steven J., Chiesa Roberto, Roiter Ignazio, de Pedro-Cuesta Jesus, Calero Miguel, Geschwind Michael D., Yamada Masahito, Nakamura Yosikazu, Mead Simon: Age at onset in genetic prion disease and the design of preventive clinical trials NEUROLOGY. 2019.07; 93 (2): E125-E134. ( PubMed , DOI )

  15. Shintaku H, Yamaguchi M, Toru S, Kitagawa M, Hirokawa K, Yokota T, Uchihara T. : Three-dimensional surface models of autopsied human brains constructed from multiple photographs by photogrammetry. PLoS One. 2019.07; 14 (7): ( DOI )

  16. Rintaro Iwata Hara, Tatsuya Saito, Tomoki Kogure, Yuka Hamamura, Naoki Uchiyama, Yohei Nukaga, Naoki Iwamoto,Takeshi Wada: Stereocontrolled Synthesis of Boranophosphate DNA by an Oxazaphospholidine Approach and Evaluation of Its Properties Journal of Organic Chemistry. 2019.06; 84 (12): 7971-7983. ( DOI )

  17. Hashiguchi S, Doi H, Kunii M, Nakamura Y, Shimuta M, Suzuki E, Koyano S, Okubo M, Kishida H, Shiina M, Ogata K, Hirashima F, Inoue Y, Kubota S, Hayashi N, Nakamura H, Takahashi K, Katsumoto A, Tada M, Tanaka K, Sasaoka T, Miyatake S, Miyake N, Saitsu H, Sato N, Ozaki K, Ohta K, Yokota T, Mizusawa H, Mitsui J, Ishiura H, Yoshimura J, Morishita S, Tsuji S, Takeuchi H, Ishikawa K, Matsumoto N, Ishikawa T, Tanaka F: Ataxic phenotype with altered CaV3.1 channel property in a mouse model for spinocerebellar ataxia 42. Neurobiology of disease. 2019.06; 130 104516. ( PubMed , DOI )

  18. Ono D, Shishido-Hara Y, Mizutani S, Mori Y, Ichinose K, Watanabe M, Tanizawa T, Yokota T, Uchihara T, Fujigasaki H: Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain. Neuropathology : official journal of the Japanese Society of Neuropathology. 2019.06; 39 (4): 294-306. ( PubMed , DOI )

  19. Otsu S, Ishibashi S, Ozaki K, Yokota T: Elevated lipid peaks during the recovery phase of Baló's concentric sclerosis: A case report. eNeurologicalSci. 2019.06; 15 100191. ( PubMed , DOI )

  20. Ozaki K, Ansai A, Nobuhara K, Araki T, Kubodera T, Ishii T, Higashi M, Sato N, Soga K, Mizusawa H, Ishikawa K, Yokota T: Prevalence and clinicoradiological features of spinocerebellar ataxia type 34 in a Japanese ataxia cohort. Parkinsonism & related disorders. 2019.05; 65 238-242. ( PubMed , DOI )

  21. Uehara T, Choong CJ, Nakamori M, Hayakawa H, Nishiyama K, Kasahara Y, Baba K, Nagata T, Yokota T, Tsuda H, Obika S, Mochizuki H: Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease. Scientific reports. 2019.05; 9 (1): 7567. ( PubMed , DOI )

  22. Guo L, Bertola DR, Takanohashi A, Saito A, Segawa Y, Yokota T, Ishibashi S, Nishida Y, Yamamoto GL, Franco JFDS, Honjo RS, Kim CA, Musso CM, Timmons M, Pizzino A, Taft RJ, Lajoie B, Knight MA, Fischbeck KH, Singleton AB, Ferreira CR, Wang Z, Yan L, Garbern JY, Simsek-Kiper PO, Ohashi H, Robey PG, Boyde A, Matsumoto N, Miyake N, Spranger J, Schiffmann R, Vanderver A, Nishimura G, Passos-Bueno MRDS, Simons C, Ishikawa K, Ikegawa S: Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation. American journal of human genetics. 2019.05; 104 (5): 925-935. ( PubMed , DOI )

  23. Takahashi Yuko K., Nishida Yoichiro, Nose Yurie, Ishibashi Satoru, Sanjo Nobuo, Kanai Tetsuya, Uzawa Akiyuki, Oda Fumiko, Ozawa Yukiko, Kuwabara Satoshi, Yokota Takanori: Calcineurin Inhibitors Can Be Safely Reduced in Most Patients with Well-controlled Myasthenia Gravis NEUROLOGY. 2019.04; 92 (15):

  24. Takahashi Yuko K., Nishida Yoichiro, Nose Yurie, Ishibashi Satoru, Sanjo Nobuo, Kanai Tetsuya, Uzawa Akiyuki, Oda Fumiko, Ozawa Yukiko, Kuwabara Satoshi, Yokota Takanori: Calcineurin Inhibitors Can Be Safely Reduced in Most Patients with Well-controlled Myasthenia Gravis NEUROLOGY. 2019.04; 92 (15):

  25. Nico J. Diedrich, James Surmeier, Toshiki Uchihara, Sten Grillner, Christopher G. Goetz: Parkinson's disease: Is it a consequence of human brain evolution? Movement Disorders. 2019.04; 34 (4): 453-1531. ( PubMed , DOI )

  26. Rashaun S. Wilson, Navin Rauniyar, Fumika Sakaue, TuKiet T. Lam, Kenneth R. Williams, Angus C. Nairn: Development of Targeted Mass Spectrometry-Based Approaches for Quantitation of Proteins Enriched in the Postsynaptic Density (PSD) proteomes. 2019.04; 7 (2): ( PubMed , DOI )

  27. Hirata K, Numasawa Y, Kobayashi Z, Yokota T: Bilateral Optic Tract Hyperintensity due to Pituitary Apoplexy. Internal medicine (Tokyo, Japan). 2019.04; 58 (8): 1185-1186. ( PubMed , DOI )

  28. Nishida Yoichiro, Hizume Masaki, Fumimura Yuichi, Ichikawa Tadashi: ドネペジルにより改善した小脳性認知情動症候群(Cerebellar Cognitive Affective Syndrome Improved by Donepezil) Internal Medicine. 2019.04; 58 (7): 1003-1006. ( 医中誌 )

  29. Ebashi M, Toru S, Nakamura A, Kamei S, Yokota T, Hirokawa K, Uchihara T: Detection of AD-specific four repeat tau with deamidated asparagine residue 279-specific fraction purified from 4R tau polyclonal antibody. Acta neuropathologica. 2019.04; 138 (1): 163-166. ( PubMed , DOI )

  30. Furukawa F, Ishikawa K, Yokota T, Sanjo N: Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease. European neurology. 2019.04; 81 (1-2): 13-18. ( PubMed , DOI )

  31. Hashimoto S, Inaji M, Nariai T, Kobayashi D, Sanjo N, Yokota T, Ishii K, Taketoshi M: Usefulness of [11C] Methionine PET in the Differentiation of Tumefactive Multiple Sclerosis from High Grade Astrocytoma. Neurologia medico-chirurgica. 2019.04; 59 (5): 176-183. ( PubMed , DOI )

  32. Yokote H., Amano R., Toru S., Hattori T., Nishida Y., Sanjo N., Yokota T.: Brain Atrophy is Associated with Higher Serum Amyloid A Levels in Patients with Relapsing and Remitting Multiple Sclerosis and Clinically Isolated Syndrome MULTIPLE SCLEROSIS JOURNAL. 2019.03; 25 (3): 442.

  33. Yokote H., Amano R., Toru S., Hattori T., Nishida Y., Sanjo N., Yokota T.: Brain Atrophy is Associated with Higher Serum Amyloid A Levels in Patients with Relapsing and Remitting Multiple Sclerosis and Clinically Isolated Syndrome MULTIPLE SCLEROSIS JOURNAL. 2019.03; 25 (3): 442.

  34. Sanjo N, Nose Y, Shishido-Hara Y, Mizutani S, Sekijima Y, Aizawa H, Tanizawa T, Yokota T: A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy. Journal of neurology. 2019.02; 266 (2): 369-377. ( PubMed , DOI )

  35. Suzuki S, Naito S, Numasawa Y, Asada M, Shoji N, Zeniya M, Takahashi D, Sato H, Iimori S, Nomura N, Sohara E, Okado T, Ishiwata Y, Nagata M, Rai T, Yokota T, Uchida S: Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient. Internal medicine (Tokyo, Japan). 2019.02; ( PubMed , DOI )

  36. Maeda Y, Iwata Hara R, Nishina K, Yoshida-Tanaka K, Sakamoto T, Yokota T, Wada T: Artificial cationic peptides that increase nuclease resistance of siRNA without disturbing RNAi activity. Nucleosides, nucleotides & nucleic acids. 2019.01; 38 (5): 338-348. ( PubMed , DOI )

  37. Takahashi K, Yanai S, Takisawa S, Kono N, Arai H, Nishida Y, Yokota T, Endo S, Ishigami A: Vitamin C and vitamin E double-deficiency increased neuroinflammation and impaired conditioned fear memory. Archives of biochemistry and biophysics. 2019.01; 663 120-128. ( PubMed , DOI )

  38. Amano E, Ozaki K, Ishibashi S, Sanjo N, Yokota T: Remarkable improvement in progressive multifocal leukoencephalopathy following acute pyelonephritis with bacteremia. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2019.01; 62 226-228. ( PubMed , DOI )

  39. Eiichiro Amano, Kokoro Ozaki, Satoru Ishibashi, Nobuo Sanjo, Takanori Yokota. : Remarkable improvement in progressive multifocal leukoencephalopathy following acute pyelonephritis with bacteremia. Journal of Clinical Neuroscience . 2019; 62 226-228.

  40. Y. Nishida, Y. K. Takahashi, T. Kanai, Y. Nose, S. Ishibashi, N. Sanjo, A. Uzawa, F. Oda, Y. Ozawa, S. Kuwabara, E. Noguchi, S. Suzuki, J. Nakahara, N. Suzuki, T. Ogawa, K. Yokoyama, N. Hattori, S. Konno, T. Fujioka, N. Kawaguchi, Y. Hatanaka, M. Sonoo, J. Kaneko, M. Ogino, K. Nishiyama, K. Nomura, T. Yokota. : Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis. European Journal of Neurology . 2019; 27 (1): 100-104.

  41. Eric Vallabh Minikel, Sonia M Vallabh, Margaret C Orseth, Jean-Philippe Brandel, Stéphane Haïk, Jean-Louis Laplanche, Inga Zerr, Piero Parchi, Sabina Capellari, Jiri Safar, Janna Kenny, Jamie C Fong, Leonel T Takada, Claudia Ponto, Peter Hermann, Tobias Knipper, Christiane Stehmann, Tetsuyuki Kitamoto, Ryusuke Ae, Tsuyoshi Hamaguchi, Nobuo Sanjo, Tadashi Tsukamoto, Hidehiro Mizusawa, Steven J Collins, Roberto Chiesa, Ignazio Roiter, Jesús de Pedro-Cuesta, Miguel Calero, Michael D Geschwind, Masahito Yamada, Yosikazu Nakamura, Simon Mead. : Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology. 2019; 93 125-134.

  1. Ozaki K, Ohkubo T, Yamada T, Yoshioka K, Ichijo M, Majima T, Kudo S, Akashi T, Honda K, Ito E, Watanabe M, Sekine M, Hamagaki M, Eishi Y, Sanjo N, Ishibashi S, Mizusawa H, Yokota T: Progressive Encephalomyelitis with Rigidity and Myoclonus Resolving after Thymectomy with Subsequent Anasarca: An Autopsy Case Internal Medicine. 2018.12; 57 (23): 3451-3458. ( 医中誌 )

  2. Otani T, Irioka T, Takahashi YK, Soga K, Igarashi S, Kaneko K, Takahashi T, Yokota T: Two cases of late-onset neuromyelitis optica spectrum disorder initially presenting with isolated cerebral white matter lesions. eNeurologicalSci. 2018.12; 13 35-37. ( PubMed , DOI )

  3. Nishida Y, Hizume M, Fumimura Y, Ichikawa T: Cerebellar Cognitive Affective Syndrome Improved by Donepezil. Internal medicine (Tokyo, Japan). 2018.12; ( PubMed , DOI )

  4. Sano T, Kobayashi Z, Takaoka K, Ota K, Onishi I, Iizuka M, Tomimitsu H, Shintani S: Retrobulbar optic neuropathy associated with sphenoid sinus mucormycosis. Neurology and clinical neuroscience. 2018.09; 6 (5): 146-147. ( PubMed , DOI )

  5. Miho Akaza, Itaru Akaza, Tadashi Kanouchi, Tetsuo Sasano, Yuki Sumi, Takanori Yokota: Nerve conduction study of the association between glycemic variability and diabetes neuropathy. Diabetol Metab Syndr. 2018.09; 10 69. ( PubMed , DOI )

  6. Miura M, Numasawa Y, Takahisa M, Ozaki K, Irioka T, Nishida Y, Ishibashi S, Yokota T: Levodopa-responsive truncal tremor in a patient with spinocerebellar ataxia type 3. Journal of the neurological sciences. 2018.09; 392 32-33. ( PubMed , DOI )

  7. Rintaro Iwata Hara, Yusuke Maeda, Haruna Fujimaki, Takeshi Wada: Enhancement in RNase H activity of a DNA/RNA hybrid duplex using artificial cationic oligopeptides Chemical Communications. 2018.08; 54 (61): 8526-8529. ( DOI )

  8. Nakamura Tsutomu, Sakaue Fumika, Nasu-Nishimura Yukiko, Takeda Yasuko, Matsuura Ken, Akiyama Tetsu: The Autism-Related Protein PX-RICS Mediates GABAergic Synaptic Plasticity in Hippocampal Neurons and Emotional Learning in Mice. EBioMedicine. 2018.08; 34 189-200. ( PubMed , DOI )

  9. Ozaki K, Ohkubo T, Yamada T, Yoshioka K, Ichijo M, Majima T, Kudo S, Akashi T, Honda K, Ito E, Watanabe M, Sekine M, Hamagaki M, Eishi Y, Sanjo N, Ishibashi S, Mizusawa H, Yokota T: Progressive Encephalomyelitis with Rigidity and Myoclonus Resolving after Thymectomy with Subsequent Anasarca: An Autopsy Case. Internal medicine (Tokyo, Japan). 2018.07; ( PubMed , DOI )

  10. Sasaguri H, Nagata K, Sekiguchi M, Fujioka R, Matsuba Y, Hashimoto S, Sato K, Kurup D, Yokota T, Saido TC: Introduction of pathogenic mutations into the mouse Psen1 gene by Base Editor and Target-AID. Nature communications. 2018.07; 9 (1): 2892. ( PubMed , DOI )

  11. Yokote H, Kamata T, Toru S, Sanjo N, Yokota T: Brain volume loss is present in Japanese multiple sclerosis patients with no evidence of disease activity. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2018.07; 39 (10): 1713-1716. ( PubMed , DOI )

  12. Honda T, Nagao S, Hashimoto Y, Ishikawa K, Yokota T, Mizusawa H, Ito M: Tandem internal models execute motor learning in the cerebellum. Proceedings of the National Academy of Sciences of the United States of America. 2018.07; 115 (28): 7428-7433. ( PubMed , DOI )

  13. Guo Huijia, Yoshioka Kotaro, Kunieda Taiki, Asami Yutaro, Miyata Haruka, Yoshida-Tanaka Kie, Nagata Tetsuya, Yokota Takanori: Efficacy of microRNA silencing by lipid-conjugated double-stranded antisense oligonucleotides Journal of Medical and Dental Sciences. 2018.06; 65 (2): 83-88. ( 医中誌 )

  14. Rintaro Iwata Hara, Aya Yaoita, Katsuya Takeda, Hiroaki Ueki, Ayumu Ishii, Hideyuki Imoto, Satoshi Kobayashi, Michi Sano, Mihoko Noro, Kazuki Sato, Takeshi Wada: Solid-Phase Synthesis of Fluorinated Analogues of Glycosyl 1-Phosphate Repeating Structures from Leishmania using the Phosphoramidite Method ChemistryOpen. 2018.06; 7 439-446. ( DOI )

  15. Asada K, Ito K, Yui D, Tagaya H, Yokota T: Cytosolic Genomic DNA functions as a Natural Antisense. Scientific reports. 2018.06; 8 (1): 8551. ( PubMed , DOI )

  16. Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S, Japanese Eculizumab Trial for GBS (JET-GBS) Study Group.: Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial. The Lancet. Neurology. 2018.06; 17 (6): 519-529. ( PubMed , DOI )

  17. Itaya Sakiko, Kobayashi Zen, Ozaki Kokoro, Sato Nozomu, Numasawa Yoshiyuki, Ishikawa Kinya, Yokota Takanori, Matsuda Hiroshi, Shintani Shuzo: Spinocerebellar Ataxia Type 31 with Blepharospasm Internal Medicine. 2018.06; 57 (11): 1651-1654. ( 医中誌 )

  18. Li Fuying, Ishibashi Satoru, Iwasawa Eri, Suzuki Motohiro, Ichinose Keiko, Yokota Takanori: Upregulation of lipoprotein receptors on brain endothelial cells and neurons in the early phase of ischemic stroke in mice Journal of Medical and Dental Sciences. 2018.06; 65 (2): 59-71. ( 医中誌 )

  19. Eri Iwasawa, Satoru Ishibashi, Motohiro Suzuki, FuYing Li, Masahiko Ichijo, Kazunori Miki, Takanori Yokota: Sphingosine-1-Phosphate Receptor 1 Activation Enhances Leptomeningeal Collateral Development and Improves Outcome after Stroke in Mice. J Stroke Cerebrovasc Dis. 2018.05; 27 (5): 1237-1251. ( PubMed , DOI )

  20. Higashi M, Ozaki K, Hattori T, Ishii T, Soga K, Sato N, Tomita M, Mizusawa H, Ishikawa K, Yokota T: A diagnostic decision tree for adult cerebellar ataxia based on pontine magnetic resonance imaging. Journal of the neurological sciences. 2018.04; 387 187-195. ( PubMed , DOI )

  21. Hattori T, Ito K, Nakazawa C, Numasawa Y, Watanabe M, Aoki S, Mizusawa H, Ishiai S, Yokota T: Structural connectivity in spatial attention network: reconstruction from left hemispatial neglect. Brain imaging and behavior. 2018.04; 12 (2): 309-323. ( PubMed , DOI )

  22. Amano Eiichiro, Ozaki Kokoro, Egawa Satoru, Suzuki Motohiro, Hirai Takashi, Ishibashi Satoru, Ohkubo Takuya, Yoshii Toshitaka, Okawa Atsushi, Yokota Takanori: Dynamic spinal compression revealed by computed tomography myelography in overshunting-associated myelopathy: A case report. Medicine (Baltimore). 2018.03; 97 (10): e0082. ( PubMed , DOI )

  23. Hiroki Yamada, Takahiro Takeda, Toshiki Uchihara, Shizuko Sato, Susumu Kirimura, Yuka Hirota, Makoto Kodama, Masanobu Kitagawa, Katsuiku Hirokawa, Takanori Yokota, Shuta Toru: Macroscopic Localized Subicular Thinning as a Potential Indicator of Amyotrophic Lateral Sclerosis. Eur. Neurol.. 2018.03; 79 (3-4): 200-205. ( PubMed , DOI )

  24. Nishimaki K, Asada T, Ohsawa I, Nakajima E, Ikejima C, Yokota T, Kamimura N, Ohta S: Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment. Current Alzheimer research. 2018.03; 15 (5): 482-492. ( PubMed , DOI )

  25. Hiroya Kuwahara, Jindong Song, Takahiro Shimoura, Kie Yoshida-Tanaka, Tadahaya Mizuno, Tatsuki Mochizuki, Satoshi Zeniya, Fuying Li, Kazutaka Nishina, Tetsuya Nagata, Shingo Ito, Hiroyuki Kusuhara, Takanori Yokota: Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in vivo. Sci Rep. 2018.03; 8 (1): 4377. ( PubMed , DOI )

  26. Rintaro Iwata Hara, Yuki Hisada, Yusuke Maeda, Takanori Yokota, Takeshi Wada: Artificial cationic oligosaccharides for heteroduplex oligonucleotide-type drugs. Sci Rep. 2018.03; 8 (1): 4323. ( PubMed , DOI )

  27. Yoko Ito, Nobuo Sanjo, Masaki Hizume, Atsushi Kobayashi, Tetsuya Ohgami, Katsuya Satoh, Tsuyoshi Hamaguchi Masahito Yamada, Tetsuyuki Kitamoto, Hidehiro Mizusawa, Takanori Yokota: Biochemical features of genetic Creutzfeldt-Jakob disease with valine-to-isoleucine substitution at codon 180 on the prion protein gene. Biochemical and Biophysical Research Communications. 2018.02; 496 (4): 1055-1061. ( PubMed , DOI )

  28. Rintaro Iwara Hara, Yuta Mitsuhashi, Keita Saito, Yusuke Maeda, Takeshi Wada: Solid-phase synthesis of oligopeptides containing sterically hindered amino acids on non-swellable resin using 3-nitro-1,2,4-triazol-1-yl-tris(pyrrolidin-1-yl)phosphonium hexafluorophosphate (PyNTP) as the condensing reagent ACS Combinatrial Science. 2018.01; 20 132-136. ( DOI )

  29. Ohara Masahiro, Ozaki Kokoro, Ohkubo Takuya, Yamada Akane, Numasawa Yoshiyuki, Tanaka Keisuke, Tomii Shohei, Ishibashi Satoru, Sanjo Nobuo, Yokota Takanori: Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy INTERNAL MEDICINE. 2018; 57 (4): 601-604. ( PubMed , DOI )

  30. Hara Y, Mizobe Y, Miyatake S, Takizawa H, Nagata T, Yokota T, Takeda S, Aoki Y: Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy. Methods in molecular biology (Clifton, N.J.). 2018; 1828 553-564. ( PubMed , DOI )

  31. Furukawa F, Sanjo N, Kobayashi A, Hamaguchi T, Yamada M, Kitamoto T, Mizusawa H, Yokota T: Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene. Prion. 2018; 12 (5-6): 315-319. ( PubMed , DOI )

  1. Yuko Yamagishi, Hidekazu Suzuki, Masahiro Sonoo, Satoshi Kuwabara, Takanori Yokota, Kyoichi Nomura, Atsuro Chiba, Ryuji Kaji, Takashi Kanda, Kenichi Kaida, Shu-Ichi Ikeda, Tatsuro Mutoh, Ryo Yamasaki, Hiroshi Takashima, Makoto Matsui, Kazutoshi Nishiyama, Gen Sobue, Susumu Kusunoki: Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study. J. Peripher. Nerv. Syst.. 2017.12; 22 (4): 433-439. ( PubMed , DOI )

  2. Masaaki Niino,Toshiyuki Fukazawa,Jun-ichi Kira,Tatsusada Okuno,Masahiro Mori,Nobuo Sanjo,Takashi Ohashi,Hiroaki Fukaura,Juichi Fujimori,Yuko Shimizu,Nobuhiro Mifune,Yusei Miyazaki,Eri Takahashi,Seiji Kikuchi,Dawn Langdon,Ralph HB Benedict,Makoto Matsui: Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan. Multiple Sclerosis Journal. 2017.12; 26 (3): ( PubMed , DOI )

  3. Shuta Toru, Tadashi Kanouchi, Takanori Yokota, Yosuke Yagi, Akira Machida, Takayoshi Kobayashi: Utility of Autonomic Function Tests to Differentiate Dementia with Lewy Bodies and Parkinson Disease with Dementia from Alzheimer Disease. Eur. Neurol.. 2017.11; 79 (1-2): 27-32. ( PubMed , DOI )

  4. Yajun Hu, Yuji Hashimoto, Takashi Ishii, Mamut Rayle, Kazumasa Soga, Nozomu Sato, Michi Okita, Miwa Higashi, Kokoro Ozaki, Hidehiro Mizusawa, Kinya Ishikawa, Takanori Yokota: Sequence configuration of spinocerebellar ataxia type 8 repeat expansions in a Japanese cohort of 797 ataxia subjects. J. Neurol. Sci.. 2017.11; 382 87-90. ( PubMed , DOI )

  5. Tetsuya Kanai, Akiyuki Uzawa, Yasunori Sato, Shigeaki Suzuki, Naoki Kawaguchi, Keiichi Himuro, Fumiko Oda, Yukiko Ozawa, Jin Nakahara, Norihiro Suzuki, Yuko K Takahashi, Satoru Ishibashi, Takanori Yokota, Takashi Ogawa, Kazumasa Yokoyama, Nobutaka Hattori, Shoko Izaki, Satoru Oji, Kyoichi Nomura, Juntaro Kaneko, Kazutoshi Nishiyama, Ichiro Yoshino, Satoshi Kuwabara: A clinical predictive score for postoperative myasthenic crisis. Ann. Neurol.. 2017.11; 82 (5): 841-849. ( PubMed , DOI )

  6. Nishida Y., Winkler E., Sagare A., De Vivo D., Zlokovic B.: Decreased glucose transporter 1 expression at the blood-brain barrier exacerbates Alzheimer disease-like phenotypes in mouse models JOURNAL OF THE NEUROLOGICAL SCIENCES. 2017.10; 381 768. ( DOI )

  7. Yamada A., Numasawa Y., Hattori T., Ozaki K., Ishibashi S., Nishida Y., Kanouchi T., Sanjo N., Takanori Y.: Signal changes of skeletal muscle MRI in peripheral nerve disorders JOURNAL OF THE NEUROLOGICAL SCIENCES. 2017.10; 381 1068. ( DOI )

  8. Ichinose K., Ishibashi S., Miyashita A., Sanjo N., Uchida K., Suzuki Y., Sekine M., Kobayashi D., Eishi Y., Yokota T.: Clinicopathological features of neuromuscular sarcoidosis and its immunoreactivity profiles of P. acne JOURNAL OF THE NEUROLOGICAL SCIENCES. 2017.10; 381 465. ( DOI )

  9. Numasawa Y., Hattori T., Ishiai S., Kobayashi Z., Kamata T., Kotera M., Ishibashi S., Sanjo N., Mizusawa H., Yokota T.: Components of depressive disorder due to raphe-nuclei damage: Subclass analysis of patients with brainstem infarction JOURNAL OF THE NEUROLOGICAL SCIENCES. 2017.10; 381 636. ( DOI )

  10. Hamaguchi T., Sakai K., Kobayashi A., Kitamoto T., Ae R., Nakamura Y., Sanjo N., Arai K., Koide M., Katada F., Tsukamoto T., Mizusawa H., Yamada M.: Investigation of clinical and pathological features of "sporadic Creutzfeldt-Jakob disease" with history of neurosurgery to identify iatrogenic cases JOURNAL OF THE NEUROLOGICAL SCIENCES. 2017.10; 381 416-417. ( DOI )

  11. Y Anraku, H Kuwahara, Y Fukusato, A Mizoguchi, T Ishii, K Nitta, Y Matsumoto, K Toh, K Miyata, S Uchida, K Nishina, K Osada, K Itaka, N Nishiyama, H Mizusawa, T Yamasoba, T Yokota, K Kataoka: Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain. Nat Commun. 2017.10; 8 (1): 1001. ( PubMed , DOI )

  12. Yuki Kishimoto, Akane Fujii, Osamu Nakagawa, Tetsuya Nagata, Takanori Yokota, Yoshiyuki Hari, Satoshi Obika: Synthesis and thermal stabilities of oligonucleotides containing 2'-O,4'-C-methylene bridged nucleic acid with a phenoxazine base. Org. Biomol. Chem.. 2017.10; 15 (38): 8145-8152. ( PubMed , DOI )

  13. Nozomu Sato, Nozomi Toide, Mami Kizawa, Takuya Ohkubo, Satoru Ishibashi, Nobuo Sanjo, Takanori Yokota: Methotrexate-associated lymphoproliferative disorder in a patient with neuromyelitis optica spectrum disorder: An implication for pathogenesis mediated by Epstein-Barr virus. J. Neurol. Sci.. 2017.08; 379 219-221. ( PubMed , DOI )

  14. Yokote H, Kamata T, Toru S, Sanjo N, Yokota T: Serum retinol levels are associated with brain volume loss in patients with multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical. 2017.07; 3 (3): 2055217317729688. ( PubMed , DOI )

  15. Hiroaki Yokote,Tomoyuki Kamata,Nobuo Sanjo,Takanori Yokota: Serum retinol levels are associated with brain volume loss in patients with multiple sclerosis. Multiple Sclerosis Journal 2017. 2017.07; 3 (3): ( DOI )

  16. Maya Higuma,Nobuo Sanjo,Hiroshi Mitoma,Mitsuru Yoneyama,Takanori Yokota: Whole-day gait monitoring in patients with Alzheimer's disease: a relationship between attention and gait cycle. Journal of Alzheimer's Disease Reports 2017 . 2017.07; 1 (1): 1-8. ( DOI )

  17. Ohyagi M, Ishibashi S, Ohkubo T, Kobayashi Z, Mizusawa H, Yokota T, Emoto H, Kiyosawa M: Subacute Supranuclear Palsy in anti-Hu Paraneoplastic Encephalitis. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2017.07; 44 (4): 444-446. ( PubMed , DOI )

  18. Yoshiyuki Numasawa, Takaaki Hattori, Sumio Ishiai, Zen Kobayashi, Tomoyuki Kamata, Minoru Kotera, Satoru Ishibashi, Nobuo Sanjo, Hidehiro Mizusawa, Takanori Yokota.: Depressive disorder is associated with brainstem infarction involving raphe nuclei. Journal of Affective Disorders. 2017.04; (213): 191-198.

  19. Higuma M, Sanjo N, Mitoma H, Yoneyama M, Yokota T: Whole-Day Gait Monitoring in Patients with Alzheimer's Disease: A Relationship between Attention and Gait Cycle. Journal of Alzheimer's disease reports. 2017.04; 1 (1): 1-8. ( PubMed , DOI )

  20. Taro Ishiguro, Nozomu Sato, Morio Ueyama, Nobuhiro Fujikake, Chantal Sellier, Akemi Kanegami, Eiichi Tokuda, Bita Zamiri, Terence Gall-Duncan, Mila Mirceta, Yoshiaki Furukawa, Takanori Yokota, Keiji Wada, J. Paul Taylor, Christopher E. Pearson, Nicolas Charlet-Berguerand, Hidehiro Mizusawa, Yoshitaka Nagai, and Kinya Ishikawa: Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31. Neuron. 2017.04; 94 (1): 108-124. ( PubMed , DOI )

  21. Yoshiyuki Numasawa, Takaaki Hattori, Sumio Ishiai, Zen Kobayashi, Tomoyuki Kamata, Minoru Kotera, Satoru Ishibashi, Nobuo Sanjo, Hidehiro Mizusawa, Takanori Yokota: Depressive disorder may be associated with raphe nuclei lesions in patients with brainstem infarction. Journal of Affective Disorder. 2017.04; 213 191-198. ( PubMed , DOI )

  22. Yokota Takanori: 肝外臓器におけるDNA/RNAヘテロ二本鎖オリゴヌクレオチド(HDO)の作用(The effect of DNA/RNA heteroduplex oligonucleotide (HDO) in extrahepatic organs) Journal of Pharmacological Sciences. 2017.03; 133 (3Suppl.): S43. ( 医中誌 )

  23. Sakiko Chikazawa, Takaaki Hanafusa, Kokoro Ozaki, Takeshi Namiki, Maki Amano, Makiko Ueno, Shown Tokoro, Ken Igawa, Takefumi Sato, Kinya Ishikawa, Takanori Yokota, Hiroo Yokozeki: Incomplete Behçet's disease with calf muscle pain and MRI hyperintensity due to possible thrombophlebitis. Eur J Dermatol. 2017.02; 27 (1): 76-77. ( PubMed , DOI )

  24. Kazumasa Soga, Kinya Ishikawa, Tokuro Furuya, Tadatsune Iida, Tetsuo Yamada, Noboru Ando, Kiyobumi Ota, Hiromi Kanno-Okada, Shinya Tanaka, Masayuki Shintaku, Yoshinobu Eishi, Hidehiro Mizusawa, Takanori Yokota: Gene dosage effect in spinocerebellar ataxia type 6 homozygotes: A clinical and neuropathological study. J Neurol Sci. 2017.02; 373 321-328. ( PubMed , DOI )

  25. Keisuke Abe, Takuya Ohkubo, Takanori Yokota.: TDP-43 in the skin of amyotrophic lateral sclerosis patients. Journal of Medical and Dental Sciences. 2017.01; 64 (1): 9-17. ( PubMed , DOI )

  26. Yohsuke Yagi, Takuya Ohkubo, Hideya Kawaji, Akira Machida, Haruka Miyata, Saori Goda, Sugata Roy, Yoshihide Hayashizaki, Harukazu Suzuki, Takanori Yokota: Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes. Neurosci. Lett.. 2017.01; 636 48-57. ( PubMed , DOI )

  27. Maya Higuma, Nobuo Sanjo, Hiroshi Mitoma, Mitsuru Yoneyama, Takanori Yokota. : Whole-day gait monitoring in patients with Alzheimer disease: a relationship between attention and gait cycle. Journal of Alzheimer’s Disease Reports. 2017; 1 (1): 1-8.

  28. Iwasawa Eri, Ohkubo Takuya, Kanouchi Tadashi, Kanda Takashi, Mizusawa Hidehiro, Yokota Takanori: Long-term Effects of Intravenous Cyclophosphamide in Combination with Mesna Provided Intravenously and via Bladder Perfusion in a Patient with Severe Multifocal Motor Neuropathy INTERNAL MEDICINE. 2017; 56 (14): 1893-1896. ( PubMed , DOI )

  29. Rintaro Iwata Hara, Yuki Ogawa, Mihoko Noro, Takeshi Wada: Stereocontrolled Synthesis of P-Modified N-Acetylmannosamine-α-1-Phosphate Analogs Chemistry Letters. 2017; 46 1051-1053. ( DOI )

  30. Rintaro Iwata Hara, Satoshi Kobayashi, Mihoko Noro, Kazuki Sato, Takeshi Wada: Synthesis and properties of 2-deoxy-2-fluoromannosyl phosphate derivatives Tetrahedron. 2017; 73 4560-4565. ( DOI )

  31. Rintaro Iwata Hara, Masayuki kageyama, Koichiro Arai, Naoki Uchiyama, Takeshi Wada: Synthesis of 2'-O-monohaloethoxymethyl-modified RNAs and their duplex formation ability RSC Advances. 2017; 7 41297-41303. ( DOI )

  32. Rintaro Iwata Hara, Yusuke Maeda, Taiichi Sakamoto, Takeshi Wada: Double-stranded RNA-binding artificial cationic oligosaccharides stabilizing siRNAs with a low N/P ratio Organic & Biomolecular Chemistry. 2017; 15 (36): 1710-1717. ( DOI )

  1. Nobuko Yamaguchi, Sonoko Misawa, Yasunori Sato, Kengo Nagashima, Kanako Katayama, Yukari Sekiguchi, Yuta Iwai, Hiroshi Amino, Tomoki Suichi, Takanori Yokota, Yoichiro Nishida, Nobuo Kohara, Koichi Hirata, Kazutoshi Nishiyama, Ichiro Yabe, Ken-Ichi Kaida, Norihiro Suzuki, Hiroyuki Nodera, Shoji Tsuji, Haruki Koike, Jun-Ichi Kira, Hideki Hanaoka, Susumu Kusunoki, Satoshi Kuwabara, : A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS). JMIR Res Protoc. 2016.11; 5 (4): e210. ( PubMed , DOI )

  2. Nobutaka Ishizu, Daishi Yui, Akira Hebisawa, Hidenori Aizawa, Wanpeng Cui, Yuko Fujita, Kenji Hashimoto, Itsuki Ajioka, Hidehiro Mizusawa, Takanori Yokota, Kei Watase: Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice. Hum. Mol. Genet.. 2016.10; 25 (20): 4507-4517. ( PubMed , DOI )

  3. Ryo Yamasaki, Takuya Matsushita, Toshiyuki Fukazawa, Kazumasa Yokoyama, Kazuo Fujihara, Mieko Ogino, Takanori Yokota, Katsuichi Miyamoto, Masaaki Niino, Kyoichi Nomura, Ryo Tomioka, Masami Tanaka, Izumi Kawachi, Takashi Ohashi, Ken-Ichi Kaida, Makoto Matsui, Yuji Nakatsuji, Hirofumi Ochi, Hikoaki Fukaura, Takashi Kanda, Akiko Nagaishi, Kanae Togo, Hidehiro Mizusawa, Hiroyuki Murai, Jun-Ichi Kira: Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica. Mult. Scler.. 2016.09; 22 (10): 1337-1348. ( PubMed , DOI )

  4. Hamaguchi Tsuyoshi, Taniguchi Yu, Sakai Kenji, Kitamoto Tetsuyuki, Takao Masaki, Murayama Shigeo, Iwasaki Yasushi, Yoshida Mari, Shimizu Hiroshi, Kakita Akiyoshi, Takahashi Hitoshi, Suzuki Hiroyoshi, Naiki Hironobu, Sanjo Nobuo, Mizusawa Hidehiro, Yamada Masahito: Significant association of cadaveric dura mater grafting with subpial A beta deposition and meningeal amyloid angiopathy ACTA NEUROPATHOLOGICA. 2016.08; 132 (2): 313-315. ( PubMed , DOI )

  5. Koya Ono, Ken Murata, Toshinari Arai, Tomoyuki Kino, Keisuke Onaka, Satoru Takahashi, Hirotaka Sato, Hiroya Kuwahara: Posterior reversible encephalopathy syndrome after iron administration in a patient with chronic severe anemia. Journal of the Neurological Sciences. 2016.08; 367 333-334. ( PubMed , DOI )

  6. Mitsuru Yoneyama,Hiroshi Mitoma,Nobuo Sanjo, Maya Higuma,Hiroo Terashi,Takanori Yokota: Ambulatory Gait Behavior in Patients with Dementia: A Comparison with Parkinson's Disease. Transactions on Neural System and Rehabilitation Engineering 2015 . 2016.08; 24 (8): 817-826. ( PubMed , DOI )

  7. Iwata Masaaki, Ota Kristie T, Li Xiao-Yuan, Sakaue Fumika, Li Nanxin, Dutheil Sophie, Banasr Mounira, Duric Vanja, Yamanashi Takehiko, Kaneko Koichi, Rasmussen Kurt, Glasebrook Andrew, Koester Anja, Song Dekun, Jones Kenneth A, Zorn Stevin, Smagin Gennady, Duman Ronald S: Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor. Biol Psychiatry. 2016.07; 80 (1): 12-22. ( PubMed , DOI )

  8. Eri Iwasawa, Masahiko Ichijo, Satoru Ishibashi, Takanori Yokota: Acute development of collateral circulation and therapeutic prospects in ischemic stroke. Neural Regen Res. 2016.03; 11 (3): 368-371. ( PubMed , DOI )

  9. Nakamura Tsutomu, Arima-Yoshida Fumiko, Sakaue Fumika, Nasu-Nishimura Yukiko, Takeda Yasuko, Matsuura Ken, Akshoomoff Natacha, Mattson Sarah N, Grossfeld Paul D, Manabe Toshiya, Akiyama Tetsu: PX-RICS-deficient mice mimic autism spectrum disorder in Jacobsen syndrome through impaired GABAA receptor trafficking. Nat Commun. 2016.03; 7 10861. ( PubMed , DOI )

  10. Nobuo Sanjo,Satoko Kina,Yukiko Shishido-Hara,Yurie Nose,Satoru Ishibashi,Tetsuya Fukuda,Taketoshi Maehara,Yoshinobu Eishi,Hidehiro Mizusawa,Takanori Yokota: A Case of Progressive Multifocal Leukoencephalopathy with Balanced CD4/CD8 T-Cell Infiltration and Good Response to Mefloquine Treatment. Internal Medicine. 2016.01; 55 (12): 1631-1635. ( PubMed , DOI )

  11. Eric Vallabh Minikel,Sonia M. Vallabh,Monkol Lek,Karol O. Estrada,Kaitline E. Samocya,J. Fah Sathirapongsasuti,Cory Y. McLean,Joice Y. Tung,Linda P.C.Yu, Pierluigi Gambetti,Janis Blevins,Shuling Zhamg,Yvonne Cohen,Wei Chen,Masahito Yamada,Tsuyoshi Hamaguchi,Nobuo Sanjo,Hidehiro Mizusawa,Yoshikazu Nakamura,Tetsuyuki Kitamoto,Steven J. Collins,Alison Boyd,Robert G Will,Richard Knight,Claudia Ponto,Inga Zerr,Theo Kraus,Sabina Eigenbrod,Armin Giese,Jesus de Pedro Cuesta,Stéphane Haïk,Jean-Louis Laplanche,Jean Philippe Brandel,Michael Boenke,Markku Laakso,Karen Mohlke,Francis S.Collins,Anna Kähler,Kinberly Chambert, Steven McCarroll,Patrick Sullivan,Christina M. Hultman,Shaun M.Purcell,Pamela Sklar,Cornelia M.van Dujin,F.Rivadeneira Ramirez,Arfan Ikram,Sven J.van der Lee,Jeannette M.Vergeer-Drop,André G.Uitterlinden,Mark J.Daley,Daniel G.MacArthur,: Quantifying prion disease penetrance using large population control cohorts. Science Translational Medicine 2016. 2016.01; 8 (322): 322R9-322RA9. ( PubMed , DOI )

  12. Yutaro Asami, Kotaro Yoshioka, Kazutaka Nishina, Tetsuya Nagata, Takanori Yokota: Drug delivery system of therapeutic oligonucleotides. Drug Discov Ther. 2016; 10 (5): 256-262. ( PubMed , DOI )

  13. Mitsuru Yoneyama, Hiroshi Mitoma, Nobuo Sanjo, Maya Higuma, Hiroo Terashi, Takanori Yokota: Ambulatory Gait Behavior in Patients with Dementia: A Comparison with Parkinson’s Disease. Transactions on Neural System and Rehabilitation Engineering. 2016; 24 (8): 817-826.

  14. Ishimura Yuko, Tsukamoto Tadashi, Kuwata Kazuo, Yamada Masahito, Doh-ura Katsumi, Tsuboi Yoshio, Sato Katsuya, Nakamura Yoshikazu, Sanjo Nobuo, Tamura Chieko, Mizusawa Hidehiro: The Japan Consortium of Prion Disease (JACOP) for patients' registration and clinical studies of Prion diseases in Japan PRION. 2016; 10 S106-S107.

  15. Furukawa Fumiko, Sanjo Nobuo, Kobayashi Atsushi, Hamaguchi Tsuyoshi, Yamada Masahito, Kitamoto Tetsuyuki, Mizusawa Hidehiro, Yokota Takanori: Differential association of amyloid-beta with PrPSc pathology in each genetic prion disease PRION. 2016; 10 S85-S86.

  16. Yamada Masahito, Hamaguchi Tsuyoshi, Sakai Kenji, Nozaki Ichiro, Noguchi-Shinohara Moeko, Sanjo Nobuo, Tsukamoto Tadashi, Ae Ryusuke, Nakamura Yosikazu, Kitamoto Tetsuyuki, Mizusawa Hidehiro: Epidemiological and clinical features of human prion diseases in Japan: Prospective 17-year surveillance PRION. 2016; 10 S10-S11.

  17. Yamada K, Kobayashi H, Bo R, Takahashi T, Purevsuren J, Hasegawa Y, Taketani T, Fukuda S, Ohkubo T, Yokota T, Watanabe M, Tsunemi T, Mizusawa H, Takuma H, Shioya A, Ishii A, Tamaoka A, Shigematsu Y, Sugie H, Yamaguchi S: Clinical, biochemical and molecular investigation of adult-onset glutaric acidemia type II: Characteristics in comparison with pediatric cases. Brain Dev. 2016; 38 (3): 293-301.

  18. Enomoto M, Hirai T, Kaburagi H, Yokota T: Efficient Gene Suppression in Dorsal Root Ganglia and Spinal Cord Using Adeno-associated Virus Vectors Encoding Short-Hairpin RNA. Methods Mol Biol. 2016; 1364 277-290.

  1. Masahiro Murakami, Kazutaka Nishina, Chie Watanabe, Kie Yoshida-Tanaka, Wenying Piao, Hiroya Kuwahara, Yuji Horikiri, Kanjiro Miyata, Nobuhiro Nishiyama, Kazunori Kataoka, Masayuki Yoshida, Hidehiro Mizusawa, Takanori Yokota.: Enteral siRNA delivery technique for therapeutic gene silencing in the liver via the lymphatic route. Scientific Reports. 2015.11; 5 17035. ( PubMed , DOI )

  2. Kotaro Yoshioka, Kosuke Watanabe, Satoshi Zeniya, Yoko Ito, Masaki Hizume, Toshiro Kanazawa, Makoto Tomita, Satoru Ishibashi, Hirotomo Miake, Hiroaki Tanaka, Takanori Yokota, Hidehiro Mizusawa: A Score for Predicting Paroxysmal Atrial Fibrillation in Acute Stroke Patients: iPAB Score. J Stroke Cerebrovasc Dis. 2015.10; 24 (10): 2263-2269. ( PubMed , DOI )

  3. M Ichijo, E Iwasawa, Y Numasawa, K Miki, S Ishibashi, M Tomita, H Tomimitsu, T Kamata, H Fujigasaki, S Shintani, H Mizusawa: Significance of Development and Reversion of Collaterals on MRI in Early Neurologic Improvement and Long-Term Functional Outcome after Intravenous Thrombolysis for Ischemic Stroke. AJNR Am J Neuroradiol. 2015.10; 36 (10): 1839-1845. ( PubMed , DOI )

  4. Murai H., Nakamura Y., Kitamoto T., Tsuboi Y., Sanjo N., Yamada M., Mizusawa H., Kira J.: Clinical and epidemiological survey of gerstmann-strausslerscheinker disease with codon 102 mutation in Japan JOURNAL OF THE NEUROLOGICAL SCIENCES. 2015.10; 357 E114. ( DOI )

  5. Yoneyama M, Mitoma H, Higuma M, Sanjo N, Yokota T, Terashi H: Ambulatory Gait Behavior in Patients with Dementia: A Comparison with Parkinson's Disease. IEEE Trans Neural Syst Rehabil Eng. 2015.09;

  6. Kazutaka Nishina, Wenying Piao, Kie Yoshida-Tanaka, Yumiko Sujino, Tomoko Nishina, Tsuyoshi Yamamoto, Keiko Nitta, Kotaro Yoshioka, Hiroya Kuwahara, Hidenori Yasuhara, Takeshi Baba, Fumiko Ono, Kanjiro Miyata, Koichi Miyake, Punit P Seth, Audrey Low, Masayuki Yoshida, C Frank Bennett, Kazunori Kataoka, Hidehiro Mizusawa, Satoshi Obika, Takanori Yokota: DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing. Nat Commun. 2015.08; 6 7969. ( PubMed , DOI )

  7. Hiroya Kuwahara, Kazutaka Nishina, Takanori Yokota.: Blood-brain barrier: a novel therapeutic target in multiple sclerosis. Clinical and Experimental Neuroimmunology.. 2015.05; 6 (2): 129-138. ( DOI )

  8. Yohsuke Yagi, Hiroaki Yokote, Yukiko Watanabe, Takeshi Amino, Tomoyuki Kamata, Susumu Kusunoki: Taste impairment in Miller Fisher syndrome. Neurol. Sci.. 2015.05; 36 (5): 809-810. ( PubMed , DOI )

  9. Ethan A Winkler, Yoichiro Nishida, Abhay P Sagare, Sanket V Rege, Robert D Bell, David Perlmutter, Jesse D Sengillo, Sara Hillman, Pan Kong, Amy R Nelson, John S Sullivan, Zhen Zhao, Herbert J Meiselman, Rosalinda B Wenby, Jamie Soto, E Dale Abel, Jacob Makshanoff, Edward Zuniga, Darryl C De Vivo, Berislav V Zlokovic: GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat. Neurosci.. 2015.04; 18 (4): 521-530. ( PubMed , DOI )

  10. Furukawa Fumiko, Sanjo Nobuo, Higuma Maya, Kitamoto Tetsuyuki, Hizume Masaki, Nakamura Yoshikazu, Yukamoto Tadashi, Murayama Shigeo, Koshi Kagari, Matsukawa Takashi, Tsuji Shoji, Goto Jun, Yamada Masahito, Mizusawa Hidehiro, Yokota Takanori: Clinical features in Gerstmann-Straussler-Scheinker syndrome with P105L mutation PRION. 2015.04; 9 S16.

  11. Minikel Eric Vallabh, Vallabh Sonia M., Lek Monkol, Estrada Karol O., Samocha Kaitlin E., Sathirapongsasuti J. Fah, McLean Cory Y., Tung Joyce Y., Yu Linda P. C., Gambetti Pierluigi, Blevins Janis, Zhang Shulin, Cohen Yvonne, Chen Wei, Yamada Masahito, Hamaguchi Tsuyoshi, Sanjo Nobuo, Mizusawa Hidehiro, Nakamura Yosikazu, Kitamoto Tetsuyuki, Collins Steven J., Boyd Alison, Will Robert G., Knight Richard, Ponto Claudia, Zerr Inga, Kraus Theo F. J., Eigenbrod Sabina, Giese Armin, Calero Miguel, de Pedro-Cuesta Jesus, Haik Stephane, Laplanche Jean-Louis, Bouaziz-Amar Elodie, Brandel Jean-Philippe, Capellari Sabina, Parchi Piero, O'Donnell-Luria Anne H., Karczewski Konrad J., Marshall Jamie L., Boehnke Michael, Laakso Markku, Mohlke Karen L., Kahler Anna, Chambert Kimberly, McCarroll Steven, Sullivan Patrick F., Hultman Christina M., Purcell Shaun M., Sklar Pamela, van der Lee Sven J., Rozemuller Annemieke, Jansen Casper, Hofman Albert, Kraaij Robert, van Rooij Jeroen G. J., Ikram M. Arfan, Uitterlinden Andre G., van Duijn Cornelia M., Daly Mark J., MacArthur Daniel G.: Assessing the pathogenicity of rare PRNP variants by comparing case and control allele frequency PRION. 2015.04; 9 S90-S91.

  12. Hamaguchi Tsuyoshi, Sakai Kenji, Noguchi-Shinohara Moeko, Nozaki Ichiro, Takumi Ichiro, Sanjo Nobuo, Nakamura Yosikazu, Kitamoto Tetsuyuki, Saito Nobuhito, Mizusawa Hidehiro, Yamada Masahito: A comparative study of dura mater graft-associated Creutzfeldt-Jakob disease between Japan and other countries PRION. 2015.04; 9 S23-S24.

  13. Colangelo Christopher M, Ivosev Gordana, Chung Lisa, Abbott Thomas, Shifman Mark, Sakaue Fumika, Cox David, Kitchen Robert R, Burton Lyle, Tate Stephen A, Gulcicek Erol, Bonner Ron, Rinehart Jesse, Nairn Angus C, Williams Kenneth R: Development of a highly automated and multiplexed targeted proteome pipeline and assay for 112 rat brain synaptic proteins. Proteomics. 2015.04; 15 (7): 1202-1214. ( PubMed , DOI )

  14. Tomoko Nishina, Junna Numata, Kazutaka Nishina, Kie Yoshida-Tanaka, Keiko Nitta, Wenying Piao, Rintaro Iwata, Shingo Ito, Hiroya Kuwahara, Takeshi Wada, Hidehiro Mizusawa, Takanori Yokota.: Chimeric Antisense Oligonucleotide Conjugated to α-Tocopherol. Mol Ther Nucleic Acids.. 2015.01; 4 e220. ( PubMed , DOI )

  15. Ohmori H, Hara A, Ishikawa K, Mizusawa H, Ando Y: Clinical characteristics of combined cases of spinocerebellar ataxia types 6 and 31. J Neurogenet. 2015; 29 (2-3): 80-4.

  16. Pedroso JL, Abrahao A, Ishikawa K, Raskin S, de Souza PV, de Rezende Pinto WB, Braga-Neto P, de Albuquerque MV, Mizusawa H, Barsottini OG: When should we test patients with familial ataxias for SCA31? A misdiagnosed condition outside Japan? J Neurol Sci. 2015; 355 (1-2): 206-208.

  17. Yagi Y, Yokote H, Watanabe Y, Amino T, Kamata T, Kusunoki S: Taste impairment in Miller Fisher syndrome. Neurol Sci. 2015; 36 (5): 809-810.

  18. Ohyagi M, Nakamura K, Watanabe M, Fujigasaki H: Embolic stroke during apixaban therapy for left atrial appendage thrombus. J Stroke Cerebrovasc Dis. 2015; 24 (4): e101-102.

  19. Ozaki K, Sanjo N, Ishikawa K, Higashi M, Hattori T, Tanuma N, Miyata R, Hayashi M, Yokota T, Okawa A, Mizusawa H: Elevation of 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of three patients with superficial siderosis. Neurol Clin Neurosci. 2015; 3 (3): 108-110.

  20. Ozaki K, Irioka T, Ishikawa K, Mizusawa H: CADASIL with a novel NOTCH3 mutation (Cys478Tyr). J Stroke Cerebrovasc Dis. 2015; 24 (3): e61-62.

  21. Mitsui J, Matsukawa T, Sasaki H, Yabe I, Matsushima M, Dürr A, Brice A, Takashima H, Kikuchi A, Aoki M, Ishiura H, Yasuda T, Date H, Ahsan B, Iwata A, Goto J, Ichikawa Y, Nakahara Y, Momose Y, Takahashi Y, Hara K, Kakita A, Yamada M, Takahashi H, Onodera O, Nishizawa M, Watanabe H, Ito M, Sobue G, Ishikawa K, Mizusawa H, Kanai K, Hattori T, Kuwabara S, Arai K, Koyano S, Kuroiwa Y, Hasegawa K, Yuasa T, Yasui K, Nakashima K, Ito H, Izumi Y, Kaji R, Kato T, Kusunoki S, Osaki Y, Horiuchi M, Kondo T, Murayama S, Hattori N, Yamamoto M, Murata M, Satake W, Toda T, Filla A, Klockgether T, Wüllner U, Nicholson G, Gilman S, Tanner CM, Kukull WA, Stern MB, Lee VM, Trojanowski JQ, Masliah E, Low PA, Sandroni P, Ozelius LJ, Foroud T, Tsuji S: Variants associated with Gaucher disease in multiple system atrophy. Ann Clin Transl Neurol. 2015; 2 (4): 417-426.

  22. Takenouchi T, Ohyagi M, Torii C, Kosaki R, Takahashi T, Kosaki K: Porencephaly in a fetus and HANAC in her father: variable expression of COL4A1 mutation. Am J Med Genet A. 2015; 167A (1): 156-158.

  23. Nishida Y, Ueda A, Ando Y, Ichikawa T: Skin biopsy-based diagnosis of CADASIL with atypical MRI findings. Intern Med. 2015; 54 (5): 537-538.

  24. Kimura K, Morita H, Daimon M, Kawata T, Nakao T, Lee SL, Hirokawa M, Ebihara A, Nakajima T, Ozawa T, Yonemochi Y, Aida I, Motoyoshi Y, Mikata T, Uchida I, Komori T, Kitao R, Nagata T, Takeda S, Komaki H, Segawa K, Takenaka K, Komuro I : Prognostic impact of venous thromboembolism in patients with Duchenne muscular dystrophy: Prospective multicenter 5-year cohort study. Int J Cardiol. 2015; 191 178-180.

  25. Echigoya Y, Aoki Y, Miskew B, Panesar D, Touznik A, Nagata T, Tanihata J, Nakamura A, Nagaraju K, Yokota T: Long-term efficacy of systemic multiexon skipping targeting dystrophin exons 45-55 with a cocktail of vivo-morpholinos in mdx52 mice. Mol Ther Nucleic Acids. 2015; 4 e225.

  26. Colangelo CM, Ivosev G, Chung L, Abbott T, Shifman M, Sakaue F, Cox D, Kitchen RR, Burton L, Tate SA, Gulcicek E, Bonner R, Rinehart J, Nairn AC, Williams KR: Development of a highly automated and multiplexed targeted proteome pipeline and assay for 112 rat brain synaptic proteins. Proteomics. 2015; 15 (7): 1202-1214.

  27. Masaki Y, Inde T, Nagata T, Tanihata J, Kanamori T, Seio K, Takeda S, Sekine M: Enhancement of exon skipping in mdx52 mice by 2’-O-methyl-2-thioribothymidine incorporation into phosphorothioate oligonucleotides. Med Chem Commun. 2015; 6 630-633.

  28. Yabe I, Matsushima M, Yoshida K, Ishikawa K, Shirai S, Takahashi I, Sasaki H: Rare frequency of downbeat positioning nystagmus in spinocerebellar ataxia type 31. J Neurol Sci. 2015; 350 (1-2): 90-92.

  29. Ishibashi K, Miura Y, Ishikawa K, Ishii K, Ishiwata K: Decreased metabotropic glutamate receptor type 1 availability in a patient with spinocerebellar ataxia type 6: A (11)C-ITMM PET study. J Neurol Sci. 2015; 355 (1-2): 202-205.

  30. Nakamaura Y, Ae R, Takumi I, Sanjo N, Kitamoto T, Yamada M, Mizusawa H: Descriptive epidemiology of prion disease in Japan: 1999-2012. J Epidemiol. 2015; 25 (1): 8-14.

  31. Obayashi M, Stevanin G, Synofzik M, Monin ML, Duyckaerts C, Sato N, Streichenberger N, Vighetto A, Desestret V, Tesson C, Wichmann HE, Illig T, Huttenlocher J, Kita Y, Izumi Y, Mizusawa H, Schöls L, Klopstock T, Brice A, Ishikawa K, Dürr A: Spinocerebellar ataxia type 36 exists in diverse populations and can be caused by a short hexanucleotide GGCCTG repeat expansion. J Neurol Neurosurg Psychiatry. 2015; 86 (9): 986-995.

  32. Rintaro Iwata, Akiko Doi, Yusuke Maeda, Takeshi Wada: Synthesis of oligodiaminomannoses and analysis of their RNA duplex binding properties and their potential application as siRNA-based drugs Organic Biomolecular Chemistry. 2015; 13 9504-9515. ( DOI )

  33. Yosikazu Nakamaura, Ryusuke Ae, Ichiro Takumi, Nobuo Sanjo, Tetsuyuki Kitamoto, Masahito Yamada, Hidehiro Mizusawa. : Descriptive epidemiology of prion disease in Japan: 1999-2012. Journal of Epidemiology . 2015; 25 (1): 8-14.

  34. Yoichiro Nishida, Akihiko Ueda, Yukio Ando, Tadashi Ichikawa: Skin Biopsy-based Diagnosis of CADASIL with Atypical MRI Findings. Intern. Med.. 2015; 54 (5): 537-538. ( PubMed , DOI )

  35. Masahiko Ichijo, Satoru Ishibashi, Fuying Li, Daishi Yui, Kazunori Miki, Hidehiro Mizusawa, Takanori Yokota: Sphingosine-1-Phosphate Receptor-1 Selective Agonist Enhances Collateral Growth and Protects against Subsequent Stroke. PLoS ONE. 2015; 10 (9): e0138029. ( PubMed , DOI )

  36. Daishi Yui, Yoichiro Nishida, Tomoko Nishina, Kaoru Mogushi, Mio Tajiri, Satoru Ishibashi, Itsuki Ajioka, Kinya Ishikawa, Hidehiro Mizusawa, Shigeo Murayama, Takanori Yokota: Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme. PLoS ONE. 2015; 10 (12): e0143518. ( PubMed , DOI )

  37. Iwata R, Nakayama F, Hirochi S, Sato K, Piao W, Nishina K, Yokota T, Wada T: Synthesis and properties of vitamin E analog-conjugated neomycin for delivery of RNAi drugs to liver cells. Bioorg Med Chem Lett. 2015; 25 (4): 815-819.

  38. Yui D, Nishida Y, Nishina T, Mogushi K, Tajiri M, Ishibashi S, Ajioka I, Ishikawa K, Mizusawa H, Murayama S, Yokota T: Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme. PLoS One. 2015; 10 (12): e0143518.

  39. Azuma R, Ishikawa K, Hirata K, Hashimoto Y, Takahashi M, Ishii K, Inaba A, Yokota T, Orimo S: A novel mutation of PDE8B Gene in a Japanese family with autosomal-dominant striatal degeneration. Mov Disord. 2015; 30 (14): 1964-1967.

  40. Murakami M, Nishina K, Watanabe C, Yoshida-Tanaka K, Piao W, Kuwahara H, Horikiri Y, Miyata K, Nishiyama N, Kataoka K, Yoshida M, Mizusawa H, Yokota T: Enteral siRNA delivery technique for therapeutic gene silencing in the liver via the lymphatic route. Sci Rep. 2015; 5 17035.

  41. Nishina T, Numata J, Nishina K, Yoshida-Tanaka K, Nitta K, Piao W, Iwata R, Ito S, Kuwahara H, Wada T, Mizusawa H, Yokota T: Chimeric Antisense Oligonucleotide Conjugated to α- Tocopherol. Mol Ther Nucleic Acids. 2015; 4 e220.

  42. Nishina K, Piao W, Yoshida-Tanaka K, Sujino Y, Nishina T, Yamamoto T, Nitta K, Yoshioka K, Kuwahara H, Yasuhara H, Baba T, Ono F, Miyata K, Miyake K, Seth PP, Low A, Yoshida M, Bennett CF, Kataoka K, Mizusawa H, Obika S, Yokota T: DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing. Nat Commun. 2015; 6 7969.

  43. Yoshioka K, Watanabe K, Zeniya S, Ito Y, Hizume M, Kanazawa T, Tomita M, Ishibashi S, Miake H, Tanaka H, Yokota T, Mizusawa H: A Score for Predicting Paroxysmal Atrial Fibrillation in Acute Stroke Patients: iPAB Score. J Stroke Cerebrovasc Dis. 2015; 24 (10): 2263-2269.

  44. Hattori T, Arai A, Yokota T, Imadome K, Tomimitsu H, Miura O, Mizusawa H: Immune-mediated Neuropathy with Epstein-Barrvirus-positive T-cell Lymphoproliferative Disease. Intern Med. 2015; 54 (1): 69-73.

  45. Mizutani S, Usui N, Yokota T, Mizusawa H, Taira M, Katsuyama N: Depth perception from moving cast shadow in macaque monkey. Behav Brain Res. 2015; 288 63-70.

  46. Ozaki K, Doi H, Mitsui J, Sato N, Iikuni Y, Majima T, Yamane K, Irioka T, Ishiura H, Doi K, Morishita S, Higashi M, Sekiguchi T, Koyama K, Ueda N, Miura Y, Miyatake S, Matsumoto N, Yokota T, Tanaka F, Tsuji S, Mizusawa H, Ishikawa K: A Novel Mutation in ELOVL4 Leading to Spinocerebellar Ataxia (SCA) With the Hot Cross Bun Sign but Lacking Erythrokeratodermia: A Broadened Spectrum of SCA34. JAMA Neurol. 2015; 72 (7): 797-805.

  47. Yokote H, Nose Y, Ishibashi S, Tanaka K, Takahashi T, Fujihara K, Yokota T, Mizusawa H: Spinal cord ring enhancement in patients with neuromyelitis optica. Acta Neurol Scand. 2015; 132 (1): 37-41.

  48. Hashimoto Y, Honda T, Matsumura K, Nakao M, Soga K, Katano K, Yokota T, Mizusawa H, Nagao S, Ishikawa K: Quantitative evaluation of human cerebellum-dependent motor learning through prism adaptation of hand-reaching movement. PLoS One. 2015; 10 (3): e0119376.

  49. Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S, Kong P, Nelson AR, Sullivan JS, Zhao Z, Meiselman HJ, Wenby RB, Soto J, Abel ED, Makshanoff J, Zuniga E, De Vivo DC, Zlokovic BV: GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci. 2015; 18 (4): 521-530.

  50. Aikawa T, Mogushi K, Iijima-Tsutsui K, Ishikawa K, Sakurai M, Tanaka H, Mizusawa H, Watase K: Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model. Hum Mol Genet. 2015; 24 (17): 4780-4791.

  1. Yosikazu Nakamaura, Ryusuke Ae, Ichiro Takumi, Nobuo Sanjo, Tetsuyuki Kitamoto, Masahito Yamada, Hidehiro Mizusawa: Descriptive Epidemiology of Prion Disease in Japan: 1999-2012. J Epidemiol. 2014.10; ( PubMed )

  2. Kazuo Iwasa, Keisuke Shima, Kiyonobu Komai, Yoichiro Nishida, Takanori Yokota, Masahito Yamada: Retinitis pigmentosa and macular degeneration in a patient with ataxia with isolated vitamin E deficiency with a novel c.717 del C mutation in the TTPA gene. J. Neurol. Sci.. 2014.10; 345 (1-2): 228-230. ( PubMed , DOI )

  3. Fumiko Furukawa, Satoru Ishibashi, Nobuo Sanjo, Hiroshi Yamashita, Hidehiro Mizusawa: Serial magnetic resonance imaging changes in sporadic Creutzfeldt-Jakob disease with valine homozygosity at codon 129 of the prion protein gene. JAMA Neurol. 2014.09; 71 (9): 1186-1187. ( PubMed , DOI )

  4. Masahiko Ichijo, Satoru Ishibashi, Takuya Ohkubo, Shosaku Nomura, Nobuo Sanjo, Takanori Yokota, Hidehiro Mizusawa: Elevated platelet microparticle levels after acute ischemic stroke with concurrent idiopathic thrombocytopenic purpura. J Stroke Cerebrovasc Dis. 2014.03; 23 (3): 587-589. ( PubMed , DOI )

  5. Rintaro Iwata, Kazutaka Nishina, Takanori Yokota, Takeshi Wada: Synthesis and properties of double-stranded RNA-bindable oligodiaminogalactose derivatives conjugated with vitamin E BIOORGANIC & MEDICINAL CHEMISTRY. 2014.02; 22 (4): 1394-1403. ( DOI )

  6. Hirai Takashi, Enomoto Mitsuhiro, Kaburagi Hidetoshi, Sotome Shinichi, Yoshida-Tanaka Kie, Ukegawa Madoka, Kuwahara Hiroya, Yamamoto Mariko, Tajiri Mio, Miyata Haruka, Hirai Yukihiko, Tominaga Makoto, Shinomiya Kenichi, Mizusawa Hidehiro, Okawa Atsushi, Yokota Takanori.: Intrathecal AAV serotype 9-mediated delivery of shRNA against TRPV1 attenuates thermal hyperalgesia in a mouse model of peripheral nerve injury. Molecular Therapy.. 2014.02; 22 (2): 409-419. ( PubMed , DOI )

  7. Kuwahara Hiroya, Tsuchiya Kuniaki, Kobayashi Zen, Inaba Akira, Akiyama Haruhiko, Mizusawa Hidehiro.: Cryptococcal meningitis accompanying lymphocytic inflammation predominantly in cerebral deep white matter: a possible manifestation of immune reconstitution inflammatory syndrome. Neuropathology.. 2014.02; 34 (1): 45-48. ( PubMed , DOI )

  8. Teruhiko Sekiguchi, Tadashi Kanouchi, Kazumoto Shibuya, Yu-ichi Noto, Yohsuke Yagi, Akira Inaba, Keisuke Abe, Sonoko Misawa, Satoshi Orimo, Takayoshi Kobayashi, Tomoyuki Kamata, Masanori Nakagawa, Satoshi Kuwabara, Hidehiro Mizusawa, Takanori Yokota: Spreading of amyotrophic lateral sclerosis lesions--multifocal hits and local propagation? J. Neurol. Neurosurg. Psychiatr.. 2014.01; 85 (1): 85-91. ( PubMed , DOI )

  9. Yu Mizuno, Yasuhisa Sakurai, Izumi Sugimoto, Keiko Ichinose, Shoichiro Ishihara, Nobuo Sanjo, Hidehiro Mizusawa, Toru Mannen: Delayed leukoencephalopathy after carbon monoxide poisoning presenting as subacute dementia. Intern. Med.. 2014; 53 (13): 1441-1445. ( PubMed )

  10. Temu Qina, Nobuo Sanjo, Masaki Hizume, Maya Higuma, Makoto Tomita, Ryuichiro Atarashi, Katsuya Satoh, Ichiro Nozaki, Tsuyoshi Hamaguchi, Yosikazu Nakamura, Atsushi Kobayashi, Tetsuyuki Kitamoto, Shigeo Murayama, Hiroyuki Murai, Masahito Yamada, Hidehiro Mizusawa: Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene. BMJ Open. 2014; 4 (5): e004968. ( PubMed , DOI )

  11. Temu Qina, Nobuo Sanjo, Masaki Hizume, Maya Higuma, Makoto Tomita, Ryuichiro Atarashi, Katsuya Satoh, Ichiro Nozaki, Tsuyoshi Hamaguchi, Yosikazu Nakamura, Atsushi Kobayashi, Tetsuyuki Kitamoto, Shigeo Murayama, Hiroyuki Murai, Masahito Yamada, Hidehiro Mizusawa.: Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene. BMJ Open . 2014; 4 (5): e004968.

  12. Furukawa Fumiko, Sanjo Nobuo, Kobayashi Atsushi, Kitamoto Tetsuyuki, Shiraishi Atsushi, Ishikawa Kinya, Honda Haruhisa, Yamada Masahito, Mizusawa Hidehiro: Clinical features of Gerstmann-Straussler-Scheinker syndrome with a P105L mutation and a valine-encoding polymorphic codon 129 in the prion protein gene PRION. 2014; 8 130-131.

  1. Kuwahara Hiroya, Suzuki Shigeharu, Matsumura Ken, Watanabe Mutsufusa, Yakushiji Fumiatsu, Fujigasaki Hiroto.: Ocular flutter, generalized myoclonus, and truncal ataxia in a patient with Graves' ophthalmopathy. Journal of Neurology.. 2013.11; 260 (11): 2906-2907. ( PubMed , DOI )

  2. Tsuyoshi Hamaguchi, Kenji Sakai, Moeko Noguchi-Shinohara, Ichiro Nozaki, Ichiro Takumi, Nobuo Sanjo, Atsuko Sadakane, Yosikazu Nakamura, Tetsuyuki Kitamoto, Nobuhito Saito, Hidehiro Mizusawa, Masahito Yamada: Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan. J. Neurol. Neurosurg. Psychiatr.. 2013.10; 84 (10): 1171-1175. ( PubMed , DOI )

  3. Yohsuke Yagi, Yukiko Watanabe, Hiroaki Yokote, Takeshi Amino, Tomoyuki Kamata: Cervical dystonia in an Alzheimer's disease patient treated with donepezil. Acta Neurol Belg. 2013.09; 113 (3): 363-364. ( PubMed , DOI )

  4. Machida Akira, Kuwahara Hiroya, Mayra Azat, Kubodera Takayuki, Hirai Takashi, Sunaga Fumiko, Tajiri Mio, Hirai Yukihiko, Shimada Takashi, Mizusawa Hidehiro, Yokota Takanori.: Intraperitoneal administration of AAV9-shRNA inhibits target gene expression in the dorsal root ganglia of neonatal mice. Molecular Pain.. 2013.07; 9 36. ( PubMed , DOI )

  5. Yohsuke Yagi, Yukiko Watanabe, Hiroaki Yokote, Takeshi Amino, Tomoyuki Kamata: Transient Charles Bonnet syndrome in a patient with reversible cerebral vasoconstriction syndrome. Neurol. Sci.. 2013.06; 34 (6): 1023-1025. ( PubMed , DOI )

  6. Yohsuke Yagi, Yukiko Watanabe, Hiroaki Yokote, Takeshi Amino, Tomoyuki Kamata: Lacunar thalamic infarction with isolated dysesthesia in contralateral fingers. Acta Neurol Belg. 2013.06; 113 (2): 199-200. ( PubMed , DOI )

  7. Hiroaki Yokote, Yohsuke Yagi, Yukiko Watanabe, Takeshi Amino, Tomoyuki Kamata, Hidehiro Mizusawa: Serum amyloid A level is increased in neuromyelitis optica and atypical multiple sclerosis with smaller T2 lesion volume in brain MRI. J. Neuroimmunol.. 2013.06; 259 (1-2): 92-95. ( PubMed , DOI )

  8. Abhay P Sagare, Robert D Bell, Alaka Srivastava, Jesse D Sengillo, Itender Singh, Yoichiro Nishida, Nienwen Chow, Berislav V Zlokovic: A lipoprotein receptor cluster IV mutant preferentially binds amyloid-β and regulates its clearance from the mouse brain. J. Biol. Chem.. 2013.05; 288 (21): 15154-15166. ( PubMed , DOI )

  9. Hiroya Kuwahara.: Persistent hemichorea. New England Journal of Medicine. 2013.05; 368 (20): e26. ( PubMed , DOI )

  10. Yusuke Maeda, Rintaro Iwata, Takeshi Wada: Synthesis and properties of cationic oligopeptides with different side chain lengths that bind to RNA duplexes BIOORGANIC & MEDICINAL CHEMISTRY. 2013.04; 21 (7): 1717-1723. ( DOI )

  11. Piao Wenying, Nishina Kazutaka, Yoshida-Tanaka Kie, Kuwahara Hiroya, Nishina Tomoko, Sakata Mina, Mizusawa Hidehiro, Yokota Takanori: Efficient in vivo delivery of antisense oligonucleotide to choroid plexus. J Med Dent Sci. 2013.03; 60 (1): 9-16. ( PubMed )

  12. Kotaro Yoshioka, Satoru Ishibashi, Atsushi Shiraishi, Takanori Yokota, Hidehiro Mizusawa: Distal hyperintense vessels on FLAIR images predict large-artery stenosis in patients with transient ischemic attack. Neuroradiology. 2013.02; 55 (2): 165-169. ( PubMed , DOI )

  13. Teruhiko Sekiguchi, Hiroyuki Tomimitsu, Teruhiko Sekiguchi, Yoichiro Nishida, Takashi Irioka, Akira Inaba, Yoshinobu Hoshii: ATTR amyloidosis complicated by phrenic nerve palsy. Can J Neurol Sci. 2013.01; 40 (1): 129-130. ( PubMed )

  14. Zen Kobayashi, Miho Akaza, Yoshiyuki Numasawa, Shoichiro Ishihara, Hiroyuki Tomimitsu, Kazuo Nakamichi, Masayuki Saijo, Tomohiro Morio, Norio Shimizu, Nobuo Sanjo, Shuzo Shintani, Hidehiro Mizusawa: Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection. J. Neurol. Sci.. 2013.01; 324 (1-2): 190-194. ( PubMed , DOI )

  15. Kuwahara Hiroya, Matsumura Ken, Watanabe Mutsufusa, Fujigasaki Hiroto: Intravenous t-PA for the occlusion of an accessory MCA. Intern Med. 2013.01; 52 (1): 163. ( PubMed )

  16. Yusuke Maeda, Rintaro Iwata, Takeshi Wada: Synthesis of Novel Oligocationic Peptides Binding to RNA Duplexes Peptide Science 2012. 2013; 23-24.

  17. Kazunori Sano, Katsuya Satoh, Ryuichiro Atarashi, Hiroshi Takashima, Yasushi Iwasaki, Mari Yoshida, Nobuo Sanjo, Hiroyuki Murai, Hidehiro Mizusawa, Matthias Schmitz, Inga Zerr, Yong-Sun Kim, Noriyuki Nishida: Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS ONE. 2013; 8 (1): e54915. ( PubMed , DOI )

  18. Maya Higuma, Nobuo Sanjo, Katsuya Satoh, Yusei Shiga, Kenji Sakai, Ichiro Nozaki, Tsuyoshi Hamaguchi, Yosikazu Nakamura, Tetsuyuki Kitamoto, Susumu Shirabe, Shigeo Murayama, Masahito Yamada, Jun Tateishi, Hidehiro Mizusawa: Relationships between clinicopathological features and cerebrospinal fluid biomarkers in Japanese patients with genetic prion diseases. PLoS ONE. 2013; 8 (3): e60003. ( PubMed , DOI )

  19. Takumi Hori, Nobuo Sanjo, Makoto Tomita, Hidehiro Mizusawa: Visual Reproduction on the Wechsler Memory Scale-Revised as a predictor of Alzheimer's disease in Japanese patients with mild cognitive impairments. Dement Geriatr Cogn Disord. 2013; 35 (3-4): 165-176. ( PubMed , DOI )

  20. Kenji Sakai, Tsuyoshi Hamaguchi, Moeko Noguchi-Shinohara, Ichiro Nozaki, Ichiro Takumi, Nobuo Sanjo, Yosikazu Nakamura, Tetsuyuki Kitamoto, Nobuhito Saito, Hidehiro Mizusawa, Masahito Yamada: Graft-related disease progression in dura mater graft-associated Creutzfeldt-Jakob disease: a cross-sectional study. BMJ Open. 2013; 3 (8): e003400. ( PubMed , DOI )

  21. Kenji Sakai, Tsuyoshi Hamaguchi, Moeko Noguchi-Shinohara, Ichiro Nozaki, Ichiro Takumi, Nobuo Sanjo, Yosikazu Nakamura, Tetsuyuki Kitamoto, Nobuhito Saito, Hidehiro Mizusawa, Masahito Yamada.: Graft-related disease progression in dura mater graft-associated Creutzfeldt-Jakob disease: a cross-sectional study. BMJ Open. 2013; 3 (8): e003400.

  22. Kazunori Sano, Katsuya Satoh, Ryuichiro Atarashi, Hiroshi Takashima, Yasushi Iwasaki, Mari Yoshida, Nobuo Sanjo, Hiroyuki Murai, Hidehiro Mizusawa, Matthias Schmitz, Inga Zerr, Yong-Sun Kim, Noriyuki Nishida.: Early Detection of Abnormal Prion Protein in Genetic Human Prion Diseases Now Possible Using Real-Time QUIC Assay. PLoS One. 2013; 8 (1): e54915.

  23. Maya Higuma, Nobuo Sanjo, Katsuya Satoh, Yusei Shiga, Kenji Sakai, Ichiro Nozaki, Tsuyoshi Hamaguchi, Yosikazu Nakamura, Tetsuyuki Kitamoto, Susumu Shirabe, Shigeo Murayama, Masahito Yamada, Jun Tateishi, Hidehiro Mizusawa.: Relationships between Clinicopathological Features and Cerebrospinal Fluid Biomarkers in Japanese Patients with Genetic Prion Diseases. PLoS One. 2013; 8 (3): e60003.

  24. Takumi Hori, Nobuo Sanjo, Makoto Tomita, Hidehiro Mizusawa. : Visual Reproduction on the Wechsler Memory Scale-Revised as a predictor of Alzheimer’s disease in Japanese patients with mild cognitive impairments. Dementia and Geriatric Cognitive Disorders. 2013; 35 165-176.

  25. Masaki Ohyagi, Takuya Ohkubo, Yousuke Yagi, Satoru Ishibashi, Junko Akiyama, Masakazu Nagahori, Mamoru Watanabe, Takanori Yokota, Hidehiro Mizusawa: Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with Crohn's disease. Intern. Med.. 2013; 52 (1): 125-128. ( PubMed )

  26. Yohsuke Yagi, Nobuo Sanjo, Takanori Yokota, Hidehiro Mizusawa: Tacrolimus monotherapy: a promising option for ocular myasthenia gravis. Eur. Neurol.. 2013; 69 (6): 344-345. ( PubMed , DOI )

  27. Teruhiko Sekiguchi, Yoichiro Nishida, Akira Inaba, Shigeo Toyota: Mesothelioma-mimicking multiple myeloma with dumbbell-type progression. Intern. Med.. 2013; 52 (11): 1287-1288. ( PubMed )

  1. Yohsuke Yagi, Akira Machida, Shuta Toru, Takayoshi Kobayashi, Tomonari Amano, Katsuiku Hirokawa, Masanobu Kitagawa: Myotonic dystrophy and lipoma: a new association. Neurol. Sci.. 2012.12; 33 (6): 1477-1478. ( PubMed , DOI )

  2. 三條 伸夫, Qina Temu, 日熊 麻耶, Fraser Paul, 水澤 英洋: アミロイドβ産生に及ぼすI143Tの変異を持つPSEN1の影響(An Effect of PSEN1 with I143T Mutation on Amyloid β Production) Dementia Japan. 2012.10; 26 (4): 515. ( 医中誌 )

  3. Masaki Ohyagi, Nobuo Sanjo, Takanori Yokota, Hidehiro Mizusawa: Hereditary neuropathy with liability to pressure palsy combined with suspected schwannomas of the peroneal and radial nerves. J. Neurol.. 2012.05; 259 (5): 977-979. ( PubMed , DOI )

  4. Hirai Takashi, Enomoto Mitsuhiro, Machida Akira, Yamamoto Mariko, Kuwahara Hiroya, Tajiri Mio, Hirai Yukihiko, Sotome Shinichi, Mizusawa Hidehiro, Shinomiya Kenichi, Okawa Atsushi, Yokota Takanori: Intrathecal shRNA-AAV9 inhibits target protein expression in the spinal cord and dorsal root ganglia of adult mice. Hum Gene Ther Methods. 2012.04; 23 (2): 119-127. ( PubMed , DOI )

  5. Kuwahara Hiroya, Yokota Takanori: Delivery of siRNA into the blood-brain barrier: recent advances and future perspective. Ther Deliv. 2012.04; 3 (4): 417-420. ( PubMed )

  6. Uchida Azusa, Sasaguri Hiroki, Kimura Nobuyuki, Tajiri Mio, Ohkubo Takuya, Ono Fumiko, Sakaue Fumika, Kanai Kazuaki, Hirai Takashi, Sano Tatsuhiko, Shibuya Kazumoto, Kobayashi Masaki, Yamamoto Mariko, Yokota Shigefumi, Kubodera Takayuki, Tomori Masaki, Sakaki Kyohei, Enomoto Mitsuhiro, Hirai Yukihiko, Kumagai Jiro, Yasutomi Yasuhiro, Mochizuki Hideki, Kuwabara Satoshi, Uchihara Toshiki, Mizusawa Hidehiro, Yokota Takanori: Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43. Brain. 2012.03; 135 (Pt 3): 833-846. ( PubMed , DOI )

  7. Kuwahara Hiroya, Matsunaga Shin-ichi: Central pontine myelinolysis associated with pancreatic diabetes. J Neurol. 2012.02; 259 (2): 353-354. ( PubMed , DOI )

  8. Yusuke Maeda, Rintaro Iwata, Takeshi Wada: Synthesis of Novel Oligocationic Peptides which Bind to A-Type Nucleic Acid Duplexes Peptide Science 2011. 2012; 231-232.

  9. Koji Fujita, Masafumi Harada, Makoto Sasaki, Tatsuhiko Yuasa, Kenji Sakai, Tsuyoshi Hamaguchi, Nobuo Sanjo, Yusei Shiga, Katsuya Satoh, Ryuichiro Atarashi, Susumu Shirabe, Ken Nagata, Tetsuya Maeda, Shigeo Murayama, Yuishin Izumi, Ryuji Kaji, Masahito Yamada, Hidehiro Mizusawa: Multicentre multiobserver study of diffusion-weighted and fluid-attenuated inversion recovery MRI for the diagnosis of sporadic Creutzfeldt-Jakob disease: a reliability and agreement study. BMJ Open. 2012; 2 (1): e000649. ( PubMed , DOI )

  10. Koji Fujita, Masafumi Harada, Makoto Sasaki, Tatsuhiko Yuasa, Kenji Sakai, Tsuyoshi Hamaguchi, Nobuo Sanjo, Yusei Shiga, Katsuya Satoh, Ryuichiro Atarashi, Susumu Shirabe, Ken Nagata, Tetsuya Maeda, Shigeo Murayama, Yuishin Izumi, Ryuji Kaji, Masahito Yamada, Hidehiro Mizusawa. : Multicentre, multiobserver study of diffusion-weighted and fluid-attenuated inversion recovery MRI for the diagnosis of sporadic Creutzfeldt–Jakob disease: a reliability and agreement study. BMJ open. 2012; 2 e000649.

  11. Yoichiro Nishida, Tadashi Ichikawa: Pontine hyperperfusion during recovery from central pontine myelinolysis. Intern. Med.. 2012; 51 (7): 817-818. ( PubMed )

  12. Sanjo Nobuo: Clinical features of genetic prion disease and cerebrospinal fluid findings in Japanese patients PRION. 2012; 6 128.

  1. Yoko Ito,Nobuo Sanjo,Kinya Ishikawa,Osamu Tao,Takanori Yokota,Hidehiro Mizusawa: Brainstem congestion due to carotid-cavernous fistula via a shunt from the external calotid artery. Journal of Neurology . 2011.12; (258): 2288-2290. ( PubMed , DOI )

  2. Kuwahara H, Nishina K, Yoshida K, Nishina T, Yamamoto M, Saito Y, Piao W, Yoshida M, Mizusawa H, Yokota T: Efficient in vivo delivery of siRNA into brain capillary endothelial cells along with endogenous lipoprotein. Mol Ther. 2011.12; 19 (12): 2213-2221. ( PubMed , DOI )

  3. Yohsuke Yagi, Akira Machida, Shuta Toru, Takayoshi Kobayashi, Toshiki Uchihara: Sialidosis type I with neoplasms in siblings: the first clinical cases. Neurol. Sci.. 2011.08; 32 (4): 737-738. ( PubMed , DOI )

  4. Kuwahara Hiroya, Nakatsuru Enichi, Ozawa Naoko: Exertional rhabdomyolysis affecting anterior compartment of unilateral lower leg. Intern Med. 2011.04; 50 (7): 793. ( PubMed )

  5. Rintaro Iwata, Masafumi Sudo, Kenta Nagafuji, Takeshi Wada: Synthesis of Oligodiaminosaccharides Having alpha-Glycoside Bonds and Their Interactions with Oligonucleotide Duplexes Journal of Organic Chemistry. 2011; 76 (15): 5895-5906. ( DOI )

  1. Kuwahara Hiroya, Noguchi Yoshimasa, Saito Yukinobu, Inaba Akira: Multiple cavernous angiomas in the brain and spinal cord. Arch Neurol. 2010.11; 67 (11): 1405-1406. ( PubMed , DOI )

  2. Nobuo Sanjo, Taiichi Katayama, Hiroshi Hasegawa, Haifeng Jin, Monika Duthie, Howard T J Mount, Hidehiro Mizusawa, Peter St George-Hyslop, Paul E. Fraser: Localization and trafficking of endogenous anterior pharynx-defective 1, a component of Alzheimer's disease related gamma-secretase. Neurosci. Lett.. 2010.10; 483 (1): 53-56. ( PubMed , DOI )

  3. Ichiro Nozaki, Tsuyoshi Hamaguchi, Nobuo Sanjo, Moeko Noguchi-Shinohara, Kenji Sakai, Yosikazu Nakamura, Takeshi Sato, Tetsuyuki Kitamoto, Hidehiro Mizusawa, Fumio Moriwaka, Yusei Shiga, Yoshiyuki Kuroiwa, Masatoyo Nishizawa, Shigeki Kuzuhara, Takashi Inuzuka, Masatoshi Takeda, Shigetoshi Kuroda, Koji Abe, Hiroyuki Murai, Shigeo Murayama, Jun Tateishi, Ichiro Takumi, Susumu Shirabe, Masafumi Harada, Atsuko Sadakane, Masahito Yamada: Prospective 10-year surveillance of human prion diseases in Japan. Brain. 2010.10; 133 (10): 3043-3057. ( PubMed , DOI )

  4. Kuwahara Hiroya, Tsuchiya Kuniaki, Saito Yukinobu, Kobayashi Zen, Miyazaki Hiroshi, Izumiyama Yoko, Akiyama Haruhiko, Arai Tetsuaki, Mizusawa Hidehiro: Frontotemporal lobar degeneration with motor neuron disease showing severe and circumscribed atrophy of anterior temporal lobes. J Neurol Sci. 2010.10; 297 (1-2): 92-96. ( PubMed , DOI )

  5. Yoichiro Nishida, Takashi Irioka, Teruhiko Sekiguchi, Hidehiro Mizusawa: Pure sensory infarct in the territories of anterior cerebral artery. Neurology. 2010.07; 75 (3): 287. ( PubMed , DOI )

  6. Nakamura Tsutomu, Hayashi Tomoatsu, Mimori-Kiyosue Yuko, Sakaue Fumika, Matsuura Ken, Iemura Shun-ichiro, Natsume Toru, Akiyama Tetsu: The PX-RICS-14-3-3zeta/theta complex couples N-cadherin-beta-catenin with dynein-dynactin to mediate its export from the endoplasmic reticulum. J Biol Chem. 2010.05; 285 (21): 16145-16154. ( PubMed , DOI )

  7. Haifeng Jin, Nobuo Sanjo, Toshiki Uchihara, Kazuhiko Watabe, Peter St George-Hyslop, Paul E Fraser, Hidehiro Mizusawa: Presenilin-1 holoprotein is an interacting partner of sarco endoplasmic reticulum calcium-ATPase and confers resistance to endoplasmic reticulum stress. J. Alzheimers Dis.. 2010; 20 (1): 261-273. ( PubMed , DOI )

  8. Nobuo Sanjo, Taiichi Katayama, Hiroshi Hasegawa, Haifeng Jin, Monika Duthie, Howard T.J. Mount, Hidehiro Mizusawa, Peter St George-Hyslop, Paul E. Fraser. : Localization and trafficking of endogenous anterior pharynx-defective 1, a component of Alzheimer's disease related γ-secretase. Neuroscience Lett 2010; 483(1): 53-56. 2010; 483 (1): 53-56.

  9. 三條伸夫, 佐々木真理, 水澤英洋, プリオン病画像小委員会: 脳外科手術によるCJDリスク保因可能性者事例の経過と注意すべきプリオン病画像診断のポイント. CI研究. 2010; 31 (4): 233-239.

  10. Ichiro Nozaki, Tsuyoshi Hamaguchi, Nobuo Sanjo, Kenji Sakai, Moeko Noguchi-Shinohara, Yosikazu Nakamura, Takeshi Sato, Tetsuyuki Kitamoto, Hidehiro Mizusawa, Fumio Moriwaka, Yusei Shiga, Yoshiyuki Kuroiwa, Masatoyo Nishizawa, Shigeki Kuzuhara, Takashi Inuzuka, Masatoshi Takeda, Shigetoshi Kuroda, Koji Abe, Hiroyuki Murai, Shigeo Murayama, Jun Tateishi, Ichiro Takumi, Susumu Sirabe, Masafumi Harada, Masahito Yamada. : Prospective 10-years surveillance for human prion diseases in Japan. Brain 133(10); 2010, 3043-57. 2010; 133 (10): 3043-3057.

  1. Yoichiro Nishida, Shingo Ito, Sumio Ohtsuki, Naoki Yamamoto, Tsubura Takahashi, Nobuhisa Iwata, Kou-Ichi Jishage, Hiromi Yamada, Hiroki Sasaguri, Shigefumi Yokota, Wenying Piao, Hiroyuki Tomimitsu, Takaomi C Saido, Katsuhiko Yanagisawa, Tetsuya Terasaki, Hidehiro Mizusawa, Takanori Yokota: Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease. J. Biol. Chem.. 2009.11; 284 (48): 33400-33408. ( PubMed , DOI )

  2. Rintaro Iwata, Masafumi Sudo, Kenta Nagafuji, Takeshi Wada: Stabilization of A-type nucleic acid duplexes by novel oligodiaminosaccharides Nucleic Acids Symposium Series. 2009.10; 53 (1): 113-114. ( DOI )

  3. Takashi Irioka, Ayaka Yamanami, Yohsuke Yagi, Hidehiro Mizusawa: Aortic dissection as a possible cause of pure transient global amnesia: a case report and literature review. Neurol. Sci.. 2009.06; 30 (3): 255-258. ( PubMed , DOI )

  4. Yoichiro Nishida, Yuki Saito, Takanori Yokota, Takashi Kanda, Hidehiro Mizusawa: Skeletal muscle MRI in complex regional pain syndrome. Intern. Med.. 2009; 48 (4): 209-212. ( PubMed )

  1. Nakamura Tsutomu, Hayashi Tomoatsu, Nasu-Nishimura Yukiko, Sakaue Fumika, Morishita Yasuyuki, Okabe Toshio, Ohwada Susumu, Matsuura Ken, Akiyama Tetsu: PX-RICS mediates ER-to-Golgi transport of the N-cadherin/beta-catenin complex. Genes Dev. 2008.05; 22 (9): 1244-1256. ( PubMed , DOI )

  1. Hayashi Tomoatsu, Okabe Toshio, Nasu-Nishimura Yukiko, Sakaue Fumika, Ohwada Susumu, Matsuura Ken, Akiyama Tetsu, Nakamura Tsutomu: PX-RICS, a novel splicing variant of RICS, is a main isoform expressed during neural development. Genes Cells. 2007.08; 12 (8): 929-939. ( PubMed , DOI )

  2. Katayama Taiichi, Sanjo Nobuo, Fraser Paul, George-Hyslop Peter St., Sato Kohji: インビボクロスリンク法を用いたガンマセクレターゼ新規構成蛋白質の探索(A screening for novel components of gamma-secretase complex using by in vivo crosslink method) 神経化学. 2007.08; 46 (2-3): 484. ( 医中誌 )

  3. Yoichiro Nishida, Hiroshi Komachi, Hidehiro Mizusawa: A case of Listeria meningitis associated with increased adenosine deaminase in cerebrospinal fluid. Diagn. Microbiol. Infect. Dis.. 2007.04; 57 (4): 435-437. ( PubMed , DOI )

  4. Shiraishi Atsushi, Hino Taro, Kyodo Toride, Sanjo Nobuo, Ishibashi Satoru, Machida Akira, Mizutani Saneyuki, Shintani Shuzo, Mizusawa Hidehiro: Dual-plane diffusion-weighted imaging can improve the detection of diffusion-restricted lesions in patients who were suspected of stroke with mild severity: Axial and coronal DWI for acute stroke (ACORDAS) study STROKE. 2007.02; 38 (2): 495.

  1. Yoichiro Nishida, Takanori Yokota, Tsubura Takahashi, Toshiki Uchihara, Kou-ichi Jishage, Hidehiro Mizusawa: Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem. Biophys. Res. Commun.. 2006.11; 350 (3): 530-536. ( PubMed , DOI )

  2. Yong-Ri Ren, Yoichiro Nishida, Kenji Yoshimi, Toru Yasuda, Kou-Ichi Jishage, Toshiki Uchihara, Takanori Yokota, Yoshikuni Mizuno, Hideki Mochizuki: Genetic vitamin E deficiency does not affect MPTP susceptibility in the mouse brain. J. Neurochem.. 2006.09; 98 (6): 1810-1816. ( PubMed , DOI )

  3. Fusheng Chen, Hiroshi Hasegawa, Gerold Schmitt-Ulms, Toshitaka Kawarai, Christopher Bohm, Taiichi Katayama, Yongjun Gu, Nobuo Sanjo, Michael Glista, Ekaterina Rogaeva, Yosuke Wakutani, Raphaëlle Pardossi-Piquard, Xueying Ruan, Anurag Tandon, Frédéric Checler, Philippe Marambaud, Kirk Hansen, David Westaway, Peter St George-Hyslop, Paul Fraser: TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature. 2006.04; 440 (7088): 1208-1212. ( PubMed , DOI )

  4. Sasaki Takahiro, Gotow Takahiro, Shiozaki Motoko, Sakaue Fumika, Saito Taro, Julien Jean-Pierre, Uchiyama Yasuo, Hisanaga Shin-Ichi: Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants. Hum Mol Genet. 2006.03; 15 (6): 943-952. ( PubMed , DOI )

  5. Toshiki Uchihara, Nobuo Sanjo, Ayako Nakamura, Kyung Han, Si-Young Song, Peter St George-Hyslop, Paul E Fraser: Transient abundance of presenilin 1 fragments/nicastrin complex associated with synaptogenesis during development in rat cerebellum. Neurobiol. Aging. 2006.01; 27 (1): 88-97. ( PubMed , DOI )

  6. Uchihara T, Sanjo N, Nakamura A, Han K, Song SY, St George-Hyslop P, Fraser P.: Transient abundance of presenilin 1 fragments/nicastrin complex associated with synaptogenesis during development in rat cerebellum. Neurobiol Aging . 2006; 27 (1): 88-97.

  1. Agnes Petit, Toshitaka Kawarai, Erwan Paitel, Nobuo Sanjo, Mary Maj, Michael Scheid, Fusheng Chen, Yongjun Gu, Hiroshi Hasegawa, Shabnam Salehi-Rad, Linda Wang, Ekaterina Rogaeva, Paul Fraser, Brian Robinson, Peter St George-Hyslop, Anurag Tandon: Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem.. 2005.10; 280 (40): 34025-34032. ( PubMed , DOI )

  2. Sakaue Fumika, Saito Taro, Sato Yutaka, Asada Akiko, Ishiguro Koichi, Hasegawa Masato, Hisanaga Shin-ichi: Phosphorylation of FTDP-17 mutant tau by cyclin-dependent kinase 5 complexed with p35, p25, or p39. J Biol Chem. 2005.09; 280 (36): 31522-31529. ( PubMed , DOI )

  3. Koyama Rikako, Nakanishi Koji, Kato Masako, Yamashita Shigeo, Kuwahara Hiroya, Katori Hideyuki: Hypoglycemia and hyperglycemia due to insulin antibodies against therapeutic human insulin: treatment with double filtration plasmapheresis and prednisolone. Am J Med Sci. 2005.05; 329 (5): 259-264. ( PubMed )

  4. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M, Chen F, Gu Y, Hasegawa H, Salehi-Rad S, Wang L, Rogaeva E, Fraser P, Robinson B, St George-Hyslop P, Tandon A (2005): Wild-type PINK1 Prevents Basal and Induced Neuronal Apoptosis, a Protective Effect Abrogated by Parkinson Disease-related Mutations. J Biol Chem. 2005; 280 34025-34032.

  1. Y Nishida, N Sodeyama, Y Toru, S Toru, T Kitamoto, H Mizusawa: Creutzfeldt-Jakob disease with a novel insertion and codon 219 Lys/Lys polymorphism in PRNP. Neurology. 2004.11; 63 (10): 1978-1979. ( PubMed )

  2. Hiroshi Hasegawa, Nobuo Sanjo, Fusheng Chen, Yong-Jun Gu, Cortney Shier, Agnes Petit, Toshitaka Kawarai, Taiichi Katayama, Stephen D Schmidt, Paul M Mathews, Gerold Schmitt-Ulms, Paul E Fraser, Peter St George-Hyslop: Both the sequence and length of the C terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes. J. Biol. Chem.. 2004.11; 279 (45): 46455-46463. ( PubMed , DOI )

  3. Yongjun Gu, Nobuo Sanjo, Fusheng Chen, Hiroshi Hasegawa, Agnes Petit, Xueying Ruan, Wenping Li, Cortney Shier, Toshitaka Kawarai, Gerold Schmitt-Ulms, David Westaway, Peter St George-Hyslop, Paul E Fraser: The presenilin proteins are components of multiple membrane-bound complexes that have different biological activities. J. Biol. Chem.. 2004.07; 279 (30): 31329-31336. ( PubMed , DOI )

  4. Sumio Ishiai, Yasumasa Koyama, Naomi Nakano, Keiko Seki, Yoichiro Nishida, Kazuko Hayashi: Image of a line is not shrunk but neglected. Absence of crossover in unilateral spatial neglect. Neuropsychologia. 2004; 42 (2): 251-256. ( PubMed )

  5. Hasegawa H, Sanjo N, Chen F, Gu YJ, Shier C, Petit A, Kawarai, T., Katayama, T., Schmidt, S. D., Mathews, P. M., Schmitt-Ulms, G., Fraser, P. E., St George-Hyslop, P. : Both the sequence and length of the C-terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes. Journal of Biological Chemistry . 2004; 279 (45): 46455-46463.

  6. Gu Y*, Sanjo N*, Chen F*, Hasegawa H, Petit A, Ruan X, Li, W., Shier, C., Kawarai, T., Schmitt-Ulms, G., Westaway, D., St George-Hyslop, P., Fraser, P. E. (*: equally contributed): The presenilin proteins are components of multiple membrane-bound complexes which have different biological activities. Journal of Biological Chemistry . 2004; 279 (30): 31329-31336.

  1. Fusheng Chen, Anurag Tandon, Nobuo Sanjo, Yong-Jun Gu, Hiroshi Hasegawa, Shigeki Arawaka, Frank J S Lee, Xueying Ruan, Peter Mastrangelo, Serap Erdebil, Linda Wang, David Westaway, Howard T J Mount, Bruce Yankner, Paul E Fraser, Peter St George-Hyslop: Presenilin 1 and presenilin 2 have differential effects on the stability and maturation of nicastrin in Mammalian brain. J. Biol. Chem.. 2003.05; 278 (22): 19974-19979. ( PubMed , DOI )

  2. Kazuko Aoki, Toshiki Uchihara, Nobuo Sanjo, Ayako Nakamura, Kenji Ikeda, Kuniaki Tsuchiya, Yoshihiro Wakayama: Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. Stroke. 2003.04; 34 (4): 875-880. ( PubMed , DOI )

  3. Yongjun Gu, Fusheng Chen, Nobuo Sanjo, Toshitaka Kawarai, Hiroshi Hasegawa, Monica Duthie, Wenping Li, Xueying Ruan, Anchla Luthra, Howard T J Mount, Anurag Tandon, Paul E Fraser, Peter St George-Hyslop: APH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin.nicastrin complexes. J. Biol. Chem.. 2003.02; 278 (9): 7374-7380. ( PubMed , DOI )

  4. Aoki K., Uchihara T., Sanjo N., Nakamura A., Ikeda K., Tsuchiya K. and Wakayama Y. : Increased Expression of Neuronal Apolipoprotein E in Human Brain With Cerebral Infarction. Stroke 2003; 34: 875-80.. 2003; 34 875-880.

  5. Chen F., Tandon A., Sanjo N., Gu Y. J., Hasegawa H., Arawaka S., Lee F. J., Ruan X., Mastrangelo P., Erdebil S., Wang L., Westaway D., Mount H. T., Yankner B., Fraser P. E. and St George-Hyslop P. : Presenilin 1 and presenilin 2 have differential effects on the stability and maturation of nicastrin in mammalian brain. Journal of Biological Chemistry. 2003; 278 (22): 19974-19979.

  6. Gu Y, Chen F, Sanjo N, Kawarai T, Hasegawa H, Duthie M, Li W, Ruan X, Luthra A, Mount HT, Tsndon A, Fraser PE and St. George-Hyslop P. : APH-1 Interacts with Mature and Immature Forms of Presenilins and Nicastrin and May Play a Role in Maturation of Presenilin-Nicastrin Complexes Journal of Biological Chemistry. 2003; 278 7374-7380.

  1. Y Nishida, M Yamada, K Hara, T Tsunemi, M Yamawaki, R Shimokawa, R Okeda, T Tsutsumi, H Mizusawa: Creutzfeldt-Jakob disease after Jannetta's operation with cadaveric dura mater graft: initial manifestations related to the grafted site. J. Neurol.. 2002.04; 249 (4): 480-483. ( PubMed , DOI )

  1. 三條 伸夫, 上原 晋, 井浦 泰夫, 松本 卓, 市川 忠.: MRI上椎骨・脳底動脈領域血管に異常を有する脳血管障害患者における未破裂脳動脈瘤保有率の検討. リハビリテーション医学. 2000; 37 165-170.

  1. K Owada, N Sanjo, T Kobayashi, H Mizusawa, H Muramatsu, T Muramatsu, M Michikawa: Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J. Neurochem.. 1999.11; 73 (5): 2084-2092. ( PubMed )

  2. Owada K, Sanjo N, Kobayashi T, Mizusawa H, Muramatsu H, Muramatsu T, Michikawa M.: Midkine inhibits Caspase-dependent apoptosis via the activation of Mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. Journal of Neurochemistory . 1999; 73 (5): 2084-2092.

  3. Owada K, Sanjo N, Kobayashi T, Kamata T, Mizusawa H, Muramatsu H, Muramatsu T and Michikawa M. : Midkine inhibits apoptosis via extracellular signal regulated kinase (ERK) activation in PC12 cells. Journal of Medical and Dental Science . 1999; 46 45-51.

  1. N Sanjo, K Owada, T Kobayashi, H Mizusawa, A Awaya, M Michikawa: A novel neurotrophic pyrimidine compound MS-818 enhances neurotrophic effects of basic fibroblast growth factor. J. Neurosci. Res.. 1998.12; 54 (5): 604-612. ( PubMed )

  1. N Sanjo, T Yokota, Y Saitou, H Miake, H Tanaka: Painful bilateral abducens nerve palsy associated with anti-neutrophil cytoplasmic autoantibodies. J. Neurol.. 1996.08; 243 (8): 612-613. ( PubMed )

  1. 小川 祥, 相馬 亮子, 竹内 弥生, 石黒 太郎, 横田 隆徳, 大野 京子: 後天性卵黄状病巣に同側のサルコイドーシス視神経浸潤を合併した1例 眼科臨床紀要. 2024.09; 17 (9): 664-670. ( 医中誌 )

  2. 中谷 なつき, 小野 大介, 平田 浩聖, 吉岡 耕太郎, 遠藤 浩信, 小野 賢二郎, 樋口 真人, 横田 隆徳: 左大脳後部皮質を中心とした後部皮質萎縮症で仮名に選択的な失読を呈した1例 臨床神経学. 2024.08; 64 (8): 557-563. ( 医中誌 )

  3. 三浦 元輝,坂上 史佳,永田 哲也: 筋萎縮性側索硬化症に対する新しい治験の動向 脳神経内科. 2024.08; 101 (2): 181-189.

  4. 永田 哲也, 原 倫太朗, 横田 隆徳: AMED「RNA標的創薬技術開発事業」から創薬を目指して 臨床医の立場からRNA創薬による次世代医療への期待 バイオサイエンスとインダストリー. 2024.07; 82 (4): 424-429. ( 医中誌 )

  5. Nakatani N, Ono D, Hirata K, Yoshioka K, Endo H, Ono K, Higuchi M, Yokota T: [A case of left posterior cortical atrophy presenting with kana-predominant reading impairment]. Rinsho shinkeigaku = Clinical neurology. 2024.07; ( PubMed , DOI )

  6. Kuwahara H, Yokota T: [Peripheral Nerve and Muscle Disorders Associated with Sjögren's Syndrome]. Brain and nerve = Shinkei kenkyu no shinpo. 2024.05; 76 (5): 588-597. ( PubMed , DOI )

  7. 桑原 宏哉, 横田 隆徳: 【末梢神経・筋肉の自己免疫性・炎症性疾患ハンドブック】(第2章)疾患各論 シェーグレン症候群の末梢神経・筋障害 BRAIN and NERVE: 神経研究の進歩. 2024.05; 76 (5): 0588-0597. ( 医中誌 )

  8. 三浦 元輝, 横田 隆徳: 本年の動向 新規RNA標的医薬品の研究開発 Annual Review神経. 2024.04; 2024 95-100. ( 医中誌 )

  9. 中山 東城, 桑原 宏哉, 横田 隆徳: 難病医療 核酸医薬を用いた神経希少疾患に対する個別化医療の展望と課題 難病と在宅ケア. 2024.02; 29 (11): 43-46. ( 医中誌 )

  1. 赤座 実穂, 大谷 泰, 夏井 洋和, 叶内 匡, 横田 隆徳: 【生体磁界計測による脊髄・神経・筋活動の評価】磁場測定による運動単位の電気活動評価 臨床神経生理学. 2023.12; 51 (6): 674-681. ( 医中誌 )

  2. 西田 陽一郎: 【重症筋無力症 update】治療 カルシニューリン阻害薬 Clinical Neuroscience. 2023.11; 41 (11): 1454-1456. ( 医中誌 )

  3. 大谷木 正貴, 横田 隆徳: 【RNA制御と免疫疾患・感染症】核酸医薬による免疫細胞の制御 臨床免疫・アレルギー科. 2023.10; 80 (4): 460-466. ( 医中誌 )

  4. 坂上 史佳, 横田 隆徳: 【いま新薬で加速する 神経変性疾患研究 異常タンパク質の構造、凝集のしくみから根本治療の真の標的に迫る】(第4章)治療法の現状と展望 神経変性疾患に対する核酸医薬 実験医学. 2023.08; 41 (12): 2013-2019. ( 医中誌 )

  5. 中山 東城, 横田 隆徳: 希少疾病の核酸医薬による超個別化医療(N of 1治療)の展開 核酸医薬を用いた神経希少疾患に対する個別化医療の展望と課題 米国で先行する超希少疾病の個別化医療 神経治療学. 2023.07; 40 (4): 526-530. ( 医中誌 )

  6. 中山 東城, 桑原 宏哉, 横田 隆徳: 【核酸医薬の最近の進歩】神経疾患に対する核酸医薬 超希少疾病の核酸医薬による個別化医療 脳神経内科. 2023.06; 98 (6): 881-885. ( 医中誌 )

  7. 横田 隆徳: 【核酸医薬の最近の進歩】血液脳関門通過型ヘテロ2本鎖核酸医薬 脳神経内科. 2023.06; 98 (6): 873-880. ( 医中誌 )

  8. 吉岡 耕太郎, 横田 隆徳: 【核酸医薬と神経疾患】核酸医薬による分子標的メカニズム Clinical Neuroscience. 2023.05; 41 (5): 604-607. ( 医中誌 )

  9. 原倫太朗: 核酸分解酵素 CLINICAL NEUROSCIENCE. 2023.05; 41 (5): 681-683.

  10. 勝山 真帆, 吉岡 耕太郎, 横田 隆徳: 神経・筋疾患を標的とした核酸医薬の基礎と臨床 神経治療学. 2023.05; 40 (3): 237-241. ( 医中誌 )

  11. 中山 東城, 横田 隆徳: 【ALS-どこまでわかり,どこまで治るか】開発中の治療 核酸医薬 Clinical Neuroscience. 2023.03; 41 (3): 414-416. ( 医中誌 )

  12. 中山 東城, 桑原 宏哉, 横田 隆徳: 産業と行政 核酸医薬によるN-of-1+創薬の動向 バイオサイエンスとインダストリー. 2023.03; 81 (2): 166-169. ( 医中誌 )

  13. 八木 洋輔: 特集 しびれQ&A──ビビッとシビれるクリニカルパール付き! Q9 血液疾患、膠原病に合併したニューロパチーの診断は? 総合診療. 2023.02; 33 (2): 178-180.

  14. 夏井 洋和, 叶内 匡, 横田 隆徳: 【しびれQ&A-ビビッとシビれるクリニカルパール付き!】しびれ診療のQに答えます! small fiber neuropathyって、何? 総合診療. 2023.02; 33 (2): 181-184. ( 医中誌 )

  15. 河合 ほなみ, 横田 隆徳: 【しびれQ&A-ビビッとシビれるクリニカルパール付き!】しびれ診療のQに答えます! しびれ症状から脊髄障害を見極める方法は? 総合診療. 2023.02; 33 (2): 185-189. ( 医中誌 )

  16. 西田 陽一郎: 【しびれQ&A-ビビッとシビれるクリニカルパール付き!】しびれ診療のQに答えます! Guillain-Barre症候群とCOVID-19やワクチン接種 総合診療. 2023.02; 33 (2): 177. ( 医中誌 )

  17. 中山 東城, 桑原 宏哉, 横田 隆徳: 今月のTopic 開発 希少疾患に対する核酸医薬によるN-of-1+創薬の課題と展望 医薬品医療機器レギュラトリーサイエンス. 2023.02; 54 (1): 51-54. ( 医中誌 )

  18. 永田 哲也, 横田 隆徳: 【DDSで拓く創薬モダリティイノベーション】リガンド結合による核酸医薬の標的指向化 Drug Delivery System. 2023.01; 38 (1): 8-14. ( 医中誌 )

  19. 浅見 裕太郎, 横田 隆徳: 【日本がリードする神経難病のゲノム創薬・遺伝子治療薬開発】DNA/RNAヘテロ核酸を用いた難病に対する遺伝子治療薬開発 遺伝子医学. 2023.01; 13 (1): 35-42. ( 医中誌 )

  1. 横田 隆徳: 【BBB-単なる障壁ではない】ドラッグデリバリー 血液脳関門通過型ヘテロ2本鎖核酸医薬 Clinical Neuroscience. 2022.12; 40 (12): 1612-1616. ( 医中誌 )

  2. 松林泰毅、三條伸夫: プリオン病の病態と診断overview. 脳神経内科. 2022.11; 97 (11): 409-417.

  3. 野呂美穗子, 内藤瑞, 原倫太朗, 横田隆徳, 宮田完二郎: 核酸医薬の送達を指向したフルオロアルキル修飾ミセルの開発 AGC Research Report. 2022.10;

  4. 横田隆徳, 黒田隆之: 【神経疾患とゲノム医療】創薬・治療 核酸医薬 N-of-1+個別化医療の実現へ Clinical Neuroscience. 2022.09; 40 (9): 1087-1093. ( 医中誌 )

  5. 小野大介、三條伸夫: 脳炎と脳症 update Brain and Nerve. 2022.07; 74 (7): 845-851.

  6. 八木 洋輔, 横田 隆徳: 【Endosome、Lysosome、Exosome-小胞とは?】Exosomeの機能 Micro RNA Clinical Neuroscience. 2022.07; 40 (7): 848-850. ( 医中誌 )

  7. 八木 洋輔,横田 隆徳: Exosomeの機能-MicroRNA 月刊 臨床神経科学. 2022.07; 40 (7): 848-850.

  8. 横田 隆徳: 神経筋疾患の核酸医薬による治療戦略の最前線 血液脳関門通過型ヘテロ2本鎖核酸 神経治療学. 2022.07; 39 (4): 532-534. ( 医中誌 )

  9. 浅見裕太郎,横田隆徳: 中枢神経疾患に対する核酸医薬 Dimentia Japan. 2022.04; 36 (2): 271-279.

  10. 西 李依子,横田隆徳: 免疫介在性神経疾患治療における核酸医薬の可能性 神経治療学. 2022.04; 38 (4): 484-88.

  11. 山本 卓,横田隆徳: 大学発ベンチャーの現状と設立のためのキャリア Brain and Nerve . 2022.01; 74 (1): 71-75. ( PubMed , DOI )

  12. 平田浩聖,横田隆徳: 脳は若返るのか?-炎症と細胞内エネルギー代謝の観点からのアプローチ NEURO LOGICA. 2022.01; 4

  13. 山本 卓, 横田 隆徳: 【脳神経内科医のキャリアパスとリーダーシップ】大学発ベンチャーの現状と設立のためのキャリア BRAIN and NERVE: 神経研究の進歩. 2022.01; 74 (1): 0071-0075. ( 医中誌 )

  14. 上中 沙衿, 赤座 実穂, 川端 茂徳, 渡部 泰士, 宮野 由貴, 佐々木 亨, 叶内 匡, 足立 善昭, 関原 謙介, 角 勇樹, 大川 淳, 横田 隆徳: 超音波検査と誘発磁界計測による正中神経前腕部神経活動評価 脊髄機能診断学. 2022.01; 42 (1): 30-33. ( 医中誌 )

  15. 水口 隆介, 赤座 実穂, 川端 茂徳, 渡部 泰士, 宮野 由貴, 佐々木 亨, 叶内 匡, 足立 善昭, 関原 謙介, 角 勇樹, 大川 淳, 横田 隆徳: 磁場計測と神経超音波検査を組み合わせた正中神経肘部神経活動評価 脊髄機能診断学. 2022.01; 42 (1): 34-37. ( 医中誌 )

  16. 松林泰毅,横田隆徳: 核酸医薬の基礎と臨床 総論 神経治療学. 2022.01; 38 (3): 257-260.

  17. 横田隆徳,戸田達史: 神経筋疾患の核酸医薬の最前線 司会の言葉 神経治療学. 2022.01; 38 (3): 256.

  18. 永田哲也: デュシャンヌ型筋ジストロフィーに対する核酸医薬 神経治療学. 2022.01; 38 (3): 262.

  19. 桑原宏哉: 脳神経内科医にとっての医系技官のキャリアパス Brain and Nerve. 2022.01; 74 (1): 63-66.

  1. 大原 正裕, 横田 隆徳: 【核酸医薬の現状と今後の展望】総論 核酸医薬の現状 BIO Clinica. 2021.12; 36 (14): 1348-1350. ( 医中誌 )

  2. 永田哲也: DNA/RNA ヘテロ核酸 BIO Clinica. 2021.12; 36 (14):

  3. 横田隆徳: 核酸医薬による分子標的治療の幕開け 実験医学. 2021.11; 39 (17): 2645-2651.

  4. 東 美和,横田隆徳: 脊髄小脳失調症の評価スケールとバイオマーカー NEURO LOGICA. 2021.11; 3

  5. 横田 隆徳: 【核酸医薬 本領を発揮する創薬モダリティ 新たな作用機序を生む核酸のサイエンスから、新薬・ワクチン承認をもたらした核酸修飾・DDS技術、難治性疾患治療への挑戦まで】(第1章)モダリティ ヘテロ2本鎖核酸 実験医学. 2021.11; 39 (17): 2679-2685. ( 医中誌 )

  6. 山田 大貴, 吉岡 耕太郎, 中山 東城, 横田 隆徳: 【核酸医薬 本領を発揮する創薬モダリティ 新たな作用機序を生む核酸のサイエンスから、新薬・ワクチン承認をもたらした核酸修飾・DDS技術、難治性疾患治療への挑戦まで】核酸医薬の新しい潮流 希少疾患に対する核酸医薬を用いたN-of-1+創薬 実験医学. 2021.11; 39 (17): 2658-2664. ( 医中誌 )

  7. 吉岡 耕太郎: 【核酸医薬 本領を発揮する創薬モダリティ 新たな作用機序を生む核酸のサイエンスから、新薬・ワクチン承認をもたらした核酸修飾・DDS技術、難治性疾患治療への挑戦まで】(第7章)疾患別 神経難病に対する核酸医薬品の開発 実験医学. 2021.11; 39 (17): 2834-2840. ( 医中誌 )

  8. 坂上史佳,横田隆徳: tauとRNA―意味ある結合か? NEURO LOGICA. 2021.10; 2

  9. 吉岡耕太郎: 神経難病に対する核酸医薬品の開発 実験医学. 2021.10; 39 (17): 2834-2840.

  10. 原 倫太朗: ヌクレアーゼ/核酸分解酵素ーRNase Hを中心に 実験医学. 2021.10; 39 (17): 2764-2771.

  11. 永田哲也: 筋ジストロフィーに対する核酸医薬開発 実験医学. 2021.10; 39 (17): 2820-2827.

  12. 小野大介: 核酸医薬の細胞内導体ー一本鎖,二本鎖,DNA,RNA,ヘテロ・・・構造と挙動 実験医学. 2021.10; 39 (17): 2759-2763.

  13. 横田 隆徳: ヘテロ核酸の免疫介在性神経疾患治療における核酸医薬の可能性 実験医学. 2021.09; 39 (15): 2479-2485. ( 医中誌 )

  14. 浅見 裕太郎, 吉岡 耕太郎, 横田 隆徳: 【神経疾患を克服する-わが国の戦略(1)】研究手法の最新の話題 核酸医薬 Clinical Neuroscience. 2021.09; 39 (9): 1114-1118. ( 医中誌 )

  15. 原倫太朗, 佐藤一樹, 和田猛: 糖-1-リン酸繰り返し構造およびその化学修飾アナログの合成 有機合成化学協会誌. 2021.06; 79 (6): 558-569. ( DOI )

  16. 松林 泰毅, 横田 隆徳: 神経筋疾患の核酸医薬の最前線 核酸医薬の基礎と臨床 総論 神経治療学. 2021.05; 38 (3): 257-260. ( 医中誌 )

  17. 桑原宏哉,横田隆徳: アルツハイマー病における脈絡叢容積 NEURO LOGICA. 2021.05; 1 15.

  18. 杉田陽一郎,山田大貴,横田隆徳: 神経障害の治療 Clinical Neuroscience . 2021.03; 39 (3): 346-349.

  19. 酒井 爽子, 竹中 彩乃, 石黒 太郎, 八木 洋輔, 西田 陽一郎, 石橋 哲, 三條 伸夫, 横田 隆徳: 左視神経病変で発症し、多発リンパ節腫脹、FDG-PETでリンパ節に高度の集積を認め、悪性リンパ腫との鑑別を要した全身性サルコイドーシスの53歳女性例 臨床神経学. 2021.01; 61 (1): 65. ( 医中誌 )

  1. 西 李依子,永田哲也,横田隆徳: RNAサイレンシングと神経疾患 Medical Science Digest. 2020.08; 46 (9): 15-18.

  2. 横田隆徳: ビタミンE欠乏 Clinical Neuroscience. 2020.08; 38 (8): 44-45.

  3. 原 倫太朗, 横田隆徳: 核酸医薬の基礎と臨床 総論・化学 神経治療学. 2020.05; 37 (3):

  4. 原 倫太朗, 横田隆徳: 【核酸創薬に貢献するバイオマテリアル】ヘテロ核酸 バイオマテリアル-生体材料-. 2020.04; 38 (2): 100-105. ( 医中誌 )

  5. 青木 華古, 横田 隆徳: 革新的領域 核酸医薬とは 現状と今後の展望 難病と在宅ケア. 2020.04; 26 (1): 36-39. ( 医中誌 )

  6. 原倫太朗, 横田隆徳: ヘテロ核酸 バイオマテリアル-生体材料-. 2020.04; 38 (2): 238-241.

  7. 吉岡耕太郎,横田隆徳: Basic Neuroscience 生化学(分子生物学) 神経疾患に対する核酸医薬の現状と展望 Annual Review 神経. 2020.04; 2020 37-44.

  8. 柳平 貢, 永田 哲也, 横田 隆徳: 【よくわかる遺伝子治療-実用化の現状と展望】遺伝子治療総論 DNA/RNAヘテロ核酸による遺伝子発現抑制 Clinical Neuroscience. 2020.03; 38 (3): 319-322. ( 医中誌 )

  9. 柳平 貢, 吉岡 耕太郎, 登利屋 修一, 横田 隆徳: 核酸医薬品の創出に向けた産官学の取り組み(第(5)回) ヘテロ2本鎖核酸 PHARM TECH JAPAN. 2020.03; 36 (4): 661-667. ( 医中誌 )

  10. 桑原宏哉: 神経疾患治療ノート ビタミンB6欠乏症 Clinical Neuroscience. 2020.03; 38 (3): 385-387.

  11. 三浦 元輝, 永田 哲也, 横田 隆徳: 【ALS(筋萎縮性側索硬化症)治療の最前線】ALS治療の新たなモダリティとしての核酸医薬 医学のあゆみ. 2020.02; 272 (6): 511-516. ( 医中誌 )

  12. 中島 健二, 祖父江 元, 長谷川 一子, 饗場 郁子, 青木 正志, 阿部 康二, 池内 健, 小野寺 理, 梶 龍兒, 吉良 潤一, 桑原 聡, 小久保 康昌, 斎藤 加代子, 佐々木 秀直, 佐野 輝, 高橋 良輔, 辻 省次, 戸田 達史, 中川 正法, 野元 正弘, 服部 信孝, 村田 美穂, 村山 繁雄, 望月 秀樹, 森田 光哉, 横田 隆徳, 吉田 眞理, 渡辺 保裕, 保住 功, Huntington病の診断、治療、療養の手引きガイドライン作成委員会: Huntington病の診断、治療、療養の手引き 神経治療学. 2020.01; 37 (1): 61-104. ( 医中誌 )

  13. 原倫太朗, 横田隆徳: 核酸医薬の基礎と臨床 総論・化学 神経治療学. 2020; 37 (3): 238-241.

  1. 桑原 宏哉, 横田 隆徳: 【中枢神経疾患に対するDDSのトランスレーショナルリサーチ】血中グルコース濃度の変化に応答した効率的な血液脳関門通過型DDS Drug Delivery System. 2019.11; 34 (5): 352-359. ( 医中誌 )

  2. 荻野 絢, 大谷 泰, 宮本 翔平, 宮下 明子, 梅澤 夏佳, 小林 正樹, 西田 陽一郎, 石橋 哲, 三條 伸夫, 石川 欽也, 横田 隆徳: 抗HMGCR抗体陽性壊死性ミオパチー3症例の治療法の検討 臨床神経学. 2019.11; 59 (Suppl.): S310. ( 医中誌 )

  3. 西田 陽一郎, 杉田 陽一郎, 鬼木 絢子, 松林 泰毅, 河合 ほなみ, 宮本 翔平, 八木 洋輔, 横田 隆徳: 直接経口抗凝固薬内服開始後に無症候性円蓋部くも膜下出血を認めた脳梗塞の2例 臨床神経学. 2019.11; 59 (Suppl.): S264. ( 医中誌 )

  4. 杉田 陽一郎, 西田 陽一郎, 清澤 源弘, 河合 ほなみ, 横田 隆徳: 発作性複視・斜視を呈したOcular neuromyotoniaの69歳女性の一例と文献的考察 臨床神経学. 2019.11; 59 (Suppl.): S321. ( 医中誌 )

  5. 桑原宏哉,横田隆徳: 【中枢神経疾患に対するDDSのトランスレーショナルリサーチ】血中グルコース濃度の変化に応答した効率的な血液脳関門通過型DDS Drug Delivery System. 2019.11; 34 (5): 352-359.

  6. 野田 浩太郎, 八木 洋輔, 西田 陽一郎, 石橋 哲, 三條 伸夫, 横田 隆徳: IVIg投与に関連して血栓症を起こした3例の報告と血栓症発症リスクの考察 臨床神経学. 2019.11; 59 (Suppl.): S285. ( 医中誌 )

  7. 関口 縁, 三澤 園子, 鈴木 陽一, 常山 篤子, 水地 智基, 網野 寛, 西田 陽一郎, 横田 隆徳, 野寺 裕之, 幸原 伸夫, 桑原 聡: エクリズマブによるギラン・バレー症候群の長期予後 病型との関連 臨床神経生理学. 2019.10; 47 (5): 479. ( 医中誌 )

  8. 高橋 祐子, 西田 陽一郎, 金井 哲也, 能勢 裕里江, 石橋 哲, 三條 伸夫, 鵜沢 顕之, 桑原 聡, 鈴木 重明, 中原 仁, 鈴木 則宏, 横山 和正, 服部 信孝, 藤岡 俊樹, 川口 直樹, 園生 雅弘, 西山 和利, 野村 恭一, 横田 隆徳: 抗AChR抗体陽性重症筋無力症におけるタクロリムス減量による再発危険因子の検討 神経治療学. 2019.10; 36 (6): S245. ( 医中誌 )

  9. 杉田 陽一郎, 西田 陽一郎, 横田 隆徳: 抗NMDA受容体脳炎患者における血漿交換療法前後での髄液所見の検討 神経免疫学. 2019.09; 24 (1): 161. ( 医中誌 )

  10. 玉木 香菜, 三條 伸夫, 西田 陽一郎, 横田 隆徳: 抗アクアポリン4(AQP4)抗体陽性視神経脊髄炎関連疾患(NMOSD)における脊髄病変と臨床所見の解離の特徴 神経免疫学. 2019.09; 24 (1): 134. ( 医中誌 )

  11. 藤田 明日菜, 三條 伸夫, 西田 陽一郎, 今井 耕輔, 松林 泰毅, 森尾 友宏, 横田 隆徳: 非血縁者間同種造血幹細胞移植に伴う免疫異常を背景とした重症肺炎球菌性髄膜炎の37歳女性例 NEUROINFECTION. 2019.09; 24 (2): 147. ( 医中誌 )

  12. 浜口 毅, 三條 伸夫, 中村 好一, 北本 哲之, 村山 繁雄, 高尾 昌樹, 佐藤 克也, 原田 雅史, 水澤 英洋, 山田 正仁: MM2視床型孤発性Creutzfeldt-Jakob病の臨床像 NEUROINFECTION. 2019.09; 24 (2): 164. ( 医中誌 )

  13. 横手 裕明, 融 衆太, 西田 陽一郎, 服部 高明, 三條 伸夫, 横田 隆徳: MS/NMO 2 多発性硬化症において側頭極容積は低下しており、血清アミロイドA値と有意に逆相関する 神経免疫学. 2019.09; 24 (1): 120. ( 医中誌 )

  14. 柳平 貢, 西田 陽一郎, 石橋 哲, 三條 伸夫, 横田 隆徳: エクリズマブ加療中に臨床症状と血清補体価を経時的に評価した重症筋無力症の一例 神経免疫学. 2019.09; 24 (1): 170. ( 医中誌 )

  15. 吉岡 耕太郎, 石橋 哲: 【臨床予測ルールを救急で正しく活用しよう!Clinical prediction rule「そのルール、目の前の患者さんに使っていいんですか?」論文から読み解く本当の目的と使いどころ】【よく出合う疾患の臨床予測ルール】脳卒中 レジデントノート. 2019.08; 21 (7): 1226-1233. ( 医中誌 )

  16. 杉田 陽一郎, 西田 陽一郎, 服部 高明, 石橋 哲, 三條 伸夫, 横田 隆徳: 血漿交換前後で髄液中IgGの減少を確認した抗NMDA受容体脳炎の38歳女性 臨床神経学. 2019.07; 59 (7): 466. ( 医中誌 )

  17. 西田 陽一郎, 桑原 宏哉, 三條 伸夫, 横田 隆徳: Alzheimer病研究の新しい潮流-4 血液脳関門通過型Aβオリゴマー抗体の開発 神経治療学. 2019.07; 36 (4): 532-536. ( 医中誌 )

  18. 西田陽一郎,桑原宏哉,三條伸夫,横田隆徳: 血液脳関門通過型Aβオリゴマー抗体の開発 神経治療学. 2019.07; 36 (4): 532-536.

  19. 桑原宏哉: 臨床研究法にどう対応するか 臨床研究法の概要 日本臨床麻酔学会誌. 2019.07; 39 (4): 416-422.

  20. 吉岡 耕太郎: 難治性神経筋疾患で始まった核酸医薬による原因治療-1 核酸医薬総論 神経治療学. 2019.05; 36 (3): 305-309. ( 医中誌 )

  21. 山田 大貴, 吉岡 耕太郎, 横田 隆徳: 【加速する核酸医薬開発】 第3の核酸医薬プラットフォーム・ヘテロ2本鎖核酸 医薬ジャーナル. 2019.02; 55 (2): 607-613. ( 医中誌 )

  22. 横手 裕明, 横田 隆徳: 【視神経脊髄炎スペクトル障害(NMO-SD)】 NMO-SDにおける視床下部障害 脳神経内科. 2019.01; 90 (1): 30-34. ( 医中誌 )

  23. 横田 隆徳: 総論 核酸医薬 メディカル・サイエンス・ダイジェスト. 2019.01; 45 (1): 10-12.

  24. 市野瀬慶子,横田隆徳: DNA/RNAヘテロ2本鎖核酸(HDO)の開発 メディカル・サイエンス・ダイジェスト. 2019.01; 45 (1): 28-31.

  1. 張 由絹, 宮本 翔平, 八木 洋輔, 尾崎 心, 西田 陽一郎, 石橋 哲, 野老 翔雲, 横関 博雄, 石川 欣也, 三條 伸夫, 横田 隆徳: 不全型ベーチェット病に伴うステロイド反応性不良のミオパチーに対しアダリムマブを使用した1例 神経治療学. 2018.11; 35 (6): S229. ( 医中誌 )

  2. 大原正裕, 永田 哲也, 横田 隆徳: 【核酸医薬研究の進歩】 核酸医薬総論とヘテロ2本鎖核酸 神経内科. 2018.11; 89 (5): 510-517. ( 医中誌 )

  3. 村井 弘之, 中村 好一, 坪井 義夫, 松下 拓也, 三條 伸夫, 北本 哲之, 山田 正仁, 水澤 英洋: P102L変異を有するGSSの臨床疫学的検討 V180I変異を有する遺伝性CJDおよび孤発性CJDとの比較検討 NEUROINFECTION. 2018.10; 23 (2): 241. ( 医中誌 )

  4. 尾崎 心, 水澤 英洋, 石川 欽也, 横田 隆徳: 脂肪酸伸長酵素ELOVL4/5の変異がもたらす脊髄小脳失調症 お茶の水医学雑誌. 2018.10; 66 (2): 297-305. ( 医中誌 )

  5. 山田 茜, 阿部 圭輔, 沼沢 祥行, 尾崎 心, 横田 隆徳: 眼で見る神経内科 痙性対麻痺を主徴とし頭部MRIで小脳に異常信号を認めた脳腱黄色腫症 神経内科. 2018.10; 89 (4): 439-440. ( 医中誌 )

  6. 齋藤 明日香,三條 伸夫: プリオン病 日本医師会雑誌. 2018.10; 147 (特別号(2)): 122-124.

  7. 横田 隆徳: ついに実現した核酸医薬による神経難病治療の幕開け 日本認知症学会誌. 2018.10; 32 (4): 587-588.

  8. 齋藤 明日香, 三條 伸夫: 【認知症トータルケア】代表的な認知症疾患 プリオン病 日本医師会雑誌. 2018.10; 147 (特別2): S122-S124. ( 医中誌 )

  9. 八木洋輔,横田隆徳: 【ニューロパチー Basics & Updates】免疫性介在ニューロパチー慢節炎症性脱髄性多発根ニューロパチー Clinical Neurology. 2018.09; 36 (9): 1046-1050. ( 医中誌 )

  10. 玉木 香菜, 阿部 圭輔, 西田 陽一郎, 石橋 哲, 三條 伸夫, 横田 隆徳: 全身型MGに対してEFT(Early Fast-acting Treatment)を試み初期増悪した72歳女性の一例 神経免疫学. 2018.09; 23 (1): 145. ( 医中誌 )

  11. 浜口 毅, 坂井 健二, 三條 伸夫, 阿江 竜介, 中村 好一, 北本 哲之, 高尾 昌樹, 村山 繁雄, 佐藤 克也, 原田 雅史, 塚本 忠, 水澤 英洋, 山田 正仁: MM2皮質型孤発性Creutzfeldt-Jakob病の臨床診断基準案の提案 Dementia Japan. 2018.09; 32 (3): 457. ( 医中誌 )

  12. 八木 洋輔,横田 隆徳: 慢性炎症性脱髄性多発根ニューロパチー (CIDP) 月刊 臨床神経科学. 2018.09; 36 (9): 1046-1050.

  13. 青木 華古, 服部 高明, 張 由絹, 尾崎 心, 石橋 哲, 三條 伸夫, 横田 隆徳: HIV非感染・免疫抑制剤未使用下で小脳症状を呈し、PMLを疑った77歳男性 臨床神経学. 2018.08; 58 (8): 523. ( 医中誌 )

  14. 森 容子, 水谷 真之, 小野 大介, 市野瀬 慶子, 渡邊 睦房, 横田 隆徳: 肺腺癌との関連が疑われる片側舞踏運動を呈した81歳女性例 臨床神経学. 2018.07; 58 (7): 430-434. ( 医中誌 )

  15. 横田隆徳: 神経難病治療の可能性 医薬ジャーナル. 2018.07; 54 (7): 63-64.

  16. 天野 晶子、三條伸夫: アルツハイマー病の創薬の展望 医薬ジャーナル. 2018.07; 54 (7): 113-118.

  17. Mori Y, Mizutani S, Ono D, Ichinose K, Watanabe M, Yokota T: [A case of hemichorea associated with lung adenocarcinoma]. Rinsho shinkeigaku = Clinical neurology. 2018.07; 58 (7): 430-434. ( PubMed , DOI )

  18. 山田 大貴, 永田 哲也, 横田 隆徳: 【神経難病と創薬】 神経難病と核酸医薬による分子標的治療の現状 医薬ジャーナル. 2018.07; 54 (7): 1613-1621. ( 医中誌 )

  19. 國枝 泰希, 吉岡 耕太郎: 【核酸医薬の現状と展望】 microRNAを標的にした核酸医薬の現状 最新医学. 2018.06; 73 (6): 787-793. ( 医中誌 )

  20. 小泉 誠, 小比賀 聡, 横田 隆徳: 【核酸医薬の現状と展望】 核酸医薬の現状と展望 最新医学. 2018.06; 73 (6): 737-745. ( 医中誌 )

  21. 馬嶋 貴正, 永田 哲也, 仁科 一隆, 横田 隆徳: 【核酸医薬の現状と展望】 ヘテロ核酸の現状 最新医学. 2018.06; 73 (6): 781-786. ( 医中誌 )

  22. 横田 隆徳: 【核酸医薬の現状と展望】 核酸医薬総論 最新医学. 2018.06; 73 (6): 746-750. ( 医中誌 )

  23. 平井 高志, 榎本 光弘, 鏑木 秀俊, 横山 裕之, 永田 哲也, 横田 隆徳, 大川 淳: 【腰痛治療の革新-慢性腰痛・神経障害性疼痛に対する治療のbreakthrough】 神経障害性疼痛のメカニズム探索と分子標的による新規治療戦略 Journal of Spine Research. 2018.06; 9 (6): 1022-1030. ( 医中誌 )

  24. 横田 隆徳: 神経筋疾患で始った核酸医薬による分子標的治療 臨床神経学. 2018.05; 58 (5): 337. ( 医中誌 )

  25. Ohara Masahiro, Ozaki Kokoro, Ohkubo Takuya, Yamada Akane, Numasawa Yoshiyuki, Tanaka Keisuke, Tomii Shohei, Ishibashi Satoru, Sanjo Nobuo, Yokota Takanori: 胸腺摘除術後、長期にわたりタクロリムス療法を行った、重症筋無力症に合併した非特定型末梢性T細胞リンパ腫(PTCL-NOS)(Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified(PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy) Internal Medicine. 2018.02; 57 (4): 601-604. ( 医中誌 )

  26. 大谷木 正貴, 永田 哲也, 横田 隆徳: 【核酸医薬】DNA/RNAヘテロ2本鎖核酸(HDO)の開発 BIO Clinica. 2018.01; 33 (1): 6-10. ( 医中誌 )

  27. 坂上 史佳, 横田 隆徳: 本年の動向 筋萎縮性側索硬化症と異常タンパク質(TDP-43・C9ORF72) Annual Review神経. 2018.01; 2018 114-120. ( 医中誌 )

  28. 原(岩田) 倫太朗,和田 猛: 核酸医薬の安定化と高活性化を実現する新規分子技術 Dementia Japan. 2018; 32 597-606.

  1. 飯嶋 真秀, 三條 伸夫, 西田 陽一郎, 鈴木 基弘, 横田 隆徳: CIDPにおけるCyclosporine AによるIVIg投与間隔の延長効果の検討 神経治療学. 2017.11; 34 (6): S203. ( 医中誌 )

  2. 三木 一徳, 唐鎌 淳, 壽美田 一貴, 吉野 義一, 石橋 哲, 横田 隆徳, 根本 繁: 治療アルゴリズムの変遷による急性期脳梗塞に対する血行再建治療成績の変化の検討 脳血管内治療. 2017.11; 2 (Suppl.): S167. ( 医中誌 )

  3. 鳴海 純, 叶内 匡, 赤座 実穂, 飯田 真太朗, 青柳 栄子, 太田 那津美, 宮崎 健太郎, 角 勇樹, 横田 隆徳, 萩原 三千男, 東田 修二: 手根管症候群の異なる電気診断法における検査間変動を考慮した特異度に関する考察 臨床神経生理学. 2017.10; 45 (5): 451. ( 医中誌 )

  4. 齋藤 明日香, 三條 伸夫, 横手 裕明, 西田 陽一郎, 横田 隆徳: 病初期から重度の認知機能障害を呈し多発性硬化症と考えられた3症例 神経免疫学. 2017.10; 22 (1): 133. ( 医中誌 )

  5. 赤座 実穂, 赤座 至, 叶内 匡, 笹野 哲郎, 角 勇樹, 横田 隆徳: 血糖変動と糖尿病神経障害との関連の検討 臨床神経生理学. 2017.10; 45 (5): 443. ( 医中誌 )

  6. 三條伸夫、宍戸-原由紀子、三浦義治: PMLの基礎疾患の多様性:医原性を含めて 神経内科 2017、特集Ⅰ/進行性多巣性白質脳症(PML)診療の進歩. 2017.10; 87 (4): 365-371.

  7. 福島 明子, 大原 正裕, 尾崎 心, 服部 高明, 沼沢 祥行, 石橋 哲, 三條 伸夫, 横田 隆徳: 口蓋振戦と小脳失調を呈したCLIPPERSの56歳男性 臨床神経学. 2017.10; 57 (10): 627. ( 医中誌 )

  8. 東 美和, 永田 哲也, 横田 隆徳: 【脊髄小脳変性症(SCD)-最新診療マニュアル】 これからの治療への展望 核酸医薬 Clinical Neuroscience. 2017.09; 35 (9): 1124-1127. ( 医中誌 )

  9. 平田 浩聖, 永田 哲也, 三條 伸夫, 横田 隆徳: 【創薬からみたアルツハイマー病の治療戦略】 認知症に対する新規治療法の開発 タウを標的にした分子標的治療薬を中心に Dementia Japan. 2017.09; 31 (3): 361-369. ( 医中誌 )

  10. 三條 伸夫: 【認知症1,000万人時代を目前に控えて-最新の診断,マネジメント,そして分子標的治療へ】非Alzheimer型認知症の病態研究の最前線 Creutzfeldt-Jakob病 内科. 2017.08; 120 (2): 263-266. ( 医中誌 )

  11. 八木 洋輔, 横田 隆徳: 【認知症 発症前治療のために解明すべき分子病態は何か?】 (第7章)発症分子機構update 伝播仮説 エクソソーム性伝搬 実験医学. 2017.08; 35 (12): 2142-2147. ( 医中誌 )

  12. Iwasawa Eri, Ohkubo Takuya, Kanouchi Tadashi, Kanda Takashi, Mizusawa Hidehiro, Yokota Takanori: 重症多巣性運動ニューロパチー(MMN)患者に対するシクロホスファミド静注とメスナ静注/膀胱内注入併用の長期効果(Long-term Effects of Intravenous Cyclophosphamide in Combination with Mesna Provided Intravenously and via Bladder Perfusion in a Patient with Severe Multifocal Motor Neuropathy) Internal Medicine. 2017.07; 56 (14): 1893-1896. ( 医中誌 )

  13. 平井 高志, 榎本 光裕, 大川 淳, 横田 隆徳: TRPV1を標的としたshRNA-AAV serotype 9くも膜下腔投与は神経因性疼痛マウスの熱知覚過敏を有意に抑制する お茶の水医学雑誌. 2017.07; 65 (2): 237-245. ( 医中誌 )

  14. 渡辺 知恵, Yi Cheng, 渡利 彰浩, 八木 清仁, 吉岡 耕太郎, 吉田 規恵, 仁科 一隆, 横田 隆徳, 村上 正裕: 新規DNA/RNAヘテロ二本鎖核酸のm19を用いた経腸デリバリー技術による標的遺伝子抑制効果 日本DDS学会学術集会プログラム予稿集. 2017.06; 33回 219. ( 医中誌 )

  15. 山田 茜, 関口 真貴子, 阿部 圭輔, 沼沢 祥行, 尾崎 心, 石橋 哲, 三條 伸夫, 横田 隆徳: 認知障害と痙性対麻痺を呈した脳腱黄色腫症の23歳男性例 臨床神経学. 2017.06; 57 (6): 330. ( 医中誌 )

  16. 沼波 仁, 濱田 詩織, 張 由絹, 飯嶋 真秀, 鈴木 基弘, 金澤 俊郎, 田中 宏明, 横田 隆徳: 肺炎球菌性髄膜炎にADEMとacute motor-dominant polyneuropathyを合併した68歳女性例 臨床神経学. 2017.06; 57 (6): 336. ( 医中誌 )

  17. 西田 陽一郎, 横田 隆徳: ALS 筋萎縮性側索硬化症に対する核酸医薬治療 神経治療学. 2017.05; 34 (3): 258-261. ( 医中誌 )

  18. 西田 陽一郎, 横田 隆徳: ALS 筋萎縮性側索硬化症に対する核酸医薬治療 神経治療学. 2017.05; 34 (3): 258-261. ( 医中誌 )

  19. 永田 哲也, 吉岡 耕太郎, 横田 隆徳: 【ALS治療に光】 [第1部]ALSに対する核酸医薬治療 難病と在宅ケア. 2017.05; 23 (2): 24-27. ( 医中誌 )

  20. 三條伸夫、宍戸―原由紀子、三浦義治.: PMLの基礎疾患の多様性:医原性を含めて. 特集Ⅰ/進行性多巣性白質脳症(PML)診療の進歩. 神経内科 2017, 87(4), 365-371.. 2017.04;

  21. 飯嶋 真秀, 三橋 正季, 沼波 仁, 鈴木 基弘, 金澤 俊郎, 田中 宏明, 横田 隆徳: 右総頸動脈閉塞による脳梗塞を発症したループスアンチコアグラント陽性高安病の25歳女性例 臨床神経学. 2017.04; 57 (4): 191. ( 医中誌 )

  22. 金 亮秀, 山田 茜, 沼沢 祥行, 石橋 哲, 三條 伸夫, 横田 隆徳: 嚥下誘発性に一過性心房頻拍をきたした81歳女性例 臨床神経学. 2017.04; 57 (4): 197. ( 医中誌 )

  23. 大和田 潔, 長谷川 樹里, 遠藤 恵子, 横田 隆徳: 生き残りを懸けた管理栄養士のフロンティア精神(第5弾) 栄養指導による栄養治療の効果に関するエビデンスを作るための臨床研究 臨床研究を通して見える管理栄養士の将来の姿 クリニックに栄養相談専門士が存在する意義 New Diet Therapy. 2017.03; 32 (4): 59-61. ( 医中誌 )

  24. 藤原 果奈, 渡利 彰浩, 永田 哲也, 近藤 昌夫, 横田 隆徳, 八木 清仁: Homoharringtonineによる核酸医薬の経皮投与基盤技術の開発 日本薬学会年会要旨集. 2017.03; 137年会 (4): 64. ( 医中誌 )

  25. 三條伸夫. : Creutzfeldt-Jakob病. 特集:認知症1000万人時代を目前に控えて.  内科 2017, 120(2), 263-266. 2017.02;

  26. 石川 茉莉子, 下田 浩, 飯田 真太朗, 阿部 圭輔, 西田 陽一郎, 石橋 哲, 三條 伸夫, 横田 隆徳: 眼筋型重症筋無力症に甲状腺眼症を合併した84歳男性例 日本内科学会関東地方会. 2017.02; 630回 49. ( 医中誌 )

  27. 伊藤陽子、三條伸夫: 遺伝性プリオン病 Pharma Medica 2017,特集 プリオン病 その実態に迫る. 2017.02; 35 (2): 21-25.

  28. 伊藤 陽子, 三條 伸夫: 【プリオン病:その実態に迫る】ヒトのプリオン病 遺伝性プリオン病 Pharma Medica. 2017.02; 35 (2): 21-25. ( 医中誌 )

  29. 赤座 実穂, 原 恵子, 永森 千寿子, 沼沢 祥行, 叶内 匡, 相馬 沙紀, 笹野 哲郎, 稲次 基希, 角 勇樹, 前原 健寿, 横田 隆徳: 扁桃体腫大を伴う側頭葉てんかんが疑われる一例 てんかん研究. 2017.01; 34 (3): 657. ( 医中誌 )

  30. 三條伸夫.: Creutzfeldt-Jakob病 . 特集:認知症1000万人時代を目前に控えて 内科. 2017; 120 (2): 263-266.

  31. 平田浩聖、永田哲也、三條伸夫、横田隆徳: 認知症に対する新規治療法の開発:タウを標的にした分子標的治療薬を中心に. Dementia Japan. 2017; 31 361-369.

  32. 伊藤陽子、三條伸夫: 特集:プリオン病 その実態に迫る 遺伝性プリオン病. 2017; 35 (2): 21-25.

  1. 中野 雄太, 新谷 晶子, 尾崎 心, 小林 正樹, 石川 欽也, 石橋 哲, 三條 伸夫, 横田 隆徳: VCP遺伝子異常は認めなかったがIBMPFD様の臨床像を呈した60歳男性例 臨床神経学. 2016.12; 56 (12): 887. ( 医中誌 )

  2. 古川 迪子, 三條 伸夫, 松本 裕希子, 横田 隆徳: Parkinson病の重症度による非運動症状と高次脳機能の比較解析 臨床神経学. 2016.12; 56 (Suppl.): S408. ( 医中誌 )

  3. 板谷 早希子, 尾崎 心, 桑原 宏哉, 佐藤 望, 石橋 哲, 三條 伸夫, 横田 隆徳: Epstein-Barrウイルス脳炎5例の臨床経過と治療反応性の検討 臨床神経学. 2016.12; 56 (Suppl.): S497. ( 医中誌 )

  4. 横田隆徳,仁科一隆,桑原宏哉: 核酸医薬を用いた遺伝子治療の展望 神経治療学. 2016.11; 33 (3): 303-306.

  5. 佐野 達彦, 吉岡 耕太郎, 永田 哲也, 横田 隆徳: 【神経内科疾患のtrends & topics 2017】 神経疾患の核酸医学と遺伝子治療 Mebio. 2016.11; 33 (11): 89-98. ( 医中誌 )

  6. 三浦 元輝, 飯嶋 真秀, 佐藤 武文, 石橋 哲, 三條 伸夫, 横田 隆徳: ぶどう膜炎と慢性関節炎を呈し、関節滑膜生検にて関節サルコイドーシスと診断しえた64歳男性例 日本サルコイドーシス/肉芽腫性疾患学会雑誌. 2016.10; 36 (1-2): 95. ( 医中誌 )

  7. 小野 大介, 吉岡 耕太郎, 永田 哲也, 横田 隆徳: 【革新バイオ医薬品】 DNA/RNAヘテロ2本鎖核酸の開発 Medical Science Digest. 2016.09; 42 (10): 458-461. ( 医中誌 )

  8. 横手 裕明, 鎌田 智幸, 融 衆太, 三條 伸夫, 横田 隆徳: NEDA-3を満たすがNEDA-4を満たさない多発性硬化症患者の臨床的特徴 病態修飾薬との関連性 神経免疫学. 2016.09; 21 (1): 101. ( 医中誌 )

  9. 三條 伸夫, 宍戸 由紀子[原], 中道 一生, 西條 政幸, 三浦 義治, 雪竹 基弘, 高橋 健太, 鈴木 忠樹, 岸田 修二, 澤 洋文, 中村 好一, 浜口 毅, 山田 正仁, 水澤 英洋, 横田 隆徳: PMLとPMLサーベイランス NEUROINFECTION. 2016.09; 21 (2): 192. ( 医中誌 )

  10. 古川 迪子, 三條 伸夫: 【アルツハイマー病と新オレンジプラン】原因と発症機序 孤発性アルツハイマー病の遺伝要因 Clinical Neuroscience. 2016.09; 34 (9): 980-981. ( 医中誌 )

  11. 古川迪子、三條伸夫: 孤発性アルツハイマー病の遺伝要因 Clinical Neuroscience 特集「アルツハイマー病と新オレンジ・プラン」. 2016.09; 34 (9): 980-981.

  12. 宍戸-原由紀子,内原俊記,三條伸夫: 炎症反応を伴った進行性多巣性白質脳症 〜免疫不全の原因の多様性と病理所見〜 BRAIN and NERVE 2016. 2016.04; 68 (4): 479-488.

  13. Shishido-Hara Y, Uchihara T, Sanjo N: [Progressive Multifocal Leukoencephalopathy with Inflammatory Reactions]. Brain and nerve = Shinkei kenkyu no shinpo. 2016.04; 68 (4): 479-88. ( PubMed , DOI )

  14. 吉岡 耕太郎, 笹栗 弘貴, 横田 隆徳: 【筋萎縮性側索硬化症の最近の知見とリハビリテーション】 病態と治療の現況、未来 Journal of Clinical Rehabilitation. 2016.03; 25 (3): 216-223. ( 医中誌 )

  15. 天野 永一朗, 鈴木 基弘, 尾崎 心, 大久保 卓哉, 石橋 哲, 三條 伸夫, 江川 聡, 横田 隆徳: VPシャント後に頸髄萎縮を認めた77歳男性 臨床神経学. 2016.03; 56 (3): 216. ( 医中誌 )

  16. 太組一朗、三條伸夫、高柳俊作、斉藤延人、水澤英洋: プリオン病の感染予防対策-インシデント事例対策を中心に- 神経内科. 2016.03; 84 (3): 280-284.

  17. 横田隆徳、叶内 匡、大久保卓哉: ALS:新たな視点による進行様式の定量的解析 厚生労働科学研究費補助金 難治性疾患政策研究事業 神経変性疾患領域における基盤的調査研究 平成27年度 総括・分担研究報告書. 2016.03; 58-61.

  18. 古川 迪子, 永田 哲也, 三條 伸夫, 横田 隆徳: 【核酸創薬とドラッグデリバリーシステムの革新による認知症の遺伝子治療への道】革新的新規核酸医薬による神経疾患の治療 Dementia Japan. 2016.01; 30 (1): 9-19. ( 医中誌 )

  19. 小野大介,吉岡耕太郎,永田哲也,横田隆徳: DNA/RNAヘテロ2本鎖核酸の開発 Medical Science Digest. 2016; 42 (10): 18-21.

  20. 三浦義治,横田隆徳: HIV脳炎とAIDS脳症(HIV関連神経認知障害, HAND) Mebio. 2016; 33 (3): 42-47.

  21. 佐野達彦,吉岡耕太郎,永田哲也,横田隆徳: 神経疾患の核酸医学と遺伝子治療 Mebio. 2016; 33 (11): 89-98.

  22. 沼沢祥行,川越正平,横田隆徳: Parkinson病患者の自宅にある錯視の原因 内科. 2016; 118 1154.

  23. 永田哲也,横田隆徳: 国内発の核酸医薬品の開発に向けて MEDCHEM NEWS. 2016; 26 (1): 34-37.

  24. 横田隆徳: 東京医科歯科大学を「核酸医薬」における研究の中心拠点へ 医科歯科大Bloom! . 2016; 20 12-13.

  25. 吉岡耕太郎,笹栗弘貴,横田隆徳: 病態と治療の現況,未来 Journal of Clinical Rehabilitation. 2016; 25 (3): 216-223.

  26. 古川迪子、永田哲也、三條伸夫、横田隆徳: 革新的新規核酸医薬による神経疾患の治療 Dementia Japan. 2016; 30 9-19.

  1. 日熊 麻耶, 三條 伸夫, 三苫 博, 横田 隆徳: アルツハイマー病患者の歩行周期と注意・集中力との関連 臨床神経学. 2015.12; 55 (Suppl.): S425. ( 医中誌 )

  2. 仁科 一隆, 吉岡 耕太郎, 桑原 宏哉, 横田 隆徳: 【アカデミア発の創薬・研究治療】 神経疾患に対する核酸医薬による遺伝子治療 神経内科. 2015.10; 83 (4): 283-288. ( 医中誌 )

  3. 仁科一隆,吉岡耕太郎,桑原宏哉,横田隆徳.: 神経疾患に対する核酸医薬による遺伝子治療. 神経内科. 2015.10; 83 (4): 283-288.

  4. 桑原宏哉,横田隆徳.: 核酸医薬のナノDDS. 細胞工学. 2015.10; 34 (10): 939-945.

  5. 新宅 洋, 西田 陽一郎, 藤原 鷹, 鈴木 基弘, 石橋 哲, 三條 伸夫, 石川 欽也, 横田 隆徳: シェーグレン症候群に伴う感覚性ニューロパチーに多発性筋炎を合併した54歳女性例 臨床神経学. 2015.10; 55 (10): 778. ( 医中誌 )

  6. 横手 裕明, 鎌田 智幸, 三條 伸夫, 横田 隆徳: MS臨床 多発性硬化症における脳容積減少率と血中バイオマーカーとの関連性の探索 神経免疫学. 2015.09; 20 (1): 87. ( 医中誌 )

  7. 浜口 毅, 三條 伸夫, 中村 好一, 村山 繁雄, 佐藤 克也, 原田 雅史, 水澤 英洋, 山田 正仁, CJDサーベイランス委員会: MM2皮質型孤発性Creutzfeldt-Jakob病の臨床診断 Dementia Japan. 2015.09; 29 (3): 400. ( 医中誌 )

  8. 浅見 裕太郎, 三條 伸夫, 横田 隆徳: NMO臨床 視神経炎を合併した多発性硬化症(MS)、視神経脊髄炎(NMO)と視神経炎単独症例の臨床的検討 神経免疫学. 2015.09; 20 (1): 83. ( 医中誌 )

  9. 高橋 祐子, 大久保 卓哉, 西田 陽一郎, 石橋 哲, 東 盛志, 稲瀬 直彦, 三條 伸夫, 横田 隆徳: ALK陽性肺腺癌を合併した血管炎性ニューロパチーの37歳女性 臨床神経学. 2015.08; 55 (8): 617. ( 医中誌 )

  10. 吉岡 耕太郎, 桑原 宏哉, 仁科 一隆, 永田 哲也, 横田 隆徳: 核酸医薬研究の現況と展望 日本臨床. 2015.06; 73 (6): 1057-1065. ( 医中誌 )

  11. 桑原宏哉,内原俊記,河村満.: Flail arm syndromeを呈し,速やかに呼吸不全に至ったALSの48歳男性剖検例. BRAIN and NERVE.. 2015.05; 67 (5): 639-650.

  12. 古川 迪子, 三條 伸夫: 【感覚とその異常】感覚障害を呈する疾患の診断と治療 プリオン病 Clinical Neuroscience. 2015.05; 33 (5): 586-587. ( 医中誌 )

  13. 桑原宏哉, 内原俊記, 河村満: Flail arm syndromeを呈し、速やかに呼吸不全に至ったALSの48歳剖検例. BRAIN and NERVE. 2015; 67 (5): 639-650.

  1. 浜口 毅, 坂井 健二, 野崎 一朗, 篠原 もえ子, 三條 伸夫, 中村 好一, 北本 哲之, 村山 繁雄, 佐藤 克也, 原田 雅史, 水澤 英洋, 山田 正仁: MM2型孤発性Creutzfeldt-Jakob病の臨床的特徴と診断基準案の提案 臨床神経学. 2014.12; 54 (Suppl.): S206. ( 医中誌 )

  2. 三浦 愛, 三條 伸夫, 能勢 裕里江, 西 季依子, 石橋 哲, 水澤 英洋: MELAS症例の脳卒中様発作急性期のL-アルギニン治療の検討 臨床神経学. 2014.12; 54 (Suppl.): S10. ( 医中誌 )

  3. 三條伸夫、馬嶋貴正、能勢裕里江: 多発性硬化症のパラダイムシフト-病態から治療まで- Clinical Neuroscience. 2014.11; 32 (11): 1232-1235.

  4. 渡邊 耕介, 吉岡 耕太郎, 日詰 正樹, 金澤 俊郎, 田中 宏明: 妊娠中に中耳炎を生じ産褥期にseptic dural sinus thrombosisに至った1例 脳卒中. 2014.09; 36 (5): 356-360. ( 医中誌 )

  5. 古川 迪子, 石橋 哲, 三條 伸夫, 山下 拓史, 倉重 毅志, 松本 昌泰, 横田 隆徳, 水澤 英洋: MRI拡散強調画像で発症早期の変化が確認できたVV型孤発性クロイツフェルト・ヤコブ病の52歳男性例 臨床神経学. 2014.03; 54 (3): 257. ( 医中誌 )

  6. 小林 あゆみ, 宮下 彰子, 古川 迪子, 石橋 哲, 大久保 卓哉, 高山 かおる, 三條 伸夫, 横田 隆徳, 水澤 英洋: インフルエンザワクチン接種後に一過性脳梁膨大部病変を伴う無菌性髄膜脳炎を発症した1例 日本内科学会関東地方会. 2014.03; 604回 47. ( 医中誌 )

  7. 桑原宏哉,仁科一隆,横田隆徳.: 核酸医薬のドラッグデリバリーシステム(DDS). Medical Science Digest .. 2014.02; 40 (2): 19-22.

  1. 三條伸夫: 遺伝性クロイツフェルト・ヤコブ病 別冊日本臨牀 新領域別症候群シリーズ 2013 神経症候群Ⅰ(第2版). 2013.12; 26 (1): 681-686.

  2. 三條 伸夫: 【神経症候群(第2版)-その他の神経疾患を含めて-】感染性疾患 プリオン病 遺伝性プリオン病 遺伝性クロイツフェルト・ヤコブ病 日本臨床. 2013.12; 別冊 (神経症候群I): 681-686. ( 医中誌 )

  3. 浜口 毅, 坂井 健二, 篠原 もえ子, 太組 一朗, 三條 伸夫, 中村 好一, 北本 哲之, 斉藤 延人, 水澤 英洋, 山田 正仁: わが国の硬膜移植後Creutzfeldt-Jakob病の特徴 海外例との比較 臨床神経学. 2013.12; 53 (12): 1573. ( 医中誌 )

  4. 三條 伸夫: プリオン病の最新情報 プリオン病の基礎、サーベイランス、感染予防 臨床神経学. 2013.11; 53 (11): 1243-1245. ( 医中誌 )

  5. 古川 迪子, 三條 伸夫, 工藤 俊介, 中道 一生, 鈴木 忠樹, 吉岡 耕太郎, 石橋 賢士, 石原 正一郎, 石橋 哲, 大久保 卓哉, 森尾 友宏, 江石 義信, 西條 政幸, 横田 隆徳, 水澤 英洋: BKウイルス感染による後根神経節炎が疑われた原発性無ガンマグロブリン血症の30歳男性 NEUROINFECTION. 2013.09; 18 (2): 160. ( 医中誌 )

  6. 三條伸夫: 遺伝性 Creutzfeldt-Jakob 病 Clinical Neuroscience プリオン病 Up to date. 2013.09; 31 (9): 1060-1063.

  7. 三條伸夫: 変異型 Creutzfeldt Jakob 病 別冊日本臨牀 新領域別症候群シリーズ 2013 感染症症候群 上 (第2版) . 2013.09; 24 812-816.

  8. 浜口 毅, 坂井 健二, 野崎 一朗, 篠原 もえ子, 太組 一朗, 三條 伸夫, 中村 好一, 北本 哲之, 斉藤 延人, 水澤 英洋, 山田 正仁: わが国と海外の硬膜移植後Creutzfeldt-Jakob病の比較 NEUROINFECTION. 2013.09; 18 (2): 173. ( 医中誌 )

  9. 三條 伸夫: 【プリオン病-up to date】遺伝性プリオン病 遺伝性(家族性)Creutzfeldt-Jakob病 Clinical Neuroscience. 2013.09; 31 (9): 1060-1063. ( 医中誌 )

  10. 三條 伸夫, 日熊 麻耶, 北本 哲之, 佐藤 克也, 新 竜一郎, 西田 教行, 山田 正仁, 水澤 英洋: ブリオン病の最近の進歩 遺伝性プリオン病における病型と髄液所見 NEUROINFECTION. 2013.08; 18 (1): 35-40. ( 医中誌 )

  11. 三條 伸夫: 【感染症症候群(第2版)-症候群から感染性単一疾患までを含めて-[上]】プリオン病 獲得性プリオン病 変異型Creutzfeldt-Jakob病 日本臨床. 2013.07; 別冊 (感染症症候群(上)): 812-816. ( 医中誌 )

  12. Kuwahara Hiroya, Nishida Yoichiro, Yokota Takanori: Blood-brain barrier and Alzheimer's disease. Brain Nerve. 2013.02; 65 (2): 145-151. ( PubMed )

  13. Nobuo Sanjo: [Review of basic knowledge, surveillance and infectious control of prion disease]. 臨床神経学. 2013; 23 (11): 1243-1245. ( PubMed )

  14. 三條伸夫、日熊麻耶、北本哲之、佐藤克也、新竜一郎、西田教行、山田正仁、水澤英洋: 遺伝性プリオン病における病型と髄液所見 Neuroinfection「プリオン病の最新の進歩」. 2013; 18 (1): 35-40.

  1. 三條伸夫: 認知症 単なる物忘れとの違い いつか罹る病気に備える本. 2012.11;

  2. 吉岡 耕太郎: 【主訴・症状から考えられる疾患早わかりMAP付き救急看護に必要な疾患の知識 これだけBOOK】 (第2章)問診から合併症の対応まで これだけは押さえておきたい救急看護に必須の疾患別知識 (第1節)神経系疾患 一過性脳虚血発作 EMERGENCY CARE. 2012.07; (2012夏季増刊): 91-96. ( 医中誌 )

  3. 阿部 圭輔, 三條 伸夫, 三木 一徳, 横田 隆徳, 水澤 英洋: Basedow病の経過中に慢性進行性の多発脳血管狭窄をきたした29歳女性 臨床神経学. 2012.05; 52 (5): 368. ( 医中誌 )

  4. 三條伸夫、水澤英洋: 臨床講座 アルツハイマー病 Pharma Tribune . 2012.04; 40 (4): 19-29.

  5. 大久保卓哉、髙橋真、水谷真之、三條伸夫、水澤英洋: レム睡眠障害を呈するレヴィー小体型認知症の4例 東京内科医会会誌. 2012; 27 (3): 977-979.

  1. 堀匠、三條伸夫、水澤英洋: 忘れてはならない治療可能な認知症 診断と治療. 2011.03; 99 (3): 431-437.

  2. Ryo Itami, Nobuo Sanjo, Hiroya Kuwahara, Masaki Yamamoto, Ken-ichi Atarashi, Takanori Yokota, Hidehiro Mizusawa: [Rapid progressive HTLV-1-associated myelopathy with bronchoalveolar lesions and a long spinal cord lesion extending to almost the entire spinal cord]. 臨床神経学. 2011.02; 51 (2): 130-134. ( PubMed )

  3. 三條伸夫、水澤英洋: 中年期の厳格なコントロールが高齢期での発症予防に medical朝日 特集 認知症診療新時代. 2011; (8): 23-24.

  4. 三條伸夫、大久保卓哉、水澤英洋: 注意すべき認知症 東京内科医会会誌. 2011; 27 (3): 198-204.

  5. 東美和、三條伸夫、村上祥子、太田浄文、杉井直、横田隆徳、水澤英洋: 広範な脳萎縮を伴う慢性進行型神経 Behçet 病の1例 日本内科学会誌. 2011; 100 (12): 3618-3621.

  1. 六倉 和生, 佐藤 克也, 調 漸, 岸田 日帯, 黒岩 義之, 三條 伸夫, 水澤 英洋: CJDにおける血清バイオマーカーを用いた血液脳関門(BBB)についての検討 臨床神経学. 2010.12; 50 (12): 1182. ( 医中誌 )

  2. 三條伸夫: 特集:アルツハイマー病 社会資源とその活用 Clinical Neuroscience. 2010.10; 28 (9): 1054-1056.

  3. 三條伸夫、水澤英洋: 神経診察法の基本とピットフォール Clinical Neuroscience. 2010.10; 28 (10): 1092-1093.

  4. 三條伸夫、志賀裕正、佐藤克也、山田正仁、水澤英洋: 知っておきたい認知症の臨床と画像 疾患各論 13) プリオン病 臨床放射線 臨時増刊号. 2010.10; 55 (11): 223-239.

  5. 三條 伸夫, 志賀 裕正, 佐藤 克也, 山田 正仁, 水澤 英洋: 【知っておきたい認知症の臨床と画像】疾患各論 プリオン病 臨床放射線. 2010.10; 55 (11): 1523-1539. ( 医中誌 )

  6. 堀 匠, 三條 伸夫, 渡邊 睦房, 歌代 浩美, 水澤 英洋: MCI症例における日本語版WMS-RのLogical Memory IIの有用性 Dementia Japan. 2010.09; 24 (3): 341. ( 医中誌 )

  7. 三條伸夫、水澤英洋: プリオン病-本邦の特徴と診断のポイント- 臨床神経学. 2010.05; 50 (5): 287-300. ( PubMed )

  8. 吉岡 耕太郎, 水澤 英洋: 【神経内科の病気のすべて】 運動ニューロン疾患・神経系感染症 プリオン病の分類と治療 からだの科学. 2010.05; (265): 134-136. ( 医中誌 )

  9. 三條伸夫: βアミロイドの産生・分解機序とその制御 別冊「医学のあゆみ」アミロイドーシス UPDATE 脳アミロイドーシス. 2010.04; 229 (5): 399-404.

  10. 三條伸夫,佐々木真理,水澤英洋,プリオン病画像小委員会: 脳外科手術による CJD リスク保因可能性者事例の経過と注意すべきプリオン病画像診断のポイント CI 研究 2010. 2010; 31 (4): 233-239.

  11. 三條伸夫: γセクレターゼ阻害薬 Progress in Medicine. 2010; 30 (8): 2137-2143.

  12. 伊丹亮、三條伸夫、桑原宏哉、山本雅樹、新謙一、横田隆徳、水澤英洋: ほぼ全長にわたる脊髄病変と肺病変を伴った急速進行性 HTLV-1-associated myelopathy (HAM) の1例 臨床神経学. 2010; 51 130-134.

  1. 堀 匠, 三條 伸夫, 白石 淳, 横田 隆徳, 水澤 英洋: t-PA療法における施設内規の設定とその有用性についての検討 臨床神経学. 2009.12; 49 (12): 1050. ( 医中誌 )

  2. 金 海峰, 三條 伸夫, 渡辺 睦房, 水澤 英洋, 内原 俊記: Sarco ER Ca2+-ATPaseとの結合を介した全長型Presenilin1の細胞保護作用 臨床神経学. 2009.12; 49 (12): 1010. ( 医中誌 )

  3. 六倉 和生, 佐藤 克也, 江口 勝美, 調 漸, 長郷 国彦, 岸田 日帯, 黒岩 義之, 三條 伸夫, 水澤 英洋: クロイツフェルト・ヤコブ病(CJD)における血清学的マーカーについての検討 臨床神経学. 2009.12; 49 (12): 995. ( 医中誌 )

  4. 吉岡 耕太郎, 石井 昭広, 山田 正俊: 化学療法後に胃横隔膜病変部の穿孔をきたし膿胸を合併し死亡に至った悪性リンパ腫の1例 旭中央病院医報. 2009.10; 31 135-140. ( 医中誌 )

  5. Miho Akaza, Taiji Tsunemi, Nobuo Sanjo, Hiroaki Wakimoto, Daisuke Kobayashi, Hidehiro Mizusawa: [Malignant lymphoma presented as left trigeminal neuralgia]. 臨床神経学. 2009.07; 49 (7): 432-436. ( PubMed )

  6. 三條 伸夫: 【アミロイドーシスUPDATE】脳アミロイドーシス βアミロイドの産生・分解機序とその制御 医学のあゆみ. 2009.05; 229 (5): 399-404. ( 医中誌 )

  7. 三條伸夫、水澤英洋: 話題の論文:プレセニリンは SERCA ポンプ活性の調節因子であり、SERCA ポンプ活性はγセクレターゼ調節作用を有する。 Cognition and Dementia . 2009.01; 8 (1): 50-51.

  8. 赤座実穂、常深泰司、三條伸夫、脇本浩明、小林大輔、水澤英洋: 左三叉神経障害障害にて発症したと思われる悪性リンパ腫の1例 臨床神経学. 2009; 49 432-436.

  1. 橋本 祐二, 渡邊 睦房, 三條 伸夫, 石川 欽也, 横田 隆徳, 加藤 剛, 四宮 謙一, 水澤 英洋: ALSと頸椎症性脊髄症における血清CKの比較・検討 臨床神経学. 2008.12; 48 (12): 1201. ( 医中誌 )

  2. 野崎 一朗, 浜口 毅, 篠原 もえ子, 北本 哲之, 佐藤 猛, 水澤 英洋, 中村 好一, 森若 文雄, 志賀 裕正, 三條 伸夫, 黒岩 義之, 西澤 正豊, 武田 雅俊, 葛原 茂樹, 黒田 重利, 村井 弘之, 村山 繁雄, 立石 潤, 山田 正仁: わが国におけるプリオン病の発症状況 臨床神経学. 2008.12; 48 (12): 1046. ( 医中誌 )

  3. 堀匠、三條伸夫、水澤英洋: プリオン病 アレルギー・免疫. 2008.11; 15 (11): 72-82.

  4. 町田明、三條伸夫、水澤英洋: プリオン病と鑑別すべき疾患の画像 神経内科. 2008.10; 69 (4): 329-335.

  5. 堀 匠, 三條 伸夫, 水澤 英洋: 【国際的な感染症 ウイルス感染を中心として】プリオン病 アレルギー・免疫. 2008.10; 15 (11): 1536-1546. ( 医中誌 )

  6. 三條伸夫: 素顔のニューロサイエンティスト Peter St. George-Hyslop. Clinical Neuroscience . 2008.07; 26 (07): 812.

  7. 桑原宏哉,野口悦正,稲葉彰,水澤英洋: ビタミンB6欠乏により遅発性に持続性部分てんかんを呈したテオフィリン関連痙攣の81歳女性例 臨床神経学. 2008.02; 48 (2): 125-129. ( PubMed )

  1. 三條伸夫: 感染性CJD(クールー、医原性CJD、変異型CJD) 日本臨床. 2007.08; 65 (8): 1438-1445. ( PubMed )

  2. 三條伸夫、水澤英洋: わが国のプリオン病サーベイランスの現況 医学のあゆみ. 2007.02; 220 (6): 536-628.

  1. 三條 伸夫, 水澤 英洋: 【プリオン】プリオン病の早期臨床診断 そのポイントとピットフォール Brain Medical. 2006.12; 18 (4): 359-364. ( 医中誌 )

  2. 桑原 宏哉, 赤座 実穂, 融 衆太, 三條 伸夫, 横田 隆徳, 水澤 英洋: 8ヵ月の経過で完全寛解したposterior reversible encephalopathy syndrome(PRES)の75歳男性例 神経治療学. 2006.05; 23 (3): 261. ( 医中誌 )

  3. 三條伸夫、水澤英洋: プリオン病の早期臨床診断-そのポイントとピットフォール- Brain Medical . 2006; 18 (12): 57-62.

  1. 三條 伸夫, 水澤 英洋: 【精神神経疾患とゲノム 最近の動向】アルツハイマー病の遺伝子 ゲノム医学. 2005.06; 5 (3): 247-252. ( 医中誌 )

  2. 三條伸夫、水澤英洋: アルツハイマー病の遺伝子 ゲノム医学. 2005; 5 (3): 27-32.

  1. 松本 卓, 三條 伸夫, 市川 忠: SCDの嚥下評価とリクライニング法の検討 臨床神経学. 2000.12; 40 (12): 1464. ( 医中誌 )

  2. 大和田 潔, 水澤 英洋, 三條 伸夫, 道川 誠, 望月 秀樹: PC12細胞の神経栄養因子によるNFκBの活性化とカスパーゼ活性化 臨床神経学. 2000.12; 40 (12): 1341. ( 医中誌 )

  3. 三條伸夫: 神経内科領域での三次元CTの撮影・処理方法 神経内科. 2000.09; 53 (3): 241-249.

  4. 三條伸夫、上原晋、井浦泰夫、松本卓、市川忠: MRI上椎骨・脳底動脈領域血管に異常を有する脳血管障害患者における未破裂動脈瘤保有率の検討 リハビリテーション医学. 2000; 37 (3): 165-170.

  1. 三條伸夫: Nuclear factor κB (NFκB). 脳の科学. 1999.01; 21 10-11.

  1. 三條伸夫、水澤英洋: パーキンソン病の遺伝子治療 脳の科学. 1998.10; 20 (10): 221-225.

  2. 三條伸夫: ピリミジン化合物 MS-818 の神経栄養因子作用-マウス大脳皮質ニューロンとマウス胚性腫瘍細胞形を用いて- お茶の水医学雑誌. 1998; 46 (1): 49-58.

  3. 三條 伸夫: ピリミジン化合物MS-818の神経栄養因子様作用 –マウス大脳皮質ニューロンとマウス胚性腫瘍細胞系を用いて-. お茶の水医学雑誌. 1998; 46 (1): 49-58.

  4. 三條伸夫、水澤英洋: Alzheimer 病に対する monoamine oxidase (MAO) 阻害薬および vitamin E の効果 内科. 1998; 81 158-159.

  1. M Yamawaki, J Shiraishi, N Sanjo, M Michikawa, Y Wada: [An adult case of bacterial meningitis caused by penicillin-resistant Streptococcus pneumoniae]. 臨床神経学. 1995.09; 35 (9): 1044-1047. ( PubMed )

  2. 山脇正永、白石淳、三條伸夫、道川誠、和田義晴: Penicillin 耐性肺炎球菌による細菌性髄膜炎の1成人例 臨床神経学. 1995; 35 1044-1047.

  1. N Sanjo, T Komiya, M Tamaki, M Arai, S Fukaya: [A case of adenoid cystic carcinoma manifesting Garcin's syndrome--effectiveness of cerebrospinal fluid ferritin as a tumor marker in malignant CNS involvement]. 臨床神経学. 1994.08; 34 (8): 838-841. ( PubMed )

  2. 三條伸夫、新井雅信、玉城允之、田中昌代: Amantadine hydrochloride による薬剤性肝障害 神経治療学. 1994; 11 (3): 289-291.

  3. 三條伸夫、小宮正、玉城允之、新井雅信、深谷卓: Garcin症候群を呈した顎下腺腺様嚢胞癌の1例-髄液中フェリチンの腫瘍マーカーとしての有用性- 臨床神経学. 1994; 34 838-841.

  1. Zeniya S, Kuwahara H, Daizo K, Watari A, Kondoh M, Yoshida-Tanaka K, Kaburagi H, Asada K, Nagata T, Nagahama M, Yagi K, Yokota T: Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system. Journal of controlled release : official journal of the Controlled Release Society. 2018.05; 283 126-134. ( PubMed , DOI )

  1. Yoshioka K, Kuwahara H, Nishina K, Nagata T, Yokota T: [Recent progress and prospect in oligonucleotide therapeutics]. Nihon rinsho. Japanese journal of clinical medicine. 2015.06; 73 (6): 1057-1065. ( PubMed )

このページの先頭へ▲